Global Advisory Panel on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies

Tools

GAP Annual Report 2015
GAP ANNUALREPORT 2015Good Governance, safe bloodCONTENTSOVERVIEWOverview1GAPs purposeVision and missionMessage from the President2015 Performance HighlightsGovernance4MembershipExecutive BoardZonal CoordinatorsGAP ElectionsIFRCThe Global Advisory Panel onCorporate Governanceand Risk Management of Blood Services in Red Crossand Red Crescent Societies (GAP) is a global networkof Red Cross and Red Crescent Blood Services withspecific expertise in risk management and corporategovernance of blood programmes.8Memorandum of UnderstandingWorld Blood Donor DayEveryone Counts ReportIFRC Reference CentreGAP is an independent Association, registered underSwiss Law and affiliated with the International Federationof Red Cross and Red Crescent Societies (IFRC).The networks purpose is to:Activities10Global MappingSelf-assessmentPriority Country SupportDisaster Response Nepal EarthquakeFinanceIncome & Expenditure Report 2015Audit Report25 Provide technical advice in termsof corporate governance and riskmanagement to National Society BloodServices; Coordinated assistance to NationalSociety Blood Services in post-emergency situations including blood programrecovery; Promote knowledge sharing, networkingand partnership among andbetween National Society BloodServices and external partners; Influence global blood policyin conjunction with its partners; Develop and provide tools, guidelinesand priority country assistance toNational Society Blood Servicesmost in need; Provide advocacy and support to theIFRC and National Society Blood Serviceson issues affecting blood programmes.OUR VISIONOUR MISSIONAll Red Cross/Red Crescent blood programmes will be safe, well governed andself-sustainable, based on the principleof voluntary non remunerated blooddonation for the benefit of patients andto safeguard blood donors.GAP will support Red Cross/Red Crescent blood services in risk managementand corporate governance of blood programmes and promote good practicesand knowledge exchange.OVERVIEW| 1MESSAGE FROMTHE PRESIDENTProfessor Philippe Vandekerckhove, MD, PhDGAP President2015 has seen GAP continue to deliver itscore programme of work, which centres uponproviding assistance to Red Cross and RedCrescent National Societies to identify anypotential risks associated with their involvementin a blood programme and providing specialistsupport to help address any risk areas.Since GAPs early beginnings back in 2000,the risk identification programme has beenbased on the use of a self-assessment toolspecifically designed to highlight key areas ofrisk. The analysis by GAP of the informationprovided through the assessment, the development of advice and strategies to addressthese risks and challenges, and the provisionof advocacy for voluntary non remuneratedblood donation, remains the fundamental basis of GAPs support for National Societies.In recent years however, GAPs role hasfurther evolved and adapted to the changing needs of National Society blood programmes and their areas of activity, as wellas adapting to the needs of IFRC to supportthe implementation of the blood policy. GAPhas increased the visibility of its support service capability and expertise among NationalSocieties, through its recognised role as anIFRC reference centre. Simultaneously, GAPhas had an increased level of involvementin the field, directly supporting a numberof priority country Blood Services throughdedicated assistance programs and particularly, in the last 12 months, in the provisionof post-disaster recovery assistance andcoordination.In terms of disaster response, the existenceof a quality blood service is critical to meetthe high healthcare demand for blood duringthe initial emergency phase. While the availability of blood may be a concern in the event2| GAP ANNUAL REPORT 2015of a disaster, ensuring the safety of the bloodsupply is also of paramount concern. Therecent experience of the devastating earthquake in Nepal demonstrated the active rolethat GAP has in this arena, assisting the National Society to restore a functional and safeblood supply as soon as possible followingthe disaster and importantly in coordinatingthe long-term rebuilding and recovery of theblood programme once the initial urgencyhad passed, in conjunction with the supportof Partner National Societies.Healthcare systems world-wide require reliable access to a safe and sustainable bloodsupply, which is based on the principle of voluntary non-remunerated blood donation. Weat GAP hope to continue our path of workingtogether with Red Cross and Red CrescentNational Societies to assist them in ensuringthe availability of a safe supply of blood andblood products, and in doing so, to maximally assist those most vulnerable populationsaround the globe.OUR 2015PERFORMANCEHIGHLIGHTSGLOBAL NETWORKSCOMPLIANCESAFETY & GOVERNANCE33 Completionof GAP website33 Self-assessmentdistributed to 10 IndianRed Cross Society bloodcentres33 Priority country support to the BangladeshRed Crescent Blood Service, expertise providedby Dr Wolfgang Mayr.33 GAP recognised as anIFRC reference centre33 Participation in 2015World Blood Donor Day(Shanghai, China)33 Revision of Self-assessment questionnaire toaddress new and emerging risks33 Priority country support to the Honduran Red CrossBlood Service, expertise provided by Dr Rudolf Schwabe.33 Training programme for the Director of the Nepal RedCross Blood Service provided by GAP member, AustralianRed Cross Blood Service33 Library of resources available on the GAP websiteRELATIONSHIPSMEMBERSHIPSIFRC33 Coordination of theNepal post-earthquakerecovery for the bloodprogramme, with NRCS,IFRC and PartnerNational Societies33 New member in 2015 Indian Red Cross33 Participation of GAP in 2015 World Blood Donor Day33 Promotion of VNRBD through priority countryactivities in Bangladesh and Nepal.33 Funding of VNRBD online recruitment trainingmodule for the Honduran Red Cross Blood Service.Professor Philippe Vandekerckhove,MD, PhDGAP PresidentOVERVIEW|3GAP ASSOCIATIONGOVERNANCEMEMBERSHIPCHANGES IN 2015The Global Advisory Panel structure consists of GAP Membersand their representatives, Zonal Coordinators, GAP Executive Board,the Secretariat and IFRC representatives (permanent observeron the GAP Executive Board and Senior VNRBD Officer).GAP member representativeswho retired during the year:GAP MEMBERSHIPCollectively, GAP members provide advice on corporategovernance and risk management of blood servicesand at an individual level, GAP members contribute theirexpertise and knowledge to support a range of GAP programs designed to assist priority country blood services.A General Meeting of all GAP members is held annually.GAP Membership is open to National Society Blood Services which meet the criteria for membership,including theeffective operation of a full Level A blood service. Memberspay an annual membership fee and are represented byeither their Chief Executive, head of their National SocietyBlood Service or a nominated representative.American Red CrossBiomedical ServicesThailand NationalBlood CentreHong Kong Red CrossBlood Transfusion ServiceRichard BenjaminDr Soisaang PhikulsodDr Che Kit LinAmericas Zone CoordinatorWelcome to new memberrepresentatives in 2015:GERMANYDr Erhard SeifriedGerman Red CrossBlood Transfusion CentreFINLANDDr Martti SyrjlDr Satu PastilaFinnish Red CrossBlood ServiceDr Wolfgang MayrAustrian Red CrossBlood ServiceDr Satu PastilaTHAILANDINDIADr Ubonwon CharoonruangritDr Soisaang PhikulsodThai Red Cross NationalBlood CentreDr Veer BhushanIndian RedCross SocietyNew GAP member in 2015SWITZERLANDDr Rudolf SchwabeTransfusion SwissRed CrossDr Gabriel PictetDr Julie HallIFRC PermanentObserver on GAP| GAP ANNUAL REPORT 2015Dr Cheuk Kwong LeeHONG KONGGENEVA4Dr UbonwonCharoonruangritDr Cheuk Kwong LeeDr Che Kit LinHong Kong Red CrossBlood Transfusion ServiceMr Chris HroudaDr Richard BenjaminAmerican Red CrossBiomedical ServicesDr Elizabeth VinelliHonduran Red CrossNational Blood CentreFinnish Red CrossBlood ServiceDr Kenji TadokoroJapanese Red CrossBlood ServiceAUSTRIAHONDURASHong Kong Red CrossBlood Transfusion ServiceJAPANBELGIUMProf PhilippeVandekerckhoveBelgian Red CrossBlood ServiceAMERICAThailand NationalBlood CentreISRAELProf Eilat ShinarMagen DavidAdom - IsraelPERTHGAP SecretariatAustralian RedCross Blood ServiceAUSTRALIAMs Jennifer WilliamsAustralian RedCross Blood ServiceIndian Red Cross Society is GAPsnewest member country. India joinedGAP in December and member representation is being provided by Dr VeerBhushan, Joint Secretary of the IndianRed Cross Society.GOVERNANCE|5GAP ZONALCOORDINATORS IN 2015GAP EXECUTIVEBOARDThe GAP Executive Board members play avital role in governance and decision makingfor the organisations activities. Board members are generally appointed for a three-yearterm, but may be eligible for reappointment.In addition to the generic skills that arerequired formost boards, our Boards skillsinclude knowledge and expertise in transfu-sion medicine and National Societyblood programmes. An IFRC permanentobserver holds a position on the GAP Executive Board to ensure the flow of informationand coordination with the IFRC. The Executive Board convenes regularly to review,approve and action GAP-related activitiesand objectives.The role of the GAP Zonal Coordinatorsis to liaise closely with their local IFRCzone office and look for opportunitiesto collaborate on activities in the criticalarea of corporate governance and riskmanagement for National Societiesinvolved in blood programmes.AMERICASDr Richard Benjamin (USA)and Dr Elizabeth Vinelli (Honduras)ASIA & PACIFICProf Philippe VandekerckhovePresidentChief Executive OfficerBelgian Red CrossBlood Service FlandersDr Wolfgang MayrVice PresidentMedical CouncillorAustrian Red CrossBlood ServiceMs Jennifer WilliamsBoard memberChief Executive OfficerAustralian Red CrossBlood ServiceDr Che Kit Lin (Hong Kong)and Dr Kenji Tadokoro (Japan)EUROPE & CENTRAL ASIADr Wolfgang Mayr (Austria)MENAVacant in 2015AFRICAVacant in 2015GAP ELECTIONSDr Rudolf SchwabePermanent Board memberChief Executive OfficerTransfusion SwissRed Cross6| GAP ANNUAL REPORT 2015Dr Julie HallIFRC Permanent ObserverIn 2015, GAP held an election for all Executive Board and Zonal Coordinator positionswhich came to the end of their 3 year termsin December 2015. The result of this wasthat all members were re-elected to thesame positions commencing from1st January 2016.Prof Eilat Shinar (MDA Israel) was newlyelected to the previously vacant positionof Zone Coordinator for the Middle Eastand Northern Africa region.GOVERNANCE|739GAPs role and purpose is described in theIFRCs blood policy Promoting Safe andSustainable Blood Systems which outlinesthe specific responsibilities of the IFRC,GAP, National Societies and blood servicesin managing blood programme risk.The IFRC was instrumental in the creationof GAP and participates as a permanentobserver to ensure the flow of informationand coordination with the IFRC. Regularcommunication and constructive ties between GAP and the IFRC Secretariat ensurethe coordination of work programs andsupport links, particularly with respect toVNRBD. The IFRC has a permanent standinginvitation to attend the GAP Annual GeneralMeetings and the Executive Board meetings.Dr Gabriel Pictet (Acting Head of Health,IFRC) was the IFRC observer on GAPuntil September 2015, at which timeDr Julie Hall was appointed to thisposition (IFRC Head of Health)Memorandum of UnderstandingIFRC provided GAP with a grant in 2015to strengthen GAPs ability to act accordingto the IFRC Blood Policy Promoting Safeand Sustainable National Blood Systems.This grant was supported by a Memorandumof Understanding, agreed to by both parties.The funding was provided to supportthe following GAP activities:1. Extension of the GAP Self-assessmentprocess into an additional region in 2015The Self-assessment process wascompleted in the Middle East &Northern Africa (MENA) region andcommenced as an expanded activityin India in 2015.2. Conduct Major Material Risk(MMR) follow-up and investigation:In 2015, GAP conducted a visitto India as a follow up to theSelf-assessment process.3. Support for GAP priority countries:GAP provided support, includingin-country visits, to priority countriesBangladesh and Nepal.This was a joint initiative by the World HealthOrganisation (WHO), the International Societyof Blood Transfusion (ISBT), the InternationalFederation of Blood Donor Organisations(FIODS) and the Shanghai Blood Bank.8| GAP ANNUAL REPORT 2015Societies over the year which is measuredAlongsidetheproxyWorld HealthOrganisation, we stronglythrough the sevenkeyindicatorsbelieve in a policy of 100 per cent voluntary non-remufrom the IFRCneratedStrategicPlan.becauseOne ofblood donation,thattheseis safest.At present,only number60 countries havefully achievedthis norm. Givenindicators is theof peopledonatingworldwide shortages of blood and its components, there isblood. Each NationalSocietyprovidesthea long way to go to achieve global blood security. Culturalattitudesan undoubtedin some places.IFRC with theirown aredatafor thisconstraintindicatorand GAP providedadditionalinformationOf the 108 million blood donations collected globally,from its own globalmappingactivities.about 21 millionor a fifthare associated with Red Crossand Red Crescentblood services.GAP also contributeda narrativetoMalesthe tend to dominateas donors, and the Asia Pacific and Europe regions makepublication whichhighlightedtrendsthe most donations (Figure 5.11).of National Society involvement in blood,Operating a full-scale blood programme is a complex andas well as a humaninterest case study fromhighly technical affair, with managing risk and mainandBloodquality beingthe core concerns. Morethe AustraliantainingRedsafetyCrossService.than 80 per cent of National Societies are involved inblood-related activities. A partial survey indicates thatthis is at three levels, ranging from promotion and advocacy for voluntary unremunerated blood donation, tothe systematic recruitment of blood donors, and finally,the provision of full blood services including collecting,testing, processing, and distribution (Figure 5.12).IFRC ReferenceCentreGAP is recognised as an InternationalFederation of Red Cross and Red CrescentSocieties (IFRC) Reference Centre due to thespecialist support function that GAP providesto Red Cross and Red Crescent NationalSocieties with regard to their involvementin the provision of a blood programme. TheReference Centres are delegated functionsof the IFRC and are hosted by Red Cross/RedCrescent National Societies around the world.Each centre has a specific focus and supports knowledge exchange essential for National Society operations including training,technical assistance, advocacy, knowledgemanagement and research. Their primaryfunction as centres of excellence are to develop strategically important knowledge andbest practice that will inform the future operations of the IFRC and National Societies intheir key areas of interest and influence .2015 World Blood Donor DayIn June 2015, a GAP representative attendedthe World Blood Donor Day celebration whichalso included a round-table discussion onthe promotion of voluntary non-remuneratedblood donation (VNRBD) in Shanghai, China.To serve others by donating your spare money, time, orskills is commendable. To give of your own self is trulynoble. It is, therefore, unsurprising that the Red Crossand Red Crescent has been associated with blood servicesIn 2015, GAP evercontributedto the IFRCsince the technology became available. Safe andaccessibleblood suppliesare crucialto save or preservepublication, theEveryoneCountsreport.life in medical care and in the aftermath of accidents,This report highlightstheworkofNationalviolence, and disasters.The objective of the round table discussionwas to address the challenges of promotingVNRBD, ways to overcome barriers and toshare new initiatives for VNRBD promotion.GAP provided a presentation which includedinformation on the history and role of GAPand current activities, including the promotion of VNRBD and global mapping.In 2015, GAP was included in the IFRCReference Centres brochures publication,which provides information on the individualreference centres and the support that theyprovide. The article on GAP highlighted thepurpose and key services of the organisationas well as contact information. The IFRCReference Centres brochure was distributeddirectly to all 190 National Societies globallyand is available on both the IFRCand GAPwebsites.Figure 5.11Figure 5.12Number of blood donors(2013 data from 178 National Societies22)JPAsia PacificEuropeAmericasMiddle East andNorth AfricaAfricaDE10,036,243KR6,343,594TRTypes of National Society involvement in blood services(20132014 data from 74 National Societies)7454+ 40+ 36+OUR LINKS WITH IFRC5.5 Promoting safeEveryoneblood systemsCounts Report37%US3,753,442Full blood serviceincluding collection477,38027%139,490Recruitment ofblood donorsTop five National Societies:1. Japanese Red Cross Society2. American Red Cross3. The Republic of Korea National Red Cross4. German Red Cross5. Turkish Red Crescent Society20%Global gender breakdown of the number of blood donors65.8%658+342=MaleFemale34.2%16%Promotion andadvocacy for voluntarynon-remuneratedblood donorsNo involvementSource: FDRS22 Number of National Societies reporting on blood donors in Asia Pacific:32, Europe:51,Americas:35, Middle East and North Africa:16, Africa:44.Number of National Societies reporting on gender breakdown of blood donors:121.18Source: Global Advisory Panel on Corporate Governance and Risk Management of BloodServices in Red Cross and Red Crescent SocietiesReD CRoss ReD CResCent RefeRenCe CentResGlobAl AdVisorypAnel (GAp)on CorporAteGoVernAnCe AndrisK MAnAGeMentoF blood serViCesin red Cross Andred CresCentsoCietiesInternational Federation of Red Cross and Red Crescent SocietiesKey services (e.g. Knowledgemanagement,Everyone Counts| Progress 2015research, technical assistance, advocacy, networking)1 Provide technical advice in terms ofcorporate governance and risk managementto National Society blood programmes2 Promote knowledge sharing, networking,and partnership among and betweenRed Cross and Red Crescent blood servicesand external partners3 Develop tools and guidelines as appropriatewithin the area of National Society bloodprogramme delivery4 Coordination of Red Cross/Red Crescentassistance to National Society blood servicesin post-emergency situationsHigHligHtsPurpose of CentreThe purpose of GAP is to provide advice to NationalSocieties and their affiliated blood services, IFRCand other related bodies in matters related to bloodservice corporate governance and risk management.GAP has developed a Self-assessment tool toassist National Society blood services to ensurethe long term stability and sustainability of theirblood service without exposure to any unnecessary risk. The Self-assessment is located at:www.globaladvisorypanel.org. On completion ofthe Self-assessment, GAP provides each bloodservice with a detailed feedback report, includinganalysis of the results, identification of areas ofconcern, and providing recommendations on riskmanagement strategies to address the identifiedrisks. GAP holds regional meetings for participantblood services to compare their performanceagainst regional benchmarks and best practices.The results of the Self-assessment are outlined,regional issues are highlighted, and specific toolsand information are provided to assist bloodservices to manage their key risks. Partneringopportunities for blood services with strongerregional counterparts are also identified.Contact information: gapsecretariat@redcrossblood.org.au: www.globaladvisorypanel.org: https://fednet.ifrc.org/en/resources/health-and-care/blood/materials-and-tools/IFRC| 9GLOBAL MAPPINGIn 2015, GAP commenced a global mapping exercise to determine the level of involvement of Red Cross and Red Crescent National Societies in the provision of their national bloodprogramme. National Societies may be involved in a bloodprogramme at 3 levels - Level A (full blood service provision),B (blood donor recruitment), C (advocacy for VNRBD) or theymay have no involvement.Understanding the scale of National Society involvementin a blood programme at the global level is important asa potential risk indicator and may impact on the likelihoodof the existence of a Major Material Risk.Accurate information on all National Society Blood Services is criticalfor GAP and the IFRC to plan for future support activities and to conductSelf-assessment processes at a regional or global level.Level of involvement in Blood Program ActivityA. Full Blood Service ProvisionGovernance Advocacy for appropriate use Product distribution Component preparation Collection services/donor careDonor recruitment Promotional campaigns Education and awareness Involvement in WBDD2015 RESULTSOf the 190 surveys distributed, 57 (30%) of the190 National Societies submitted acompletedquestionnaire in the latter half of 2015.Number of responses received per zone in 2015NO.RECEIVEDNATIONALSOCIETIESIN REGIONRESPONSERATE IN 2015Africa3486%Americas143540%REGIONAsia Pacific73619%Europe & Central Asia265349%MENA71839%TOTAL5719030%Nil11B. Systematic Blood Donor RecruitmentDonor recruitment Promotional campaigns Education and awareness Involvement in WBDDC. Advocacy for VNRBDPromotional campaigns Education and awareness Involvement in WBDDThe questionnaire was developed in conjunction withthe IFRC and contained questions specifically tailoredfor particular National Societies depending on their regionand level of involvement. All National Societies were asked to provide informationon the mode of coordination of activities, funding mechanisms, donor recruitment programs (if in place) andany potential plans to expand or scale back activities. For those National Societies operating a Level Ablood service, questions were included for GAPto gain a comprehensive understanding of thescope of activity including:Number of blood collectionsInvolvement in any fractionation,transfusion or cell/tissue therapiesAccreditation The National Societies in Sierra Leone, Guineaand Liberia were asked supplementary questionsrelating to the Ebola recovery effort The survey was availablein English, French and Arabic10| GAP ANNUAL REPORT 2015The GAP global mapping questionnaire was distributedto National Societies in all IFRC regions (Africa, the Americas, Latin America & the Caribbean, Asia Pacific, Europe& Central Asia and Middle East & Northern Africa) in thesecond half of 2015.Global mapping results from all regionsin 2015 (total 57 National Societies)833 National context (size, population, economy,health system etc.)12213563125533 National Society Blood Programme (history, funding,statistics, accreditation, partnerships etc.)33 Regional and global summaries and visual mapping21Europe& Central Asia233 Any current changes in a National Society levelof activity in a blood programme or intentionsto expand/scale back the level of activityLevel BMiddle East& Northern AfricaThis report will include information on:33 National blood programme (providers, regulation,trends, VNRBD rate etc.)17Level CGlobal mapping results per region in 2015Once data collection is complete in late 2016, GAP willprepare a comprehensive report on all 190 NationalSocieties which will include the results of the global mappingquestionnaire, analysis and country narratives for each(obtained from both primary and secondary data sources).Level AAmericas21124Asia PacificAfricaACTIVITIES| 11SELF-ASSESSMENTOne of GAPs major ongoing projects isthe distribution and evaluation of theSelf-assessment survey for each NationalSociety Blood Service. The Self-assessmentquestionnaire assists National Societiesto ensure that appropriate steps are beingtaken to support the long term stability andsustainability of their blood service withoutexposure to unnecessary risk. NationalSociety Blood Services can measure theirprogress against a number of selectedcriteria identified as fundamental aspects ofcorporate governance and risk management.The Self-Assessment process providesindividual feedback to the blood service onrisk and governance issues including recommended strategies and suggested next stepsfor reducing exposure to current risks.GAP also provides de-identified regional reports to enable comparison of performanceand identification of common themes orchallenges within the region which are further discussed with National Society BloodServices at GAP regional meetings.SELF-ASSESSMENT FOCUSINDIAQUESTIONNAIRE REVIEWDuring 2015, the Self-assessment questionnaire was reviewed by GAP members at theAnnual General Meeting. A number of modifications were made including the additionof supplemental questions, refinements towording to improve clarity and improvementto the method of scoring the questionswhich are used to derive the overallpercentage score of the blood service.These opportunities for the improvementof the Self-assessment questionnaire wereidentified through: Feedback from GAP members andNational Society Blood Services undertaking the process in 2014/2015 GAP/IFRC discussions on Major MaterialRisk in developing countries due to lackof financial resources GAP priority country visits and third partyinformation which has identified newNational Society Blood Service risks.Above: Ms Tonks visitingthe Indian Red Cross SocietyNew Delhi National HQblood bank with DirectorDr Vanshree SinghBelow: GAP delegateswith Dr Agarwal (ICRSSecretary General)In 2013, GAP received a completed Self-assessment survey from the Indian RedCross Society (IRCS) New Delhi NationalHQ Blood Centre as part of the distributionof the Self-assessment (SA) to all Level ANational Society Blood Services in the AsiaPacific region. Following the return of the SAIndividual Feedback Report to the IRCS NewDelhi Blood Centre and during the follow-upby GAP to the responses provided in the survey, GAP became aware that there are 166independently operating IRCS blood banks inIndia across the 36 states and Union Territories. It was acknowledged therefore that theSelf-assessment responses provided by theIRCS New Delhi National HQ in 2013 represented the situation for one centre only andwas not indicative of the activities in otherRed Cross blood centres in India.As it was not feasible for GAP to distributethe SA to all 166 centres, an expanded GAPSelf-assessment process was undertakenin 2015 with the assistance of Dr VanshreeSingh (Blood Bank Director, India Red CrossSociety, New Delhi National HQ). GAP distributed the SA questionnaire to a subset of thelargest Red Cross blood centres in India.9 responses were received from:Ahmedabad (Gujarat);Voluntary Blood Bank and Blood Component Centre, Dist Panchmahal (Gujarat);Karnataka Red Cross Blood Bank;Tamil Nadu Branch;Blood Bank & Component SeparationUnit (Dadra & Nagar Haveli UT);Bombay City Branch Blood Centre(Maharashtra);Dr. Balchandra Blood Bank,Latur (Maharashtra);Blood Bank Service CentreThanjavur State Branch;Patna (Bihar).The updated version of the Self-assessmentquestionnaire will be distributed in 2016.ACTIVITIES| 13SELF-ASSESSMENT FOCUSINDIA cont.PRIORITYCOUNTRY SUPPORTAs resources permit, GAP provides targetedassistance to a small number of identifiedpriority country National Society Blood Services (NSBS). These NSBS are assessed byGAP as requiring specific support in corporate governance and risk management ofblood programmes following the completionof the Self-assessment questionnaireThis assistance may include:in-country support visitsprovision of GAP tools,resources and GAP expertiseidentifying partnering opportunities withother Blood Servicesco-ordination of technical assistancefrom GAP members or partnersIn 2015, GAPs priority countrieswere Nepal, Bangladesh, Honduras,Indonesia and Haiti.Above: Ms House discussingthe Self-assessmentresults with DirectorDrVanshreeSinghThe completed SA questionnaires werereceived from these IRCS blood centresbetween January and March 2015. The responses were analysed and individual bloodcentre Self-assessment feedback reportswere distributed to each centre with the assistance of Dr Vanshree Singh in May 2015.The reports provided a detailed analysisof the responses for each question anda summary of strengths and challengesfor the blood centre.In-country visitA GAP delegation (Ms Emily Tonks and MsOlivia House) visited India from 10th17thSeptember to validate the data provided inthe survey results from these IRCS centres.During the visit, the delegation met with keyrepresentatives of major stakeholders in thenational blood program. These included theIndian Red Cross Society (IRCS) at national,state and district level, the IRCS Blood BankNational Headquarters in New Delhi andtwo state IRCS blood centres, IFRC SouthAsia Regional Delegation office and NACO(National AIDS Control Organisation, IndianMinistry of Family Health & Welfare).Through these meetings, and together withinformation provided by the Indian Red Crosscentres in the GAP Self-assessment, GAPwas able to assess the blood service, itsoperational context, and identify a numberof areas of success and also some areasof remaining challenge.14| GAP ANNUAL REPORT 2015The GAP delegation visited 3 IRCS bloodcentres who had completed the SA questionnaire New Delhi National HQ, Ahmedabadand Godhra (Gujarat). The Self-assessmentresults were discussed with the blood centredirectors and representatives of the NationalSociety and a summary of the strengths andchallenges were highlighted. The delegationalso reviewed the blood centre facilities andoperations. The management and staffof the IRCS blood centres visited were highlyengaged and eager to identify any areasin which they could improve their servicesand standards.A Self-assessment sub-regional meetingwill be held in India in 2016 following thedistribution of the questionnaire to a secondsubset of IRCS blood centres. The meetingwill enable a representative of each centre tocome together to discuss the results, including country specific strengths and challenges. The meeting will also aim to enableincreased knowledge sharing and networkingon regional issues.PRIORITY COUNTRYSUPPORTNEPALGAP has a well-established association with Nepal RedCross Blood Transfusion Service through its prioritycountry support program. Since 2010 GAP has beenworking with the Nepal Red Cross Society to providespecific risk management and technical assistanceto the blood service.In December 2015, Dr Manita Rajkarnikar(Director, Nepal Red Cross Society NationalBlood Transfusion Service) commenceda 3 month training programme with theAustralian Red Cross Blood Service, providedby GAP through the 2015 GAP-IFRC Memorandum of Understanding funding for prioritycountry assistance.Dr Rajkarnikar commenced the training program in Perth, Western Australia, includingan initial introduction and orientation sessionwith the GAP secretariat. Key learningobjectives were developed by GAP for eachtraining element, to assist the delivery ofthe technical training program. The trainingschedule also included visits to AustralianRed Cross Blood Services sites in Brisbaneand Melbourne.The programme included trainingin the following key areas:Donor eligibility/selection and collection(including fixed site and mobile bloodcollection)Quality Systems (GMP requirements,external quality assurance programs,change control, corrective andpreventative measures)Donor notification andcounselling servicesTesting and processingOrder fulfilment & customer serviceVisit to a major hospital to observepre-transfusion laboratory processesand clinical use of bloodClinical transfusion practice (componentuse, transfusion guidelines, patient bloodmanagement, managing adverse events,hospital transfusion committees)Corporate and strategic planning,supply chain management andmonitoring inventoryDisaster management and contingencyMarketing and donorrecruitment strategiesFinance (cost model development)GAP received very positive feedbackfrom Dr Rajkarnikar on the training.Above: Dr Manita Rajkarnikarat the Melbourne ProcessingCentre (Australian Red CrossBlood Service)As NRCS is planning to construct new Central BloodService building and other district buildings as damagedby earth quake, this training is very fruitful to learn aboutthe system; database, new technology organizationalstructure, management and coordination with thestakeholders. Along with the training we had the chanceto work on the post EQ recovery project. I convey mysincere thanks to GAP for all support to make thistraining possible and look forward to continuedsupport and collaboration in future. I look forward toimplementing in our field whatever I have learned andgained once I return back to the home country.DR MANITA RAJKARNIKA, DIRECTORNepal Red Cross SocietyNational Blood Transfusion Service16| GAP ANNUAL REPORT 2015ACTIVITIES| 17PRIORITY COUNTRYSUPPORTHONDURASThe Honduran Red Cross Blood Service hasbeen a GAP priority country since 2012.The Swiss Red Cross (SRC) provides directsupport to the Honduran Red Cross bloodprogram as a dedicated bilateral project,including support for corporate governanceand risk management issues. GAP memberand Chief Executive Officer of TransfusionSwiss Red Cross provides expertise to theproject alongside the Medical Director of theHonduran Red Cross Blood Service (and GAPmember) Dr Elizabeth Vinelli.The bilateral project Strengthening of theHonduran Red Cross National Blood Program is scheduled to be completed by endof 2016. The overall objective of this projectis to assure the availability and security ofblood and blood products for all patients, bystrengthening the technical, administrativeand governance capacity of the HonduranRed Crosss National Blood Program.The expected outcomes are:1. Establishment of the National BloodPrograms own, duly constituted governance structure, with the delegation ofresponsibilities necessary to conducteffective technical and administrativemanagement.2. Creation of a unified coordinated National Blood System based on voluntary,non-remunerated blood donation.3. Strengthening the National Blood Programs technical and administrative, governance and risk management capacity.4. Strengthening voluntary blood donation.HAITI & INDONESIAIn April 2015, the General Assembly of theHonduran Red Cross approved the revisedstatutes and the new governance structuresof the organisation. In the revised statutes,the activities of the Blood Transfusion Service were included, and the mission to provide safe and sufficient blood products fromvoluntary non-remunerated blood donors isexplicitly mentioned.Further central activitiesof the project were: Capacity building for collaborators andexecutives of the Honduran Red CrossHaitiIndonesiaThe Haitian Red Cross was selected as aGAP priority country in 2010, following theHaiti earthquake. As GAP was not involved inany active support or engagement withthe National Society Blood Service since2012, the priority status of Haiti was closedin 2015. GAP will encourage the NationalSociety Blood Service to continue to complete the GAP Level A Self-assessmentquestionnaire when the questionnaire isnext distributed to the Americas, LatinAmerica & The Caribbean.The priority country status of PalangMerah Indonesia (PMI) was on hold in 2015pending completion of their bilateral supportprogramme with the Australian Red CrossBlood Service. Promotion of VNRBD in collaborationwith the local chapters of the HonduranRed Cross.In 2015 the Honduran Red Cross BloodService was accredited by the AABBAccreditation Standards for the 6th time.In 2015, GAP provided additional financialsupport to Outcome 4 of the project withthe approval of funding for an online donorrecruitment training module. This will also beadministered through the Swiss Red Crossas an adjunct activity to the existing bilateralsupport program. It is anticipated that thisonline tool will also be made available toother National Societies, with a view toassisting with the achievement of 100%VNRBD which is acknowledged as a majorchallenge in developing countries.Left: Workshop with theSupport commission ofthe National Blood Programof the Honduran Red Cross.ACTIVITIES| 19PRIORITY COUNTRYSUPPORTBANGLADESHThe Bangladesh Red Crescent Blood Service (BRCBS) wasselected for GAP priority country support in July 2014 following the completion of the GAP Self-assessment questionnaire, which identified that some corporate governance andrisk management challenges existed for the blood service.In consultation with Mr Afsar Uddin and Dr Tarique Mehedi,and taking into consideration the discussions held with various key stakeholders, recommendations for a plan for GAPand bilateral partner support for the BDRCBS, against thefollowing six areas of identified need were developed.In November 2014, a preliminary scoping visit was undertaken by GAP to assess the Blood Service, its operationalcontext and to identify areas of success and areas that wouldbenefit from support. Dr Wolfgang Mayr (GAP member andMedical Councillor for the Australian Red Cross Blood Service) provides ongoing advice and expertise to this project.1. Assistance in advocacy with governmentDuring 2015, two visits to Bangladesh were undertakenby GAP (in May and November) to meet with the BangladeshRed Crescent Society (BDRCS) Blood Service Director andother key stakeholders in order to:4. Training for technical staff, includingthe GAP Regional Training Programin Australia further understand BRCSs requirementsfor the specific areas of support requestedby the BRCS Blood Service; and progress the options for GAP or bilateral partner support.During each visit, the GAP delegation met with key staff ofboth the Bangladesh Red Crescent Society and Blood Service,including the BDRCS Director of Health and Blood, Mr AfsarUddin and the Deputy Director and In-Charge Dhaka BloodCentre, Dr Tarique Mehedi. The delegation reviewed of thestatus of the blood service and any progress since the lastvisit, reviewed current and emerging challenges, and plans forfuture development of the BDRCS blood program.Meetings were also held with representatives from theMinistry of Health and Family Welfare (Line Director ProfMd Shamiul Islam) and with the Bangladesh Red CrescentSociety Secretary General, BMM Mozharul Huq and Treasurer,Advocate Tauhidur Rahman.2. Support for an operationalisedstrategic plan3. Assistance to design and implementa quality system5. Assistance in business case developmentfor Dhaka facility improvement/rebuild6. Promotion to IFRC of the needfor VNRBD supportDuring the May visit, the GAP delegation attended a mobilevoluntary blood donor collection session held at StandardChartered Bank facilities in Dhaka and also observed theoperational processes for collection, testing, processing andtransfusion of blood at the Dhaka Blood Centre.As well as visiting two district blood centres (Chittagong andJessore), the focus of the November visit was on assistingthe BDRCS to commence development of a National Strategic Plan for the Bangladesh Red Crescent Blood Service asa key corporate governance and risk reduction strategy, andculminated in a strategic planning workshop. The workshopincluded blood service participants from Dhaka and 5 of the7 regional blood centres (Chittagong, Jessore, Sylhet, Natoreand Rajshani).The GAP delegation and BDRCSBlood Service Director: Discussed the workshop purposeas well as the roles and responsibilitiesof each centre and GAP Developed a shared understandingof the strategic planning processand a typical strategic plan format Commenced the strategic planningprocess for BDRCS, including:Scanning the current internal andexternal operating environmentWorkshopping of strengthsand challenges of each centreGoal setting for each centre Discussed the next part of the strategicplanning process Discussed and agreed on the next stepsfor development of the national strategicplan, including confirmation of strategicpriorities and development of activitiesunder each strategic priorityAbove: Ms Tonks observing operational processes at the Dhaka Blood CentreFollowing the advice provided by GAP toBDRCS during the November visit, the BloodService Director, Dr Mehedi progressed thestrategic planning activity by leading a localworkshop in December 2015 with representatives from all 8 BDRCS blood centresacross Bangladesh. The workshop wasalso attended by: the Chairman of BDRCS the Head of Delegation of IFRC, and the Line Director from the Ministryof Health and Family WelfareOne of the outcomes of the planningworkshop was a comparison of performanceand practice of each blood centre againstselected key parameters (such as %VNRBD,testing technologies used, percent components issued), with a view to identifying areasof focus for future strategy.Right: Dr Mayr reviewinglaboratory processeswith BDRCS Directorand laboratory manager,Dhaka blood centre.20| GAP ANNUAL REPORT 2015BDRCS continues to progress and implementtheir strategic planning at a local level.Above: Dr Mehedi (BDRCS Blood Service Director) running local workshopACTIVITIES| 21DISASTER RESPONSENEPAL EARTHQUAKEOn 25th April 2015 a devastating earthquakeof magnitude 7.9 occurred in Nepal.Inaddition to loss of lives, the earthquakecaused extensive destruction and damageto infrastructure, housing and livelihoods.Immediately following the earthquake,GAP liaised with the Director of the NepalBlood Service, Dr Manita Rajkarnikar, to provide support. The impact had resulted in significant and extensive damage to the NepalRed Cross Blood Service, both in Kathmanduand in regional and district areas. Severalblood centres were extensively damaged.The earthquake and aftershocks had intensified pre-existing vulnerabilities resulting inserious concerns that the impending monsoon season would increase both the leveland urgency of needs and the challenges forrelief and recovery.Below: Temporary bloodbank facilities in Kathmandu.The Central Blood Transfusion Service(CBTS) facility in Kathmandu, which servesas the primary coordination hub for thenational blood service, was severely damaged and was structurally unsound for use.This resulted in the CBTS being transferredto temporary and unsustainable facility arrangements in tents. Emergency blood bankinfrastructure, constructed by the British RedCross in 2014/15, helped provide mediumterm facilities support to the CBTS, whilstthey moved toward a longer term solution.GAP has a specialist role in the provisionand coordination of assistance to NationalRed Cross or Red Crescent blood servicesin post emergency situations in accordancewith GAPs Terms of Reference. This includesimmediate, short-term assistance as wellas long term support to rebuild the blood service once the initial urgency of the disasterresponse has passed. In this capacity, theNepal Red Cross Society (NRCS) SecretaryGeneral requested that GAP coordinate theNepal Blood Service reconstruction andrecovery effort following the earthquake.GAP attended the Nepal post-earthquakeplanning meeting in Kathmandu in June2015 involving senior management fromNRCS, IFRC, the International Committeeof the Red Cross (ICRC), Governmentand the United Nations. The purposeof the meeting was to: Endorse the strategic prioritiesin relation to relief, recovery andcapacity building of the NRCS; Endorse the framework forpartner support for Nepalincluding an initial mappingof needs to be addressed,objectives and targets to be met; Understand movement partnerscapacities, resources andpractical arrangementsfor working in Nepal.In August and September 2015, an expertassessment team was sent by GAP to Nepalto conduct a detailed scoping assessmentof the affected NRCS Blood Service facilities throughout the country and to developrecommendations and proposed activitiesfor the immediate and longer term supportrequirements necessary to rebuild the bloodprogram following the disaster.The team visited the CBTS in Kathmandu(as well as the Lalitpur Emergency BloodBank) and regional centres in Bhaktapur,Pokhara, Kavre, Dhading, Gorkha andNuwakot. Meetings were also held withthe Nepal Red Cross Society to reviewthe recovery proposal, which focusseson four key areas of support:22| GAP ANNUAL REPORT 2015NEPAL RECOVERY PROGRAMFour Key Areas of Support1234INFRASTRUCTURERebuild or repair damaged NRCS blood service facilities and infrastructure, including the establishmentof adequate temporary facilities for the CBTS. This includes the provision of building experts to assist withtechnical advice for the design of new buildings at CBTS and Kavre since these were extensively damagedin the earthquake and required replacement.EQUIPMENTProvision of critical blood service equipment to support blood service operations immediately andinto the future for eight NRCS blood service sites. The equipment includes transport vehicles, collections,processing and testing equipment as well as testing reagents and refrigerators.CAPABILITYDelivery of comprehensive technical training and support for central, regional and district staff to assistthe NRCS Blood Service to improve national capability. This includes training in collections, laboratorymethods, quality management, clinical practice, policy management/organisation and facilities technicalsupport (layout and GMP requirements).PROJECT MANAGEMENT AND LOCAL SUPPORTA dedicated GAP project manager will coordinate all aspects of the NRCS Blood Service recoveryprogram with support from local teams in Nepal. This includes the coordination of funding assistanceby Partner National Societies to ensure no duplication of activities or investment.DISASTER RESPONSENEPAL EARTHQUAKE cont.2016 Approved Budget(CHF)Actual I&E (CHF)1 Jan-31 Dec 2015(Includes Aust&SwissAccounts)Approved 2015 Budget(CHF)CHF account(CHF)AUD Converted to CHF(CHF)GAP will continue to maintain its close relationship with the NRCS, the NRCS NationalBlood Transfusion Service and the Blood Service Director, Dr Manita Rajkarnikar, to deliverthe post-earthquake recovery program andto enable the NRCS Blood Service to improveits own capacity to manage its challengesboth in the short term and to ensure its longterm sustainability.Total AUD Account(AUD)The GAP team also included a buildingexpert to assist with the design of the newbuildings including the Central Blood Transfusion Service and Kavre facilities as thesewere extensively damaged in the earthquakeand require replacement.The GAP delegates met with potentialpartner National Societies to discuss theNRCS blood program recovery requirementsand the proposed support plan. Thesediscussions subsequently resulted in severalpartner National Societies confirming theirsupport commitment to assist the bloodprogram recovery with GAPs coordination.NotesFollowing the assessment visits, and development of the recovery proposal a GAP delegation visited Kathmandu in November 2015to meet with potential partners, understandthe post-earthquake recovery environmentand seek funding commitments for the bloodprogram recovery. Meetings were held withthe Nepal Red Cross Society, IFRC, ICRC andpotential Partner National SocietiesFINANCIAL REPORTOpening balanceGAP accountsAustralian Account402,578326,987Swiss Account326,98797,97597,975IFRC Funding accountAustralian Account*94,52676,777497,104403,764America28,38021,000Australia28,502Finland27,113IsraelCombined opening balance at 1 January76,77797,975501,738514,37421,00021,00021,00021,00021,00021,00021,00021,00021,00021,00021,00027,60921,00021,00021,00021,000Japan27,16721,00021,00021,00021,000Switzerland26,50221,00021,00021,00021,000Germany26,52321,00021,00021,00021,000Austria26,16521,00021,00021,00021,000Belgium26,74221,00021,00021,00021,000Thailand27,25021,00021,00021,00021,00042,00042,000042,0000Income2015 Member ContributionsIndiaHong Kong - special status00Honduras - exempt00subtotal313,952252,000210,000252,000210,00087,86265,00065,00065,00065,00016,75215,7528,00015,7525,0001,3021,22518,05416,9768419,868333,97682015 IFRC MOU funding IncomeIncome2015 Interest IncomeInterest- GAP AustralianaccountInterest - GAP Swiss account8Interest - IFRC funding accountsubtotalAbove: Dr Manita Rajkarnikaat the temporary blood bankfacilities in Kathmandu.Right: GAP delegationin Nepal with Dr ManitaRajkarnikar.24| GAP ANNUAL REPORT 2015Payment from HKRC for NepalJoint Project ContributionTotal Income801,2255006,66016,9845,500281,660333,984280,500FINANCE| 252016 Approved Budget(CHF)Actual I&E (CHF)1 Jan-31 Dec 2015(Includes Aust&SwissAccounts)Approved 2015 Budget(CHF)CHF account(CHF)AUD Converted to CHF(CHF)Total AUD Account(AUD)Notes2016 Approved Budget(CHF)Actual I&E (CHF)1 Jan-31 Dec 2015(Includes Aust&SwissAccounts)Approved 2015 Budget(CHF)CHF account(CHF)AUD Converted to CHF(CHF)Total AUD Account(AUD)NotesExpenditurePriority country supportSecretariatNepalSelf Assessment costs:Salaryand oncosts@(34,595)(35,979)(458)0subtotal(35,052)(35,979)@(78,525)(81,666)Phone,rent, officesupplies,postage,stationery(2,947)0Office equipment, software, training,sundry(3,497)Online surveylicense feesSecretariat costsSecretariatsalary andoncostsSpecialist AdviceTranslation - Self assessmentreports, GAP manual, questionnairepublications/standardsProfessional expertise eg legalStakeholder meetings(e.g. IFRC, Reference Centres,WHO, ISBT)(84,968)(143,772)(135,186)(196)(184)(184)000(1,246)(1,172)(40)(37)000(120,021)(81,666)(10,000)(135,186)(1,172)(117,645)(5,000)(2,000)00(1,000)Secretariat coordination, logistics and support0Travel & accommodation(5,000)Other meeting expenses00(2,000)0(1,000)000(373)(351)(18,000)(351)(10,000)(1,953)(1,837)(10,000)(1,837)(5,000)000(30,000)(33,245)000(3,000)00(18,988)(17,854)(22,000)(17,854)(51,000)(9,107)(8,563)(37,733)(8,563)(39,242)0(10,000)(1,000)(17,637)(1,000)Travel & accommodation00(20,000)00Other expenses00(2,000)0000000000(6,000)Post disaster response Nepal(78,835)(74,127)(113,000)(74,127)(130,000)MMR followup(20,207)(19,001)(32,500)(19,001)(33,800)(4,113)(3,867)(3,867)(43,391)000(54,400)(9,461)(8,896)(8,896)(2,500)00(1,000)(1,000)(1,000)(95)(89)(24)(113)0Contingency funds000(20,000)Journal adjustment000HaitiIndonesiaTravel and accomodationGlobal mapping(new approved activity 2015-16)Website hosting and technical maintenance(7,000)(20,000)2014 IFRC Funded Activities journalled in Jan2015 (website, project support, Nepal joint GAPproject with HKRC)^0002014 HRKC Expenditure already adjusted in theopening income balance*14,22013,37013,370(340,671)(320,325)(7,186)(15,000)(7,186)(1,620)(3,800)(1,620)(2,000)Total ExpenditureGAP networking events(dinner)(1,005)(945)(2,000)(945)(2,000)Closing balanceOther expenses (annualreports)(423)(397)(1,000)(397)(1,000)Notes(9,000)00(1,200)0(2,000)Executive Board Meeting(s)Exchange rates:Opening Balance Exchange rate as per XE Currency converter website 31 Dec2014: 1 AUD = 0.8122324904 CHFWeighted average rate for report 1AUD=0.9403CHFTeleconferences(1,503)(33,245)(10,000)(7,642)(3,800)(35,357)0(1,723)(1,503)0(17,637)Travel & accommodation(1,598)00Meeting venue/cateringTeleconferencing Calls costs0(18,757)Other Expenses (online VNRBDmodule)Bank fees0Meeting venue/catering andtravel accommodation@Insurance(10,000)Annual General MeetingSupport program, travel andaccomodationStepwise accreditation (new activity for 2016)(37)0Participant costsBangladeshVietnam0Meeting costsOther expenses0Travel & accommodationRegional meetingsSupport program,travel & accommodationHondurassubtotalPostage, stationeryPost disaster support- see separate line item(2,700)Calculation of Weighted Average Rate303,349322,616 0.940300.9403CHF - OB+IncomeReceived-CBAUD - OB+Income Received-CBWeighted AvgCheck(1,024)(497,054)(321,349)(591,657)286,345514,374203,217Closing Balance Exchange rate as per Oanda websiteconversion rate - 1 AUD = 0.7243 CHF*Opening Balance in Q621 includes the adjustment of $14kHRKRC expenditure that was only reallocated to Q621 in Jan-15India membership fees for 2016 and 2017(42,000CHF) invoiced in Dec 2015, but not yet received^2014 IFRC Funded Activities relate to activities carriedout in 2014. Due to timing of costs incurred, the projectswere only finalised in early 2015.** 2016 Budget Secretariat costs converted to CHF usingthe exchange rate:AUD/CHF 0.73815 Reference: Oanda 26 May 2015@ Budget allocation for salary provided in AUD may needto be revisited if significant movement in exchange rate26| GAP ANNUAL REPORT 2015FINANCE| 27AUDIT REPORTHISTORYGAP was formed in 2000 by a group of expertsfrom National Society Blood Services in orderto share knowledge on risk management and toprovide advice to Red Cross/Red Crescent Societieson the proper management of risks associatedwith blood programmes.Since that time, GAPs membership has grownand GAP has continued to provide technical supportand assistance to National Society Blood Services.In June 2012, GAP was officially established as anindependent association registered under Swiss law,and governed by an Executive Board.Currently GAPs membership stands at thirteenNational Society Blood Services, all of whomconduct Level A blood programmes.28| GAP ANNUAL REPORT 2015CONTACT GAPGAP SECRETARIATA Level 1, 69 Walters Drive, Osborne Park WA 6017, AustraliaP +61 8 6213 5909F +61 8 6213 5949Egapsecretariat@redcrossblood.org.auWglobaladvisorypanel.orgGood Governance, safe blood
Transfusion Today - June 2016
Transfusion Today | Number 107, June 2016Alliances and networksin blood transfusionDubai CongressElections Board of Directors 2016Membership renewalCME on Blood Transfusion Services Expanding HorizonsContents16Judith ChapmanEditorialThe focus section features five organisations that some18 4of us are familiar with but many of us are not. We hope23that you will have a better understanding of each ofthe organisations after reading about them. PleaseIn Focusemail the ISBT Central Office if you have a question Regional and International Alliances and Networks in Blood Transfusion;Asia Pacific Blood Network; Asia Pacific Economic Cooperation; Allianceof Blood Operators; Global Advisory Panel; European Blood Alliance; 60years of official relationsRoche Blood Safety SolutionsCount on us, because patients are counting on you.13For more information, contact your local Roche Diagnosticsrepresentative.you will find a page dedicated to education. We haveintroduced the page to promote some of the educationalFrom ISBT Central OfficeLook out for the case studies that are being prepared byElections for vacant positions on the Board of Directors 2016;Membership renewal; Welcome to our new members; 34th InternationalCongress of the ISBT, September 3 - 8, 2016 Dubaithe Immunohaematology Working Party and which willfeature on the website in the coming months.We are looking forward to the 34th International17Technology uniquely designed to deliver a safe and efficientblood supply.Comprehensivesolutions for bloodbanks and plasmafractionatorscontact with them. In this issue and future issuesmaterial and resources that are available from ISBT.ISBT Academycongress of ISBT in Dubai. Over 800 abstracts Case studies in Immunohematology; ISBT at the 16 InternationalAs a world leader in blood screening, Roche has been committed tohelping improve safety while enhancing efficiency. And now, weretaking it to the next level. With Roche Blood Safety Solutions weprovide an expansive portfolio of pre-analytics, serology* and NATtechnologies that deliver real-time virus discrimination along withexcellent seroconversion sensitivity for early detection and safetyassurance. Because doctors and patients are counting on you,Roches advanced systems and extensive resources are there for youwhen it counts most.or comment about their work and we will put you in20thYoung Investigators (YI) indicated they wished to beRegional Newsis still time to sign up for the YI breakfast which will 1995-2015: Twenty years of haemovigilance in Greece; New TransfusionNational Guidelines; Blood transfusion in the Russian Far East region;CME on Blood Transfusion Services; External quality assessment schemefor hospital blood banks in Malawi27were received and many were high scoring. 148Haemovigilance Seminar; ISBT Academy Begins a Fourth Year FundingImmunohematology Workshops in India;Upcoming Eventsconsidered for the YI session; unfortunately we only hada few slots available in the session. If you are a YI theretake place on Monday September 5. There are manydifferent activities within the scientific programmeincluding Transfusion Practitioner sessions and a varietyof workshops. More information can be found on theDubai page of this issue of TT and on the website.We hope you will come to Dubai and delve into thescience at the congress and use your free time to takeadvantage of being in a modern vibrant city. You will bepleasantly surprised.President Celso Bianco Secretary General Roger Dodd Executive Director Judith ChapmanDesign drukkerij Teewes Photography Transfusion Today Advertising Monique van Dorp,communication@isbtweb.orgCOBAS and LIFE NEEDS ANSWERS are trademarks of Roche.2015 Roche Molecular Systems, Inc. All rights reserved.www.roche.com*The serology product range is not available for blood screening settings in Canada,Philippines, and the United States. For all other countries, please contact your localRoche representative to check availability.Statements and opinions expressed in Transfusion Today are those of the individual contributors andnot that of ISBT. Reproduction in whole or part requires permission by the publisher. ISBT membersneed not obtain permission if proper credit is given.Send all correspondence to ISBT - Marnixstraat 317, 1016 TB, Amsterdam, the Netherlands.T + 31 20 7601 760, F + 31 20 7601 761, communication@isbtweb.org.Gold membersTransfusion Today | Number 107, June 20163In Focus Alliances within the Field of Transfusion MedicineIn Focus Alliances within the Field of Transfusion MedicineRegional and InternationalAlliances and Networks inBlood TransfusionFive of the most common acronyms within the field of bloodtransfusion are ABO, APBN, APEC, EBA and GAP. They easilyroll off the tongue but more often than not people hearing orreading them do not know what is behind them. Is it a newblood group, method, machine, organisation or what?They are the acryonyms of five organisations committed topromoting safety, security and cost effectiveness within thefield of Transfusion Medicine. Each of the organisations is aregional or global alliance or network. The five articles in thefocus section of this issue of Transfusion Today will give youan insight into the membership of these organisations andtheir vision, mission and objectives. They are all working forthe benefit of transfusion services, donors and ultimately thepatient.Asia-Pacific BloodNetwork (APBN)The Asia Pacific Blood Network (APBN) is a network of notfor profit blood operators in the Asia Pacific region who arecommitted to voluntary non-remunerated blood donation.The current Members of APBN are: Australian Red Cross Blood Service Hong Kong Red Cross Blood Transfusion Service Japanese Red Cross Society Blood Service Republic of Korea National Red Cross Blood Service Macao Blood Transfusion Service New Zealand Blood Service Blood Services Group, Health Sciences Authority, Singapore Taiwan Blood Services Foundation National Blood Centre - Thai Red Cross SocietyAPBN was established in 2006 to promote blood safety andefficiency of blood service operations among members. In2014 we revised the APBN Strategic Plan which sets out thefollowing vision, mission and strategic aspirations for five yearsthrough to 2019.Vision: Our patients have access to safe, secure and effectiveblood and blood products appropriate to their needs.Mission: APBNs mission is to contribute to the safety, sufficiencyand cost effectiveness of blood and blood product supply in theregion, based on scientific and ethical principles. Our committedblood donors are key partners in achieving our mission.Objectives: Promote APBN members organisational efficiency andcost effectiveness through benchmarking, performanceimprovement, best practice achievement and knowledgeexchange Provide member value through the development of tools toensure safe, secure and effective blood and blood productsfor patients Strengthen members ability to secure a sufficient andsustainable donor panel to meet patient needs for blood andblood products Raise awareness of, and influence blood sector issues in theregion including promoting scientific and ethical principles indonor care in APBN members Provide an opportunity for a common regional voice tobetter influence and engage stakeholders at both countryand regional levels in relevant blood sector issues throughdevelopment of recommendations on key shared issues Inspire other countries in our region, and internationally, toimprove their standards by providing examples of good practice4Transfusion Today | Number 107, June 2016Transfusion Today | Number 107, June 2016Kenji TadokoroChair, Asia Pacific Blood Networkand Chief Executive Officer, BloodService Headquarters, Japanese RedCross Society Maximise value of APBN Network for membersThe APBN holds face-to-face meetings usually twice a yearas well as regular teleconferences. In these forums membersexchange ideas and insights and compare operational practices(CoP).CoP items include: blood components issued per population blood donations by types of donation donors per population new donors ratio efficiency of collection testing and processing per full time employees collection of source/recovered plasma for fractionationEvery 6 months, members also discuss updated activities ofeach blood service in areas such as management, finances,collection, testing, processing, research and development,haemovigilance, customer services, and patient bloodmanagement. These issues are discussed openly andfrankly based on the confidentiality agreement and on anappreciation that members operate in different domesticcontexts. Furthermore, Members share recent trends andideas of operation and learn from best practices to improverespective operations. We discuss in depth selected issues ofmembers interest in the general meetings. Ssubcommitteesare established on emerging infections which are or mightaffectblood safety and collection efficiency in the region. Awhite paper on Dengue virus describing the scientific data andmembers experiences is published on the website.Moreover, APBN exchanges information and shares selectedCoP data on supply/donation trends and operational efficiencieswith the Alliance of Blood Operators (ABO) under the umbrellaof a Memorandum of Understanding. We have held open forumon trends of red cell demand and patient blood managementconcurrently with the ISBT annual meeting inviting other bloodservices.APBN also seeks to provide strategic leadership in the AsiaPacific region and to support policy development. The Networkprovides a regional voice and perspective on blood-relatedthemes.Part of our activities are seen on the website,http://www.apbnonline.com/.Address of APBN secretariat is as follows;Level 1, 69 Walters Drive Osborne Park, WA 6017,Email: apbn@redcrossblood.org.au5In Focus Alliances within the Field of Transfusion MedicineIn Focus Alliances within the Field of Transfusion MedicineAsia-Pacific EconomicCooperation (APEC)Maureen M. Goodenow, Ph.D.Chair, APEC Life SciencesInnovation Forum Planning GroupSenior Science Advisor andFounded in 1989, the Asia-Pacific Economic Cooperation(APEC) forum is an intergovernmental organization of 21Member Economies that operates on the basis of non-bindingcommitments and open dialogue to strengthen intra-regionaleconomic growth. APECs Member Economies are Australia,Brunei Darussalam, Canada, Chile, China, Hong Kong-China,Indonesia, Japan, Republic of Korea, Malaysia, Mexico, NewZealand, Papua New Guinea, Peru, Philippines, Russia,Singapore, Chinese Taipei, Thailand, United States, andVietnam. APEC maintains nearly 40 permanent sub-fora withresponsibilities that span most economic sectors, includinghealth and medical life sciences. These groups manage shortand long-term initiatives that facilitate policy alignment as wellas economic and technical cooperation. Activities undertakenand recommendations made each year at the working leveladvance to policy level bodies for review and consideration.APECs working level activities and projects are guided byAPEC Senior Officials. APEC Senior Officials report to APECMinisters at the policy level. APEC Leaders (heads of state),who convene each year and set the policy agenda, consider theannual recommendations of APEC Ministers. APEC encouragesparticipation by the business community, academia and civilsociety and is chaired by a different economy each year. Peru isserving as host in 2016 and Vietnam will host in 2017.Established by APEC Leaders in 2002, the Life SciencesInnovation Forum (LSIF) is APECs leading initiative on healthand health sciences innovation. The LSIF brings togetherrepresentatives of government, the private sector and academiato advance policies that foster the growth of life sciencesinnovation and the improvement in public health in the AsiaPacific region.In October 2014, the APEC LSIF convened senior leadersfrom government, academia, the private sector, civil society,and other international and regional organizations in Manila,Philippines to discuss the regional blood safety landscapeand determine whether APEC had a role in advancing bloodsafety in the region. Delegates welcomed APECs initiativewith great enthusiasm and identified several areas whereAPEC could support the translation of global blood safetypolicy recommendations and local economy blood safetyplans into concrete, measurable results. APEC representativessubsequently developed and endorsed the APEC Blood SupplyChain 2020 Roadmap, launching a long-term multi-sectoraleffort to address blood safety policy issues and to supportcapacity development of blood services, infrastructure,governance, as well as the achievement of international safetyand quality standards for the blood supply chain.In early 2015, the APEC Blood Supply Chain PartnershipTraining Network (PTN) was established by the LSIF tosupport implementation of the APEC Blood Supply Chain2020 Roadmap. The PTN serves as an evolving network of6Jefferson Science Fellow,Department of State, United StatesProfessor andAlliance ofBlood OperatorsChris HroudaChair, Alliance of Blood OperatorsStephanyW.Holloway EndowedChair for HIV/AIDS Research,College of Medicine, University ofFloridainstitutional expertise on blood safety across government,academia, and industry in the APEC region. The networksupports and assists APEC Member Economies in designing,implementing, and promoting projects and priorities consistentwith the Roadmap. Activities are currently focused on twopriority areas: policy and quality systems capacity building.Training modules will be developed that are scalable andreproducible, and will be available for all economies to use tostrengthen their blood safety systems. The PTNs work willbe consistent and will complement and not duplicate existingactivities carried out by other international and regionalorganizations.The PTN has an Advisory Board which provides strategicdirection and oversight of the PTNs activities. It is cochaired by the U.S. Department of State and AABB and hasrepresentatives of nearly a dozen global blood safety bodiesincluding the ISBT, APBN, WHO, and the leaders of nationalblood services of 10 APEC Member Economies. There arealso two seats for representatives of the APEC Blood SafetyIndustry Coalition. The Coalition is comprised of businesseswith expertise in blood safety and is currently co-chaired byGrifols and Baxalta. The Coalition enables the private sector toprovide input into the PTNs activities in a transparent mannerand without the perception of a conflict of interest.On June 23-24, 2016, Peru will host the PTNs 1st PilotTraining program on Embracing Quality Systems at theColegio Mdico del Per in Lima, Peru. The pilot programwill convene approximately 50 blood bank managers andlaboratory leaders from the APEC sub-region (Chile, Mexico,Peru, and the United States) to learn about the principles ofQuality Management Systems in blood banks. In late 2016,Vietnam will host the 3rd APEC Blood Supply Chain PolicyForum convening approximately 150 blood safety leadersfrom throughout the Asia-Pacific region to discuss and identifyinnovative solutions to the regions priority blood safety policyissues. A 2nd PTN Pilot Program on Quality ManagementSystems will be held immediately after the policy forum andwill convene 50 blood bank managers and laboratory leadersfrom Vietnam and other Southeast Asian economies. The PTNWebsite, co-hosted by APEC and AABB, (http://blood.apec.org)will be launched in May 2016 and will serve as a library for allPTN trainings (webinars) and APEC blood safety documents.Transfusion Today | Number 107, June 2016The Alliance of Blood Operators (ABO) is a network of not forprofit blood service providers with voluntary non-remuneratedblood donor bases.ABO was established in 2002 by a small group of bloodoperator leaders who sought to improve their local bloodestablishments through the exchange of strategically usefulinformation. Since that time, ABO has grown to represent over90 blood operator members, collecting 35.5 million units ofblood for a total population of 815 million people across threecontinents: North America, Europe, and Australia.ABO membership includes: Americas Blood Centers, consisting of more than 60independent blood operators American Red Cross Australian Red Cross Blood Service Blood Systems Inc. Canadian Blood Services European Blood Alliance, comprising blood operators from25 European countries National Health Service Blood and Transplant whichprovides blood services for England and Northern WalesABOs purpose is to be a high performing internationalcollaboration of blood operators who drive memberperformance improvement, knowledge exchange and resolutionof strategic issues for the benefit of patients and the healthsystems. A number of working groups within ABO support theprogramme and currently include: Donor Engagement and Relationship: sharing strategies torecruit and retain blood donors and developing opportunitiesto access and inform donors globally Benchmarking: facilitating the identification anddevelopment of best practice, encouraging organisationallearning and performance improvement. The group collectsperformance data from participating members on an annualbasis to produce the ABO benchmarking report Medical Directors: Chief Medical Officers ensure toolsand materials to enable sustainable and effective clinicalleadership and management across the blood sector inmember organisations Cost Model: comparing the financial considerations of bloodat an operational level to understand variations in cost Risk Based Decision-Making: bringing into operationTransfusion Today | Number 107, June 2016an integrated risk-based decision-making framework,encompassing donor safety and patient outcomes which hasthe potential to guide major policy and operational change Research and Development: exchanging strategies onimproving the impact and effectiveness of ABO memberresearch and development (R&D) programs by examining themanagerial, administrative and leadership issues affectingR&DABO is further supported by a small secretariat and Point ofContact from each member organisation.Confidentiality of data is closely maintained and the groups arevery sensitive to issues of competition that may affect specificmembers and limit participation.ABO has long recognised the value of the global networkand has strived to deliver benefit to its members throughglobal sharing, horizontal learning and by providing a unitedblood operator voice on policy issues that cross internationalboundaries. Globalisation across all industries has made theworld a little smaller since 2002, but the principles establishedby the ABO Chief Executives more than a decade ago still formthe solid foundations for the 2014-2019 strategic plan.The current ABO objectives are: Objective 1: improve organisational performance Objective 2: identify, analyse, and monitor emerging trendsand strategic shifts Objective 3: transform the decision-making paradigm Objective 4: provide high value to membersABO has also recently formed a collaborative relationship withthe Asia Pacific Blood Network (APBN) which further enhancesour understanding of issues at a global level.ABO will continue to focus on performance improvement formembers as well as target complex issues where our combinedvoice, expertise and resources can achieve what is difficult toachieve individually. Through shared experience and problemsolving, we will improve our organisations and our service tocustomers.ABO is about Global sharing. Local results.For more information about ABO, please visit our websiteat:https://www.allianceofbloodoperators.org7In Focus Alliances within the Field of Transfusion MedicineIn Focus Alliances within the Field of Transfusion MedicineGlobal Advisory Panel onCorporate Governance andRisk Management of BloodServices in Red Cross andRed Crescent Societies (GAP)GAP is a global network of Red Cross and Red CrescentBlood Services with specific expertise in risk management andcorporate governance of blood programmes.The networks purpose is to: Provide technical advice in terms of corporate governanceand risk management to National Society Blood Services(NSBS); Promote knowledge sharing, networking and partnershipamong and between NSBS and external partners; Develop and provide tools, guidelines and priority countryassistance to NSBS most in need; Coordinate assistance, to NSBS in post-emergencysituations including blood program recovery; Influence global blood policy in conjunction with itspartners; Provide advocacy and support to the IFRC and NSBS onissues affecting blood programmes.Under the leadership of its dedicated Executive Board andsupported by its membership of Blood Service Chief ExecutiveOfficers, GAP pursues the vision that all Red Cross/RedCrescent blood programmes will be safe, well governed andself-sustainable, and are based on the principle of voluntarynon-remunerated blood donation for the benefit of patients andto safeguard blood donors.Dr Philippe VandekerckhoveCurrently GAPs membership is thirteen National Society BloodServices:NSBSMember representativeAustraliaShelly ParkAustriaWolfgang MayrBelgium - FlandersPhilippe VandekerckhoveHong Kong (China)Cheuk Kwong LeeFinlandSatu PastilaGermanyErhard SeifriedHondurasElizabeth VinelliIndiaVeer BhushanIsraelEilat ShinarJapanKenji TadokoroSwitzerlandRudolf SchwabeThailandUbonwon CharoonruangritAmericaChris HroudaGAP delivers its work program in close cooperation with IFRCHealth and has an IFRC observer on its Board. In addition,some of these members also act as GAP Zonal Coordinators toassist and coordinate GAP activities at a regional level, and toidentify opportunities for regional assistance and collaboration.GAPs principal tool is the Self-assessment questionnaire,which assists National Societies to ensure that appropriatesteps are being taken to support the long term stability andsustainability of their blood service without exposure tounnecessary risk. NSBS can measure their progress against anumber of selected criteria identified as fundamental aspectsof corporate governance and risk management for NSBS.The results of the self-assessment are analysed by GAP andan individual feedback report is provided outlining specificgovernance and risk management recommendations forconsideration. GAP also provides de-identified regional reportsto enable comparison of performance within the regional andidentifying common themes or challenges within the regionwhich are further discussed with NSBS at GAP regionalmeetings.As resources permit, GAP provides targeted assistance to asmall number of identified priority country blood services.Thismay include: in-country support visits, provision of GAP tools, resources and GAP expertise, identifying partnering opportunities with other BloodServices, coordination of technical assistance from GAP members orpartners.In coordination with IFRC and partners, GAP provides supportto National Society Blood Services at a global, regional andcountry level.For more information about GAP, please visit our website at:www.globaladvisorypanel.orgGAP was initially formed in May 2001 by the Finnish RedCross Blood Service, at the request of the InternationalFederation of Red Cross and Red Crescent (IFRC) to set up anexperts group from a range of countries to share knowledgeand to provide advice on the proper management of bloodprogramme risk.In 2012, GAPs role and purpose to provide expertise andadvice to blood services was cemented with the release ofthe IFRCs blood policy Promoting Safe and SustainableBlood Systems which outlined the specific responsibilities ofIFRC, GAP, National Societies and blood services in managingblood programme risk. GAP was established as a Swissbased independent association, and is governed by its electedExecutive Board.8Transfusion Today | Number 107, June 2016Transfusion Today | Number 107, June 20169In Focus Alliances within the Field of Transfusion MedicineEBAKari ArankoWillemijn KramerExecutive DirectorRCommunications andAdministrations OfficerEuropean Blood AllianceEuropean Blood Alliance is representing non-profit bloodestablishments throughout EuropeIn 1998, nine directors of Blood Establishments decidedto come together to discuss the plans of the EuropeanCommission to establish a Directive on blood safety and donorselection. According to a news item in Vox SanguinisI, the goalof their meeting was to see if they could speak with one voiceto Brussels. Besides discussing the EU Directives, the groupfound that networking and liaising on operational items wasvery helpful in their daily managerial lives. Over the years,the group grew and now comprises 25 members and twoobservers. European Blood Alliance (EBA) members are locatedthroughout the European Union and European Free TradeArea States. The observers are located in Europe and in theUnites States. Members are either the national blood service oralliances representing more than a half of the blood supply inthe country. EBAs members annually collect 16 million blooddonations, they are responsible for collecting, testing, preparingand distributing blood components from those blood donationsand serving a population of 450 million.The mission of EBA is to contribute to the safety, securityand cost effectiveness of the blood and tissue and cell supplyfor the citizens of Europe by developing and maintaining anefficient and strong collaboration amongst European blood andtissue and cell services. It does so through four key objectives: To increase public and professional awareness of voluntaryand non-remunerated donation (VNRD) of blood and bloodcomponents, and of preparation of blood components as anindispensable therapeutic means to help patients. Provide technical and professional support to nationaland European authorities, particularly those involvedin preparation / revision of regulations, standards,recommendations, guidelines, to promote best practice. To assist European blood establishments to continuouslyimprove their performance, based on scientific and ethicalprinciples for the benefit of patients To facilitate information collection and knowledge exchange.Each of the 25 member countries have a voting representativein the Board Meeting whom elect 6 Executives, including aPresident, Vice-President and Treasurer. The working structureof EBA is based on activities carried out by expert memberson a voluntary basis, which are coordinated by the EBA Office:EBA has over 150 experts working in 9 working groups andprojects. The EBA Office is in Amsterdam, in the SanquinBlood Supply head office, with 3 persons and, based in Paris,the collaborative procurement manager.To support members to improve their productivity, EBA hasa Working Group on Benchmarking, aimed at identifying bestpractices. Also, EBA invested in collaborative procurement10to address the other half of the costs base of bloodestablishments. The first joint procurement project, calledEurobloodpack, found its roots in a willingness by EBA Memberorganisations to harmonize and standardize the technicalspecifications of blood packs used for the collection andprocessing of whole blood donations throughout EuropeII.Thisproject was successfully completed securing multi-millioneuro savings and is now followed by several other projects.Another successful working group is the EBA EmergingInfectious Disease (EID) Monitor, which has established itselfas an important forum to share information on new emerginginfections and interpretation of available data.The speaking with one voice for which EBA was actuallyestablished, is still very important. EBA has collaborated withthe European Centre for Disease Control (ECDC) to furtherdevelop the European Up-Front Risk Assessment Tool calledEuFRAT: an online tool with manuals and examples supportingrisk assessment of EIDs, which can be reached at ECDCwebsiteIII. Also, EBA works together with CoE and EC withadvice, and EBA is a happy partner of ISBT in funding anddeveloping training leading to transfusion medicine certificate.EBA has a long legacy in initiating and promoting EU fundedprojects to enforce quality standardsIV V, patient bloodmanagementVI VII and currently ongoing donor healthcareVIII IX. More information of EBAs members and activities canbe found at www.europeanbloodalliance.eu. The key positionsand recommendations of EBA have been summarised in thebook Blood, tissues and cells from human origin: the EuropeanBlood Alliance PerspectiveX, which can be downloaded fromthe EBA website .We thank ISBT for a longstanding friendship and hope to beable to introduce ourselves personally to you at some event! European Blood Alliance founded, Vox Sanguinis, 1998, 75: 25.http://dx.doi.org/10.1046/j.1423-0410.1998.7530259.xII Nightingale, et al. Vox Sanguinis, 2011, 101(3):250-4.doi: 10.1111/j.1423-0410.2011.01480.xIII European UpFront Risk Assessment Tool: EUFRAT at ECDC websiteIV European standard operating procedure (SOP) methodology reflectingEuropean best practice within the area addressing the quality and safetyof blood: EU-Q-Blood-SOP projectV EU Blood Inspection: EuBISV Optimal Blood Use. Promoting and sharing best practice across the EU:Optimal Blood UseVII Van Kraaij et al., Vox Sanguinis, 2015, 109 (Suppl. 1), 14;http://onlinelibrary.wiley.com/doi/10.1111/vox.12304/epdfVIIIDonor management in Europe: DOMAINEIX The Donor Health Care programme: DoHeCaXwww.europeanbloodalliance.eu/eba-bookITransfusion Today | Number 107, June 2016CMYCMMYCYCMYKIn Focus Alliances within the Field of Transfusion MedicineFrom ISBT Central OfficePaul StrengersSecretary General of ISBT 2000 - 201060 years of official relationsbetween ISBT and WHO.IN 1956, Dr. Colonel Jean Julliard, Secretary-General ofISBT, described in his report on the The Activities of theInternational Society of Blood Transfusion that at the 15thSession of the World Health Organization in February 1955,ISBT was recognized as a scientific society and was admittedto official relations with WHO. This important event gaverecognition and international scientific credit to transfusionmedicine and to ISBT. Every following two years the ExecutiveBoard of WHO reaffirmed the official relation between WHOand ISBT as a Non-Governmental Organization (NGO) andthe Board of the WHO expressed its appreciation for ISBTscontinuing support for WHO objectives and contribution toworld health. At the beginning it was agreed that ISBT andWHO should work together on recommendations regardingpractical and psychological problems with transfusion inparticular on biological standardization, on blood donors whoshould be unconditional, voluntary and altruistic, and - it wasthe time of the Cold War - on the personnel in case of disastersand conflicts. The WHO Expert Committee of BiologicalStandardization (ECBS) still addresses each year major topicson blood and plasma and has published a great number ofrecommendations on improvements to transfusion medicineworldwide. ISBT was invited to be present at World HealthAssemblies and at sessions of the WHO Executive Council andWHO Regional Committees. In return WHO representativeswere invited to attend meetings of the ISBT Council andBoard as an observer and to give presentations at (opening)sessions of ISBT Congresses. Many common initiatives weredeveloped such as in 1976 the World Blood ResourcesCommittee to monitor the manner in which blood programsin various countries develop and for which ISBT offered theexpertise of some selected members to training courses whichwere the responsibility of the WHO and the League of the RedCross Societies. In 1980 the ISBT Code of Ethics for BloodDonation and Transfusion was adopted by the ISBT GeneralAssembly and two years later submitted for adoption to theWHO General Assembly because the consideration of thehealth of the donor and the safety of the recipient should beaccepted by every health authority as a primary responsibility.Unfortunately, WHO encountered difficulties because according12to the minutes the commercial industry was not ready toespouse these fine ethical principles. For ISBT this was adisappointing outcome and a reason for reviewing the futureof the collaboration between ISBT and WHO. Six years laterhowever, the ISBT Council strongly supported the objectives ofthe Global Blood Safety Initiative (GBSI) launched by the WHOin May 1988 in consortium with the League of Red Cross,ISBT and the United Nations Development Programme. Someyears later GBSI became integrated in the Global Program onAIDS focusing on developing countries. As in any relation ISBTand WHO had its ups and downs. The minutes of the Councilmeeting in 1992 where the WHO representative requestedISBT for funding noted politely, referring to heavy discussionsthat there was much overlap in the goals of ISBT and WHObut ISBT does not have the finances to help support the WHOprograms as requested. Luckily, problems were solved andtwo years later Dr. Antezana, Assistant-Director of the WHO,opened the International ISBT Congress with the lecture onThe role of the WHO in blood transfusion and handed over theDistant Learning Material on Safe Blood and Blood Productsto ISBT. ISBT continued its support to WHO programs suchas the Global Collaboration on Blood Safety (GCBS), the manyinformal consultation meetings on different blood transfusionaspects varying from anemia and selection of donors to qualitymanagement training courses, on putting plasma derivedmedicinal products on the WHO Essential Medicines List, onvoluntary non-remunerated blood donors, on guidelines for theproduction, control and regulation of plasma for fractionation,on collaborative studies in biological standardization, on theWHO Achilles project, etcetera. The renewed Code of Ethicswas officially adopted by WHO in 2000 and in 2004 WorldBlood Donor Day was established by ISBT, WHO, FIODSand IRCRCS in order to create awareness on the voluntary,non-remunerated blood donor. Sixty years of internationalcollaboration for improving blood transfusion medicine haveshown that the official relation between ISBT and WHOis a great asset and it is paramount for the many patientsworldwide who rely on transfusion therapy with blood andplasma products.Transfusion Today | Number 107, June 2016Elections for vacantpositions on theBoard of Directors 2016Voting commences June 14, 2016 and closesAugust 6, 2016ISBT, our society, is guided by a Board of Directors which isresponsible for development and oversight of the strategy of theorganization. The Board is comprised of, and elected by, themembership of the Society. Board members have fixed termsof service and elections are held every two years. The termsfor newly-elected Board members begin at the InternationalCongress and will be announced at the General Assembly to beheld in Dubai September 6, 2016.Nominations closed on May 17, 2016. One nomination wasreceived for the positions of Vice President, Treasurer andRegional Director for Africa and Western Pacific and thereforethese candidates are elected unopposed. Elections will takeplace for President Elect and the Regional Directors for Europeand South East Asia.Transfusion Today | Number 107, June 2016According to Article 16 of the ISBT Statutes all members of theSociety who were a member on March 1, 2016, the date of thecall for nominations, will receive an email notice on June 14,2016 inviting them to take part in the election which will beheld online. The elections will close at 23.59 CET on August 6,2016.ISBT exists for, and is guided by its members. The Board playsa vital role in this process and all of you who are eligible to voteare encouraged to exercise your right to vote for the candidateof your choice for these three positions. For your guidance eachcandidate has provided a brief biography, statement of theirinvolvement in ISBT and a statement of motivation on why theyare a suitable candidate for the position and what they intend tocontribute to the Board and the Society if elected. These will beavailable on the online voting pages.13From ISBT Central OfficeFrom ISBT Central OfficeMembership RenewalWelcome to our new members(April 2016 May 2016)It is time to renew your membershipThank you for your membership of ISBT during the membershipyear 2015/16. Your membership helps us to achieve ourmission of sharing knowledge to enhance transfusion practicethrough providing opportunities for advancing knowledgeand education. Your membership renewal means that youwill continue to receive the benefits of membership of ISBTincluding:Access to the ISBT Academy ePortal (including congresswebcasts and presentation Subscription for Vox Sanguinis (paper + online)* Receipt of Transfusion Today (paper + online)* Receipt of the monthly E-news Registration discount at ISBT congresses Online access to Working Party material* Online access only for 35 years and under feeWe kindly remind you to renew your ISBT membership for thenew membership year 2016-2017 (April 1, 2016 to March31, 2017). Continuing your ISBT membership will give youthe opportunity to connect and participate in our growingtransfusion medicine community.Please settle your membership fee before June 30th 2016.Scroll down or click on the hyperlinks for detailed informationon: How to renew | Payment methods | Invoice | Membershipcard | Fees | Discounted fee 35 years and under | Addressup-to-date? | Questions?We are looking forward to welcoming you again in the newmembership year!Best wishes,Team ISBTHow to renewLogin with your current email address and password.Click on My Membership & Payments to pay your membershipfee for 2016/2017.Payment methodsOnline payments can be made using the following methods: Recurring direct debit* Credit card (no 3D-secure) PayPal IDEAL (Netherlands only)14* Recurring direct debit is available to members resident inmost European countries. By using direct debit you authorizeISBT to collect the payment of your annual ISBT membershipfee at the start of every new membership year. This saves yourenewing your membership every year so we highly recommendit!Africa JAPAN: Hiroyuki Oguro, Yoshiyuki Akashi, NIGERIA: Garba Umar Kangiwa, Awwal Borodo, Uchenna Please make sure when paying by credit card you haveauthorization from your bank to make payments abroad andthat you have sufficient funds, otherwise the payment will becanceled. MALAYSIA: Hemalatha ShanmugamIf you do not have a credit card or PayPal account you canemail membership@isbtweb.org to arrange for a bank transferAmericas UNITED STATES OF AMERICA: Kerri Weinert, Jennifer InvoiceAn invoice is available after logging in on the Payments page.Membership cardAfter payment, your membership card will be available fordownload (in PDF-format) at your personal profile on ourwebsite from April onwards.FeesISBT Membership fees are based on your age and your country.Read more about our fees.Discounted fee for those who are 35 years and underIf you are 35 years and under, you pay a discounted fee of 55 per year. You can find more information on our discountedmembership here.Address up-to-date?To ensure that you continue to receive Vox Sanguinis andTransfusion Today and the monthly E-news, please check thatyour membership details e.g. postal and email addresses areup-to-date and complete. You can edit your details by loggingin and by going to Edit Profile. Make sure you click on Updateprofile on the bottom of the page to safe your changes.Questions?Most of the answers you can find at our Frequently AskedQuestions. If you have any other questions, please let us know.Our mailing address is:International Society of Blood TransfusionMarnixstraat 3171 st floorAmsterdam, Noord-Holland 1016 TBNetherlandsShinya Matsumoto SOUTH AFRICA: Fred Kloren, Carl Fourie TAIWAN: Yang Bing-Heng ZIMBABWE: Judith Juliet ParirewaSato, Zachary Antovich, Marsha Senter, Ashok Tholpady,Ann SmithEastern MediterraneanPAKISTAN: Saman Ansari,Maqbool Alam SAUDI ARABIA: Daryll Sulleza,Maha Eid Al-Johani UNITED ARAB EMIRATES: Hiba AlhumaidanEurope BOSNIA AND HERZEGOVINA: Jasminka Kurilic CROATIA: Nina Ipavec GREECE: Magdalini Pape, Efthymia Serafi HUNGARY: Human BioPlazma LLC IRELAND: Sanjay Shahi NETHERLANDS: Peter Ligthart, Jan-Willem Andriessen,Judith Lie, Anja Mkelburg, Lenneke Prinzen NORWAY: Janne Pedersen RUSSIA: Dmitriy Likhonin, Ivan Krivov UNITED KINGDOM: Ali Shokoohi, Stephen Smedley TURKEY: Gonca GokyarSouth East AsiaINDIA: Devi Prasad Acharya, Ganesh Mohan, Jitin Narula, Asbhisekh Gowda, Ruchi Jaipuria, Sachin GargWestern Pacific AUSTRALIA: Bronwyn Pearse, Shelly Park, Leah Kivivali,Simon Benson CHINA: Zhoulin Zhong, Yan Zhou, Mei Yu, Zhaohui Liao, Transfusion Today | Number 107, June 2016Ejikeme, Isaac OlajideWenbiao Liang, Ningyu HeTransfusion Today | Number 107, June 201615From ISBT Central OfficeISBT Academy34th International Congress of theISBT, September 3 - 8, 2016 Dubai34th International Congress of the ISBT, September 3 8,2016 DubaiScientific programmeEllen van der Schoot, our Scientific Secretary has puttogether a superb scientific programme with new speakersand new topics as well as more familiar themes. Theprogramme includes almost 90 invited speakers and 118 oralpresentations chosen from high scoring submitted abstracts.The programme has three parts; the local/regional day onSaturday September 3 this is specifically designed for peoplefrom the region, the Academy or education day on SundaySeptember 4 designed for those who want to update theirknowledge and the main scientific programme taking placefrom Monday September 5 Thursday September 8.Transfusion PractitionersNew this year are special sessions for TransfusionPractitioners. These sessions are organised by the TransfusionPractitioner sub group of the Clinical Working Party and willinclude; how the transfusion practitioner role can involvepatients in the transfusion process, single unit transfusions(how to measure practice what has worked), the use oftechnology in patient safety and a workshop on making datafun and work for you. Please spread the word in the TPcommunity about these sessions.WorkshopsA number of workshops are taking place. On September2, 2016 the Immunohaematology Working Party will behosting a day long workshop on the clinical significance ofred cell alloantibodies, on Sunday September 4 the QualityManagement Working Party will host a half day afternoon16workshop on Quality Management and the inspection ofBlood Establishments and the Clinical Working Party willhost a workshop on the most important aspects of designing,performing, analyzing, reporting and reading clinicaltransfusion research. On September 5 at 08.30 there is aworkshop on peer review which will give you an insight intothe requirements of peer reviewing and how to do it well.Visit www.isbtweb.org/Dubai to find out more about theseworkshops and to sign upExhibitionThere will be a large exhibition running alongside the scientificprogramme. You are invited to visit the exhibition and discusscurrent and upcoming technologies with the exhibitors. Weare anticipating that around 80 companies will be exhibiting.All coffee and tea breaks take place in the exhibition halls soyou also have the opportunity to meet up with colleagues andfriends from around the world.Social programmeJoin us for the opening ceremony and welcome reception. Youwill be welcomed to the opening ceremony by an Arabic danceperformance. As well as the usual speeches and award givingthe ceremony will feature a sand or collage artist and a band.Following the opening ceremony traditional food will be servedthroughout the exhibition hall.The congress party will take place in the iconic Asateer tentwhere glittering lights, oriental entertainment and a wide arrayof buffet dishes and traditional delicacies awaits you! You willexperience spectacular and dazzling views of the Dubai skylinefrom Atlantis private beach.Transfusion Today | Number 107, June 2016Case studies inImmunohematologyDr. Thierry PeyrardPharmD, PhD, EuropeanOne of the focal points of the Working Party onImmunohematology is to provide information andeducational opportunities through the ISBT WorkingParty Website. One of the most popular formats forsmall and large group meetings is ImmunohematologyCase Studies. One of the reasons these are so popularis that the participant can learn from cases thatthey may not see often but should be able to detectand handle or learn new practical approaches toantibodies that are seen in their institution.tekstThe members of the Working Party onImmunohematology are planning by the end of 2016to bring 12 case studies to the members of ISBT whoare interested in viewing them. The members who aresharing these case studies are: Sofia Lejon Crottet,Nicole Thornton, Cinzia Paccapelo, Ankit Mathur,Franz Wagner, Eduardo Muiz-Diaz, Erwin Scharberg,Susan Johnson, Anu Korhonen, Fang-Yeh Chu,Christof Weinstock and Abdullah Meshi.Specialis in ClinicalChemistry and LaboratoryMedicineDirector, NationalImmunohematology ReferenceLaboratoryNational Institute of BloodTransfusion Paris, FranceSandra J Nance, MS,MT(ASCP)SBBSenior Director, IRLsAmerican Red Cross Philadelphia, USAThese members are representative of the newWorking Party, with wide global reach (see map). TheWorking Party is excited that these case studies couldbe valuable as learning tools for all levels of thoseinterested in immunohematology. The path to find theCase Studies once signed into the ISBT Webpage isISBT Webpage>Working Parties> Working Party onImmunohematology> Education> Case Studies.We hope these cases will be of interest for all ofyou and would be happy to get your feedback andcomments.Transfusion Today | Number 107, June 201617ISBT AcademyISBT AcademyISBT at the 16th InternationalHaemovigilance SeminarThe International Haemovigilance Network (IHN)thanks the ISBT Academy for its support of the 17thInternational Haemovigilance Seminar, held in Parisfrom 7-9 March, 2016.ISBT joined French governmental, transfusionprofessional, blood establishment and industrypartners in supporting the event, which welcomed270 people from over 50 countries, includingrepresentatives from a number of countries attendingfor the very first time.Photo 1: Travel award recipients, supported by the ISBTAcademyThe program covered donor, product and transfusionrecipient vigilance, with a plenary session onhaemovigilance in African countries, and aneducation morning in French. Other sessions exploredinflammation and its consequences and the potentialof new technologies to understand it, sickle celldisease and hyperhaemolysis, and iron status (toolittle, too much) for donors and patients. Therewas a session on microbiological haemovigilanceincluding hepatitis E, and a range of presentations ondifference tools for practice improvement, includingthe use of simulation for educating and traininghealthcare professionals and patients. High qualityoral presentations and posters were presented from alarge number of submitted abstracts.Dr Luc Noel was honoured for his contributions tohaemovigilance and a coordination of vigilance effortsacross a wide range of medical products of humanorigin internationally. Dr Noel delivered the IHN Awardlecture, which can be found along with other seminarpresentations at http://ihs-seminar.org.Dr Peter Tomasulo was awarded the IHN Medal,in recognition of his contributions to IHN andto haemovigilance in the United States andinternationally, with a particular focus on donor healthissues.Erica Wood on behalf of the IHN Board,JoWiersum on behalf of the ISBT Working Partyon Haemovigilance, and Pierre Tiberghien andPhilippe Renaudier on behalf of the Local OrganisingCommitteeIHN thanks all participants and speakers andsupporting organizations who made the Seminarsuch a success. ISBT Academy funding enabled fourtravel grants, awarded to Dr Michael Acquah fromGhana, Dr Salam Sawadogo from Burkina Faso, MrAbiy Belay Ambaye from Ethiopia, and Dr Hilda MariaSilva Ballaster from Cuba. ISBTs support was greatlyappreciated.ISBT Academy Beginsa Fourth Year FundingImmunohematologyWorkshops in IndiaThe ISBT Academy entered its fourth year offunding immunohematology training in India at theend of March with the first of two annual IndianImmunohematology Initiative (III) wet workshops. Thisworkshop hosted by the Lions Blood Bank in New Delhifrom 28 March to 1 April included 14 participants inphysician and technical roles. This event came closeon the heels of a six-day workshop at Rotary ttk BloodBank in Bangalore in January, the second in the 2015Academy funding cycle. The timing of the March eventallowed III faculty members, Susan Johnson and JimPerkins, to participate in a joint congress of the BloodBanking and Transfusion society of Turkey (BBTST) andthe Asian Association of Transfusion Medicine (AATM)with two presentations each.The III is a non-profit, USA-based group of 4transfusion medicine professionals, Martha Rae CombsMT(ASCP)SBB, Janis Hamilton MS, MT(ASCP)SBB,Susan Johnson MS, MT(ASCP)SBB, and the author,who have been teaching Immunohematology in SouthAsia for over 10 years. The workshop model hasevolved over time from one of presenting antibodydetection and identification workshops at various sites,often in association with a National meeting, to thefixed-location classroom concept embodied by theabove.But after four years at these two sites, III faculty arehoping to change the model again! The local hosts inNew Delhi and Bangalore are confident that they cantake over teaching their annual, week-long workshops.The III does not expect to send two faculty membersto New Delhi again, and the Autumn workshop inBangalore is slated to be the last with two III membersat that site as well. Local faculty at these sites intendto expand their schedule to multiple events of varyinglength and with varying objectives during the year. TheIII will continue to support teaching at the two sites, butinstead of staffing the workshops personally, III facultyhope to go back on the road.As immunohematology develops in India officialsof AATM, have been encouraging the III to conductworkshops in other member countries. To do so moreNaamJimPerkins, M.D.,FunctieIIIDirectorrobust equipment, particularly a new set of serologiccentrifuges, is required to replace the current, aging setwhich will stay in the Delhi and Bangalore classrooms.The III has been working with a Mumbai equipmentmanufacturer, Remi, to develop a new, purpose-builtserologic centrifuge, the Quikfuge. The plan is fortwelve of the latter to form the nucleus of a workshopin a box. The Quikfuge has performed well, and four ofthe five machines provided for the January Bangaloreworkshop were snapped up by participants! Discussionshave begun with two other AATM member countries tohost 2017 workshops in each.Although individual workshop evaluations are stronglypositive, in 2015 the III attempted to evaluate the longterm impact of its activities in India using an onlinesurvey method. One hundred eighty five (185) pastworkshop participants with known email addresseswere sent a 15 question survey to which 66 responded.Two thirds of respondents were physicians reflectingthe bias introduced by the requirement for a currentemail contact. Although half of respondents indicatedthat they had 5 years or more experience at the timethey took the workshop, only a third of physicians and20% of technical workers reported having had previousformal training in blood group antibody detection andidentification. About 95% of participants stronglyagreed that the workshops were well organized andtaught. More to the point two thirds gave the samerating to a statement that the workshop had helpedtheir professional career, the remainder giving thestatement an agree rating. All of the physiciansand 95% of the technical workers strongly agreedor agreed that their personal ability to providecompatible RBC transfusion was improved, and95% gave the same ratings to the statement that theworkshop had improved the ability of their laboratoryas a whole. Of note however, the latter rating was evenhigher for the question whether the laboratorys abilitywould improve in the future, reflecting current resourcelimitations. Finally, about 30% of respondents reportedtraining at least 10 other individuals.ISBT members interested in observing an III workshopare invited to observe the next workshop in Bangalorein September.Photo 2: Members of the IHN Board and Local Organising Committee, with Dr Luc NoelAcademy18Transfusion Today | Number 107, June 2016Transfusion Today | Number 107, June 201619Regional EuropeRegional Europe1995-2015:Twenty years ofhaemovigilancein GreeceProf. Constantina PolitisHead of Hellenic CoordinatingHaemovigilance CenterC. Politis1, E. Zervou2, L. Kavallierou,1C.Richardson,3 G. Martinis,4 M. Hatzitaki,5P.Damaskos,1 M Parara,1 E Grouzi,6 K. Fountouli,7PHalkia,8 M. Asariotou1, E.Aliverti1,1Coordinating Haemovigilance Centre (SKAE), Hellenic Centrefor Disease Control and Prevention, Athens2University Hospital Blood Centre, Ioannina3Panteion University of Social and Political Sciences, Athens4University Hospital Blood Centre, Alexandroupolis5Koutlibaneio Hospital Blood Centre, Larisa6Agios Savas Hospital Blood Bank Athens7University Hospital Blood Bank, Heraklion, Crete8ACHEPA University Hospital Thalassaemia Unit, ThessalonikiBackgroundThe Coordinating Haemovigilance Centre (abbreviatedas SKAE in Greek) was founded by the HellenicCentre for Disease Control and Prevention (KEELPNO)in November 1995 on a voluntary basis. It wasestablished in line with European National legislation(Min.Res. 261/2011) defines SKAE competencepursuant to European Directives for the developmentand implementation of the haemovigilance systemunder the aegis of KEELPNO of the Ministry of Health.MethodsSKAE collects, monitors, and analyses all adversereactions (ARs) and adverse events (AEs) related totransfusion and donation including epidemiologicalsurveillance of transfusion transmissible infections(TTIs). EU and ISBT/IHN standard definitions maintainhomogeneity in reporting and allow benchmarking.Other activities include traceability, look-back, qualitymanagement indices, crisis management, costeffectiveness and training (Figure 1).The haemovigilance system includes networksbetween hospital clinical departments and hospitalblood banks, blood establishments, and the NationalBlood Centre (Figure 2).15% and TAD 7%). Trends over the surveillance periodshow significantly increased incidence of febrile ARsand TAD, and decrease of IBCT. Nine fatalities werereported: three ABO incompatibility, two TRALI, twobacterial, one TACO, one GvHD.Conclusions/RecommendationsTwenty years of haemovigilance in Greecedemonstrate coordinated progress towardsbetter quality and safety in blood donation andtransfusion.Two transmissions of HIV from one donor owing todonation during the window period and 54 cases ofbacterial infection were recorded. The distribution ofARs by imputability in 2014 was 18% definite, 47%probable, 29% possible and 6% impossible.However, the prevalence of TTIs remainsrelatively high especially regarding HIV andoccult HBV. At the same time notable progressin the implementation of NAT screening forHCV-RNA, HIV-RNA and HBV-DNA as well asfor WNV-RNA seasonal screening has led tosignificant advances in assuring blood safety.- Incidence of serious AEs in 2006-2014 was 1:13,368processed units of BCs. Near misses were 1:3,059units .60% of all AEs are attributed to human error.- Blood donation: the incidence of any AR in 2014 was1:86 donors (78% vasovagal). SARs were 0.3%.- Seroprevalence of infectious markers (HBsAg,anti-HIV, anti-HCV, Syphilis and anti-HTLV) in donorblood in 1996-2014 totalled 0.32 % (Figure 4). Ratesstabilized in 2008-2014 NAT yields for HIV-RNA,HCV-RNA, HBV-DNA in 2007-2014 were 1:391,255,1:195,628 and 1:8,325, respectively. WNV-RNA in2010 2014 was 1:11,289.SKAEs action plan has developed towards newactivities including haemovigilance for specificpatients groups e.g. thalassaemia, root causeanalysis (RCA) and contribution to the development ofbiovigilance (Figure 3).Continuous nursing and medical supervisionduring donation and management ofcomplications especially vagovasal reactionsand injury by the needle will contribute greatlyto safeguarding the well-being of our donors andensure their willingness to be retained as regulardonors.ResultsCoverage is 93% of total blood units issued fortransfusion. In 2014 the incidence of all ARs was1:460 units of blood components (BCs). Febrile nonhaemolytic (45%) and allergic reactions (37%) werecommonest. Serious ARs were 1:6,863 units. 34%were attributed to IBCT and 39% were associatedwith the respiratory track system (TACO 17%, TRALI20Transfusion Today | Number 107, June 2016The frequency of transfusion of wrong blood tothe wrong patient due to pre-marked samplingtubes and failure to verify identity of the patientin the clinical environment has been decliningover the second decade of the surveillanceperiod, however IBCT remains one of the mostimportant adverse events attributed mainly tohuman error.Implementation of patient identification systemand full computerized record keeping inblood services and clinical departments aswell as universal application of pre-storageleukodepletion and use of pathogen reductiontechnologies are recommended for theavoidance of adverse reactions in transfusion.Transfusion Today | Number 107, June 201621Regional Eastern EuropeRegional EuropeNew TransfusionNational GuidelinesDeveloped bythe Ministry ofHealth in UkraineUkraine is an Eastern European country and thelargest country within Europe with a populationof ~43 million of which 27.5 million are potentialdonors. The human development index of the countryin 2014 was 0.747 (high), positioned 81st accordingto the United Nations Development Programme. In2015, ~500,000 whole blood donations and over3,000 apheresis donations of plasma and plateletwere collected. The donation index is ~13 donationsper 1,000 inhabitants.In April 2016, Ukraine began developing new nationalguidelines on the clinical use of blood. The developmentof the new guidelines is a collaborative effort by theCoordination Working Group of Experts (WG) on bloodservice development of the Ministry of Health (MoH)of Ukraine and domestic and international clinicians.The project is supported under the US PresidentsEmergency Plan for AIDS Relief (PEPFAR), funded bythe U.S. Centers for Disease Control and Prevention(CDC), and implemented by American InternationalHealth Alliance (AIHA).The current official document that regulates the clinicaluse of blood and blood components is an instructionapproved by a Decree of the MoH in 1999. Followingthe active approach of the MoH to harmonize theregulatory framework on blood with EU requirementsand Directives, and based on recommendations bythe European Commission and the Council of Europe,the WG was created in September 2015. This groupdefines the priorities of blood system reform, includingthe development of evidence-based national guidelineson the clinical use of blood components.The basis for developing the new guidelines is basedon best practices developed within the PEPFARblood safety project implemented in Kyrgyzstan,where new national clinical guidelines were adoptedas federal regulations by the MoH of Kyrgyzstan inFebruary 2015. Those guidelines were the result ofa joint effort by international consultants and Kyrgyzclinicians providing expertise in different areas ofclinical practice. The Kyrgyz guidelines were suggestedto the MoH of Ukraine for review and adaptation to alocal format. Local specialists evaluated the documentagainst Ukrainian national regulatory requirements,made comments and edits which were shared withinternational consultant, Dr. Miguel Lozano.22Oleksandr SergiienkoAlexandru VolocHead of Blood Safety Sector,AIHA, Blood Safety ProjectPublic Health Department,Country DirectorMinistry of Health of UkraineMiguel LozanoISBT, European DirectorDr. Lozano met with the clinicians and MoH WG todiscuss the suggested draft guidelines, and emphasizedthe need to base them strictly on modern evidencebased medicine principles, and in parallel to follow theprovisions of the EU Directives and Commission onblood safety and quality. The guidelines will includepractical instructions to clinicians about indications,contraindications, dosage and administration, andside effects associated with each type of bloodcomponent and plasma derivative. Sections include pretransfusion testing, blood administration and criteria ofeffectiveness of a given blood product.Further steps in adopting the document includesubmission for review by Ukrainian leading specialistsand public comment over the MoH website, withsubsequent approval of the new national clinicalguidelines by a MoH decree as national regulations.Theadoption of the new clinical guidelines as aregulatory document is crucial in order to ensure astandardized approach to be followed by all clinicians inUkraine. It will also require medical schools in Ukraineto revise their curricula in accordance with the newguidelines.With approval by CDC, AIHA will continue supportingfinalization of the guidelines and promote local capacitydevelopment in training and use of blood componentsaccording to the new requirements. Dr. Lozano willcontinue participating in the process and will mentorthe new trainers.The collaboration between the international consultants,local clinical experts and the MoH in the developmentand adoption of the new national regulatory guidelineson the clinical use of blood is a significant achievementas Ukraine approaches modern evidence-basedTransfusion Medicine.Blood transfusionin the RussianFar East regionThe annual regional blood service conference took placein Khabarovsk February 10-11, 2016. 159 delegateswere present, including directors of the Blood Servicesfrom the Far Eastern regions, blood bank staff, medicaldoctors and transfusion practitioners from Baikal toPacific Ocean. Important questions for blood servicespecialists, clinical doctors with different specialties andhealth officials and medical scientists were discussed.Professor Eugene Zhiburt talked about the changes intransfusion medicine, about ensuring safety of bloodproducts, platelets pooling, pathogen inactivation andimmune hemolytic reactions. The head physician of themain Far Eastern Blood Center Oksana Kozhemyakoreported about achievements of Far Eastern BloodService in 2015. She appreciated the results ofThis article was supported by the CooperativeAgreement Number 1U2GGH000861 from the Centersfor Disease Control and Prevention. Its contents aresolely the responsibility of the authors and do notnecessarily represent the official views of the Centersfor Disease Control and Prevention.Transfusion Today | Number 107, June 2016Takhir ShikhmirzaevKhabarovsk Regional BloodTransfusion Stationcentralization of Blood Service in the Far East, wherethe process of donor blood components preparationwas concentrated mainly in 10 large institutions, for thehighest effectiveness and safety.In 2015 blood components from more than 87000donors were prepared in the Far Eastern region ofRussian Federation. Quality and safety of bloodproducts are increasing. E.g. in Yakutia all plateletconcentrates are pathogen reduced. Current FFPquarantine storage is available and good for two yeartransfusion if needed.During the master class Universal protocol for thecollection of platelets, blood processing technologyin automatic separator were demonstrated. Apheresisand pooling of platelets technologies have beenbroadly discussed. Kirill Slovesnov calculated thatpooled platelets are at two times cheaper and have thesame quality compared with apheresis platelets. Thegreat interest has been attracted with the informationprovided by Sergey Madzaev that pathogen inactivationcould replace irradiation for TA-GVHD prevention.These conferences have become a yearly event. Theygive information platform for constructive interaction ofRussian specialists from different regions of the countryand define priorities for Blood Service of the RussianFar East development. All colleagues are kindly invitedto attend the next meeting on Sakhalin Island in 2017.Transfusion Today | Number 107, June 201623Regional Southeast AsiaI M M U N O H E M AT O L O GY // I H - 5 0 0 SYST E MCME on BloodTransfusion Services-Expanding HorizonsProf Neelam MarwahaProfessor, Dept. of Transfusion Medicine, Postgraduate Institute of MedicalEducation and Research, Chandigarh,IndiaISBT Regional Director, South-EastAsiaThe Departments of Transfusion Medicine at thePostgraduate Institute of Medical Education andResearch and the Government Medical College andHospital, Chandigarh, jointly organized a CME onBlood Transfusion Services -Expanding Horizonson April 29, 2016. Prof. Atul Sachdev, DirectorPrincipal, Government Medical College and Hospital,Chandigarh inaugurated the CME and Dr. VanitaGupta, Director Health Services, UT, Chandigarhalso graced the occasion as guest of honour. Prof.Neelam Marwaha, organizing chairperson of the CMEhighlighted newer techniques in improving bloodsafety and the role of this speciality in therapeutics.Transfusion Medicine is a rapidly evolving andexpanding field. Traditionally the scope of the servicewas limited to the process of blood collection,storage and issue. But today it has emerged asa multi-faceted and multi-dimensional medicaldiscipline. It now includes innovative procedures forblood and component collection, complex laboratorytechnologies for red cell and platelet serology andtesting for transfusion transmissible infections,direct involvement in patient care through apheresistechnology and stem cell therapies, haemovigilanceand donor vigilance, platelet and plasma derivedmedicinal products. All this has to be balanced withina highly regulatory environment.The scientific programme was divided into foursessions; two sessions were lecture based,there was one panel discussion and one sessionon learning transfusion medicine through casediscussions.The first session was on Challenges of blood safetyfrom transfusion transmissible infections and waschaired by Prof Neelam Marwaha and Prof KulbirKaur. Dr. Kabita Chatterjee presented a talk on TheRole of Nucleic Acid Testing in blood safety. Shehighlighted window period reduction through NATand its feasibility in our country. Quality assurance inTTI testing was discussed by Dr Naveen Agnihotri.Prof Ravneet Kaur drew attention to the emergingand re-emerging infectious diseases which couldimpact blood safety Dengue, Chikungunya, potentialthreat of Zika virus and reported chronicity ofHepatitis E virus infection. The second session was24IH-500Innovation Driven by Experienceon Therapeutic Apheresis and included three talksby eminent speakers. Dr Rajesh Deshpande spokeabout the Principle and Technologies for therapeuticplasma exchange (TPE). Dr Rekha Hans talked aboutthe role of TPE in thrombotic microangiopathieswhere its a first-line therapy. Dr Aseem Tiwari sharedhis experience with the role of TPE in neurologicaldisorders and support in ABO incompatible kidneytransplants.Our country has always faced shortages ofplasma derived medicinal products like albumin,immunoglobulins and FVIII and FIX concentrates.Recently, Government of India has taken positivesteps to achieve self-sufficiency for plasma derivedmedicinal products and the role of TransfusionServices has further expanded to support theplasma product industry. There was a paneldiscussion moderated by Dr Gagandeep Kaur onthe Governments recent initiatives for achievingself sufficiency in blood and plasma products. Theimplementation of these guidelines was deliberatedupon intensely between the transfusion medicineexperts and the regulators. Finally, in addition to theinvited talks and panel discussions we had a highlyinteractive session on Learning Transfusion Medicinethrough case presentations. There was a postersession too for the young specialists and postgraduatestudents and awards were presented to the three bestposters. The CME was attended by 150 delegatesfrom the region. The delegates expressed immensesatisfaction and hoped for participation in more suchCMEs in the future.Transfusion Today | Number 107, June 2016Discover our Innovative Universe.Bio-Rad is one of the worlds most respected suppliersof blood screening systems.We have been serving blood banks and transfusion centersacross the world for more than 30 years, consistentlydeveloping and delivering cost-effective, high-performanceand reliable systems designed to meet your changingrequirements.We know that our future and yours depends on our abilityto search beyond todays solutions.These are the reasons behind the development of ournew fully-automated immunohematology platform,the IH-500 system.The Complete Solution for Safe TransfusionWE ARELISTENINGTO YOUIt will only take2 minutes of your time.survey2016biorad.comIH-500 is not available in the U.S.For more information: www.bio-rad.com/IH-500Follow us on Twitter: @Biorad_DiagSoluTransfusion Today | Number 107, June 20162016_03_IH 500_INNOVATION_EN ENQUETE 20 x 28 V1.indd 12506/04/2016 10:17Regional AfricaUpcoming EventsExternal qualityassessment scheme forhospital blood banks inMalawiIntroductionExternal Quality Assessment (EQA) is an importantpart of the overall quality system that should be inplace in any blood bank. There are many benefitsfor participating laboratories and for patients. EQAschemes can drive forward quality where qualitysystems are not in place and help awareness ofquality issues and need for quality systems. A goodEQA scheme will include a training element aimed ataddressing weakness identified by the Scheme.BackgroundThe Malawi Blood Transfusion Service (MBTS)collects and processes blood for all hospitals inMalawi. Hospital blood banks (HBBs) transport,store, crossmatch and issue blood from MBTS topatients. In 2007, MBTS initiated a national externalquality assessment scheme (NQAS) for grouping andcrossmatching as part of a wide strategy to improvetransfusion practice in Malawi. The scheme wasestablished with the help of a Technical Consultantfrom UK. The scheme is supported by the Ministryof Health and has designated the MBTS as referenceLaboratory in Immunoheamatology. Training for hospitalblood bank staff is a key activity in the strategy.ActivitiesA HBB is enrolled in the NQAS after one of its staffmembers has attended a training course organized byMBTS. By the end of 2015, 18 exercises had beendistributed and the number of HBBs enrolled had risenfrom 14 to 83. Each exercise consisted of 3 wholeblood samples and one serum sample/plasma, preparedat MBTS Laboratories in Blantyre and distributedto HBBs by local courier service to arrive within 72hours. At the initial stage of the program, one set ofthe samples was sent to MBTS Centre in Lilongwe andreturned to Blantyre for testing on the closing date asone way of checking the quality of sample. The programdistributes samples twice a year. HBBs that performpoorly are visited to offer technical support. Certificatesof participation are issued to HBBs that participatefully each year. The MBTS keeps a small stock of bloodgrouping and crossmatch reagents which it sells tohospitals at a small fee in case they have run out ofthese reagents.26Daniel NdhlovuQuality ManagerMalawi Blood Transfusion ServiceResultsWith one exception the samples distributed were ofgood quality and survived the rigors of transportation.On average 100% of hospitals got the ABO andRhD typing correct while 78% of the hospitals gotthe correct crossmatch results in the last exercisedistributed in 2015. The number of hospitals thatperform the Indirect Antiglobulin Test (IAT) crossmatchhas increased by 75%. All Public, Private and ChristianHospital Association of Malawi (CHAM) Hospitals areenrolled in the program. 56% of the HBBs were issuedwith certificate of participation in 2015.DiscussionThe overall performance of ABO & RhD typing wasgood. The ABO incompatibility was recognized bymost participants. Other incompatibilities were missedas 25% of HBBs do not use IAT or have no reagentsor suitable centrifuges. The program realized thatimprovements in practice could not occur if HBBstaff are equipped with knowledge only, without theappropriate infrastructure and equipment. As suchbetween 2007 and 2012 MBTS sourced and suppliedparticipating hospitals with basic equipment andrehabilitated 18 HBBs.July 13 - 15, 20162nd European Conference on DonorHealth and Management 2016Cambridge, UKwww.ecdhm.org03 - 08 September, 201621 - 24 September, 201615th International Congress onAntiphospholipid AntibodiesIstanbul, Turkeywww.apsistanbul2016.orgOctober 20 22, 201634th International Congress of the ISBTDubai, United Arab Emirateswww.isbtweb.org/dubai3rd Congress on Controversies inThrombosis and Hemostasis (CiTH)Moscow, Russiahttp://congressmed.com/cith17 - 21 June, 201725 - 28 November, 2017October 22 25, 2016AABB Annual MeetingOrlando, USAwww.aabb.orgOctober 28 30, 201621st Annual Congress of Asia PacificBlood and Marrow TransplantationGroup 2016 (APBMT 2016)Singapore, Singaporewww.apbmt2016.orgConclusionThe scheme can be considered a success. Although theresults to date might, to some in countries with moredeveloped services, seem poor; the aim of the nationalstrategy of which the scheme is a part, is to improvetransfusion practice. WHO Guidelines state that EQAschemes are essential for driving forward improvementsand this relatively simple and inexpensive scheme ishelping to do just that.RecommendationFor BTSs with low incomes to establish this type of aprogram with support from their Ministries of Health asa tool to monitor transfusion practices.Transfusion Today | Number 107, June 201627th Regional Congress of the ISBTCopenhagen, DenmarkTransfusion Today | Number 107, June 201628th Regional Congress of the ISBTGuangzhou, Peoples Republic of China27When emerging pathogenspose a risk to the blood supply,The INTERCEPT Blood System is ready.INTERCEPT is the only US FDA approved pathogen reductionsystem for platelets and plasma.Pathogen reduction has been called upon to help maintain a safe and adequateblood supply as part of epidemic preparedness planning. Examples include:2005 chikungunya (CHIKV) epidemic on Ile de La Runion, France12014 CHIKV and dengue (DENV) outbreaks in the Caribbean region22016 Zika (ZIKV) outbreak in Puerto Rico32016 WHO4 and US FDA guidances5 offer pathogen reduction as oneoption to mitigate risks related to ZIKV outbreaksBe ready.For more information on availability in your country,please visit www.interceptbloodsystem.com.1Rasongles P, et al. Transfusion 2009;49:1083-91. 2 Rico, S et al. Treatment Use Study of INTERCEPT Platelet Components in Response to the Chikungunya and Dengue Epidemic in Puerto Rico:TRUE Study. Poster presented at BMT Tandem Meeting; February 2016. 3 Cerus Corporation Press Release (March 3, 2016 ) 4 WHO Interim guidance WHO/ZIKV/HS/16.1 February 2016. 5 FDAGuidance for Industry February 2016. No pathogen inactivation system has been shown to inactivate all pathogens. The INTERCEPT Blood System is not available for sale in certain countries.2016 Cerus Corporation. Cerus, INTERCEPT and INTERCEPT Blood System are trademarks of Cerus Corporation. MKT-EN 00215-01
GAP Annual Report 2014
GAPANNUALREPORT2014Global Advisory Panel onCorporate Governance andRisk Management of BloodServices in Red Cross andRed Crescent SocietiesGood Governance, safe blood.aGAPANNUAL REPORT 2014GAPANNUAL REPORT 2014CONTENTS1. GAPs Role12. GAP Association Governance23. Strategic Plan54. Global Mapping65. Self-assessment96. Management of Risk107. Projects118. Priority Countries169. Finance19GAPANNUAL REPORT 20141.GAPS ROLEWe advocate and support the establishment of safe and sustainable bloodsystems, promote the adoption of best practice, and facilitate resourcemobilization and knowledge transfer between blood services.The purpose of GAP is to provide advice to National Red Cross and Red Crescent Societies, and their affiliatedblood services, in matters concerning corporate governance and risk management in the field of National Societyblood programmes, as well as the International Federation of Red Cross and Red Crescent Societies (IFRC)Secretariat and other relevant IFRC bodies.GAPANNUAL REPORT 20142.GAP ASSOCIATION GOVERNANCEIn 2014, Prof Philippe Vandekerckhove, Chief Executive Officer of the BelgianRed Cross Blood Service (Flanders) held the position of GAP President.GAP is comprised of an Executive Board, the members of which play a vital role in governance and decision makingfor the organisations activities. An IFRC permanent observer holds a position on the GAP Executive Board to ensurethe flow of information and coordination with the IFRC. Regular communication and constructive ties between GAPand the IFRC Secretariat ensures the coordination of work programs and supports links particularly with respectto voluntary non-remunerated blood donation (VNRBD).The GAP Zonal Coordinators liaise closely with their IFRC zone office(s) and look for opportunities to collaborateon activities in the critical area of corporate governance and risk management for National Societies involvedwith blood programmes.GAP Executive BoardAims: To provide technical advice in terms of corporate governance and risk management to National Societyblood programmes; To promote knowledge sharing, networking and partnership among and between Red Cross and Red Crescentblood services and external partners; To develop tools and guidelines as appropriate within the area of National Society blood programme delivery; To coordinate Red Cross/Red Crescent assistance to National Red Cross and Red Crescent blood servicesin post-emergency situations.1.2.1. Prof Philippe VandekerckhovePresident2. Dr Wolfgang MayrVice President3. Dr Rudolf SchwabePermanent Board member4. Ms Jennifer WilliamsBoard member3.14.5. Dr Stefan Seebacher/ Dr Gabriel PictetIFRC Permanent Observer (Absent)2GAPANNUAL REPORT 2014GAPANNUAL REPORT 2014GAP Association StructureGAP Finland representativeOne of GAPs founding members; Dr Tom Krusius from the Finnish Blood Service retired from the Blood Servicein 2014 and consequently vacated his position as GAP Zonal Coordinator for Europe and Central Asia. Dr Krusiushas been a very active GAP member, with particular contribution at the time of the 2004 Boxing Day tsunami,where he led the coordination of responses in affected countries.GAP Executive BoardDr Martti Syrjl, Chief Executive Officer, Finnish Red Cross Blood Service, is now providing Finlandsmember representation on GAP.Appointment of Europe & Central Asia Zonal CoordinatorGAP SecretariatFinancial Auditor Dr Elizabeth VinelliAustralian Red Cross Blood ServiceInternational Federation of Red Crossand Red Crescent SocietiesGAP Members, Zonal Coordinators and Permanent ObserversAfrica[ZC Position Vacant]AmericasLatin America& the CaribbeanUSADr Richard Benjamin(ZC)HondurasDr Elizabeth Vinelli (ZC)Asia & PacificChina (Hong Kong)Dr Che Kit Lin (ZC)JapanDr Kenji Tadokoro (ZC)AustraliaMs Jennifer WilliamsThailandDr Soisaang PhikulsodEurope &Central AsiaMiddle East &Northern AfricaFinlandDr Tom Krusius (ZC)Dr Martti SyrjlIsraelProf Eilat ShinarAustriaDr Wolfgang Mayr (ZC)Belgium (Flanders)Prof PhilippeVandekerckhoveGermanyDr Erhard SeifriedSwitzerlandDr Rudolf Schwabe[ZC Position Vacant]Dr Wolfgang Mayr from the Austrian Red Cross Blood Service was nominated unchallenged to the positionof GAP Zonal Coordinator for the Europe and Central Asia region in November 2014. The position wasconfirmed and Dr Mayr commenced the role in January 2015.IFRCDr Stefan SeebacherDr Gabriel Pictet(Permanent Observer)Dr Guenther Wittauer(Senior VNRBD Officer)Permanent Observer and VNRBD OfficerIn October 2014 Dr Stefan Seebacher retired fromhis position as Head of Health Department, IFRC.Dr Gabriel Pictet is currently acting in this positionand is representing the IFRC as a PermanentObserver on the GAP Executive Board.Guenther Wittauer retired from his position as SeniorVoluntary Non-Remunerated Blood Donation Officer(Health Department, IFRC) in June 2014. The positionremained vacant for the remainder of 2014.Blood Policy ReviewA review of the IFRC Blood Policy commenced in late 2014. A number of suggested changes were proposedand reviewed by the Secretariat and members. The final version of the Blood Policy will be approved by GAPand the IFRC in 2015.Memorandum of UnderstandingThe Memorandum of Understanding (MOU) between the IFRC and GAP was accepted signed by both partiesat the GAP Executive Board meeting in Madrid, April 2014. This MOU sets out the modalities of the partnershipbetween the two organisations including, but not limited to:The IFRC role in GAP;The reporting obligations including Major Material Risk;The engagement with the National Society through a Self-assessment process;Funding;Priority country support andThe coordination of blood programmes in disaster situations.34GAPANNUAL REPORT 2014GAPANNUAL REPORT 20143.4.GAPs initial strategic plan was developed in 2007 for the period 2009-2012. The plan includeda vision and mission statement, primary objectives and key outputs. During 2014, these werereviewed with feedback from members on GAPs strengths, weaknesses and opportunities.The new GAP Strategic Plan for 2014-2019 was finalised at the 2014 AGM with updatedvision and mission, key objectives and performance indicators.In 2013 and 2014, GAP conducted global mapping to determine the level of involvement thatRed Cross and Red Crescent National Societies have in the provision of their nations bloodprogramme. A survey was created by GAP and distributed to National Societies in the regionsof Africa, the Americas, Latin America & the Caribbean, Asia Pacific, Europe & Central Asia andMiddle East & Northern Africa. The survey requested the National Society to indicate whetherthey were involved in a blood programme at Level A, B or C or had no involvement.STRATEGIC PLANVISION:GLOBAL MAPPINGAll Red Cross/Red Crescent blood programmes will be safe, well governed and self-sustainable, based on theprinciple of voluntary non-remunerated blood donation for the benefit of patients and to safeguard blood donors.MISSION:A. Full Blood Service ProvisionGAP will support Red Cross/Red Crescent blood services in risk management and corporate governanceof blood programmes and promote good practices and knowledge exchange.OBJECTIVES:1.GAP to be recognized as a global network of experts in risk management and corporate governanceof blood programmes.2.Enable all Red Cross/Red Crescent blood services to undertake the GAP Self-assessment and demonstrateprogress towards achieving compliance with minimum standards and fundamental GAP requirements.3.Relationships, networks and collaborations will be developed which improve GAPs reach and effectivenessand to help execute GAPs programme of work.4.Service delivery will be enhanced through the provision of practical help to Red Cross/Red Crescent BloodServices to improve safety, sufficiency and good governance.5.Extend involvement of GAP membership to improve the reach of expertise available.6.IFRC will be supported by GAP activities in the goal of achieving 100% voluntary non-remunerated blooddonation and implementation of the IFRC Blood Policy.B. Systematic Blood Donor RecruitmentC. Advocacy for VNRBDPromotional campaignsEducation and awarenessInvolvement in WBDDDonor recruitmentPromotional campaignsEducation and awarenessInvolvement in WBDDGovernanceAdvocacy for appropriate useProduct distributionLaboratory testingComponent preparationCollection services/donor careDonor recruitmentPromotional campaignsEducation and awarenessInvolvement in WBDDOf the 186 surveys distributed in the 2 year period, only 71 (38%)National Societies responded to the global mapping exercise, a notablylow response rate. A summary of the results is displayed on thefollowing pages, these also include information gathered throughthe Self-assessment process and through GAPs member network.GAP plans to perform an extended global mapping exercise in 2015-2016 to obtain accurate information on all National Society Blood Services.This is critical for GAP and the IFRC to plan for future support activities andto conduct Self-assessment processes at regional and global levels.56GAPANNUAL REPORT 2014GAPANNUAL REPORT 20142013-2014 Global Mapping ResultsNo.National SocietyLevel of InvolvementNo.National SocietyLevel of InvolvementAsia & PacificAmericas, Latin America & the Caribbean1American Red CrossA37Pakistan Red Cross SocietyA2Colombian Red Cross SocietyA38Philippine Red CrossA3Ecuadorian Red CrossA39The Thai Red Cross SocietyA4Honduran Red CrossA5Suriname Red CrossA40Vietnam Red Cross SocietyB41Micronesia Red CrossB6Dominica Red Cross SocietyB42The Sri Lanka Red Cross SocietyB7Saint Lucia Red CrossB43Afghan Red Crescent SocietyC8Bolivian Red CrossC44New Zealand Red CrossNil9The Canadian Red Cross SocietyNil10Costa Rican Red CrossNil45Austrian Red Cross SocietyAMiddle East & Northern Africa (MENA)Europe & Central Asia46Spanish Red Cross SocietyA11Egyptian Red Crescent SocietyA47Belgian Red CrossA12Magen David Adom in IsraelA48Finnish Red CrossA13Lebanese Red CrossA49German Red CrossA14Red Crescent Society of the Islamic Republic of IranA50Luxembourg Red CrossA15Iraqi Red Crescent SocietyB16Algerian Red CrescentC51Swiss Red CrossA17The Palestine Red Crescent SocietyC52Andorran Red CrossB18Moroccan Red CrescentNil53Bulgarian Red CrossB19Qatar Red Crescent SocietyNil54Croatian Red CrossB55Cyprus Red Cross SocietyB56Hungarian Red CrossB57Red Cross of MontenegroB58Norwegian Red CrossB59The Red Cross of SerbiaB60Slovenian Red CrossB61Ukrainian Red Cross SocietyB62Albanian Red CrossC63Estonia Red CrossC64Malta Red Cross SocietyC65Red Cross Society of the Republic of MoldovaC66Romanian Red CrossC67Red Crescent Society of TajikistanC68Armenian Red Cross SocietyNil69Belarus Red CrossNil70British Red CrossNil71Danish Red CrossNil72Icelandic Red CrossNil73Irish Red Cross SocietyNil74Lithuanian Red Cross SocietyNilAfrica20Red Cross of BeninB21Togolese Red CrossB22Uganda Red Cross SocietyB23Central African Red Cross SocietyB24Red Cross Society of EritreaC25Ethiopian Red Cross SocietyC26Liberian Red Cross SocietyC27Malagasy Red Cross SocietyC28The Sudanese Red CrescentCAsia & Pacific29Australian Red CrossA30Bangladesh Red Crescent SocietA31Indian Red Cross SocietyA32Indonesian Red Cross SocietyA33Japanese Red Cross SocietyA34The Republic of Korea National Red CrossA35Laos Red CrossA36Nepal Red Cross SocietyA78GAPANNUAL REPORT 2014GAPANNUAL REPORT 20145.6.GAPs principal tool when working with National Society Blood Services is the Self-assessmentquestionnaire. The Self-assessment assists National Societies to ensure that appropriate stepsare taken to support the long term stability and sustainability of their blood service withoutexposing the Society to any unnecessary risks. It enables National Society blood programmesto measure their progress against key issues which have been identified as fundamental aspectsof corporate governance and risk management for Red Cross/Red Crescent blood programmes.GAP has a responsibility under the IFRC Blood Policy to inform both the IFRC Secretariat andconcerned National Societies of Major Material Risks (MMR) for the IFRC discovered throughthe GAP Self-assessment programme and any other GAP work.SELF-ASSESSMENTMANAGEMENT OF RISKAsia-PacificThe Self-assessment process was conducted throughout theAsia Pacific region in late 2013, with participation from 13 LevelA National Society Blood Services. Following the analysis anddistribution of the individual and regional feedback reports,a regional meeting was held on 20th September, 2014 inKathmandu, Nepal. Participants from the Blood Servicesof The Philippines, Nepal, Indonesia, Thailand, Hong Kong,Japan, Australia and the GAP Secretariat attended. Participantsprovided country updates and reviewed and discussed the regionalSelf-assessment results including potential strategies to addresscommon regional risk management challenges.Self-assessment TranslationsThe revised Self-assessmentquestionnaire has been fully translatedinto Spanish and Arabic languages.Both translations are available on theGAP and IFRC Fednet websites.Middle East and Northern Africa (MENA)In September 2014 the Self-assessment questionnaire was distributed to the National Society Blood Servicesin the MENA zone who had confirmed in the 2014 global mapping survey that they are involved in a Level A bloodprogram. Individual country feedback reports were issued to the respondents, identifying key areas of potential riskfor the blood service together with suggested strategies to address these. As there were insufficient respondentsto retain the anonymity of the supplied information, a de-identified regional report was not issued and a regionalmeeting was not held.IndiaFollow-up activity with regards to Indias 2013 Self-assessment response (Asia Pacific region) identified that thereare 166 independently operating Red Cross Blood Service centres in the country, and that the Self-assessmentdata reviewed by GAP in 2013 is not indicative of all centres. As it is not feasible for GAP to distribute the surveyto all 166 centres with its current resources, GAP will initially distribute the Self-assessment to a sub-set of thelargest Red Cross Blood Services centres. The Self-assessment questionnaire was sent out in November 2014with the assistance of the Indian Red Cross Society.Major Material Risk, is defined by GAP as being: A circumstance in which an individual National Society or BloodService knowingly endangers a high number of donors and/or recipients or acts in contravention to the principlesof the Federation, thereby exposing the IFRC or sister National Society to potential reputational damage. An MMRbehaviour is defined by GAP as being any conduct by a National Society or Blood Service which has the potentialto cause an MMR.Major Material Risk FrameworkThe IFRC Secretariat and GAP members developed a comprehensive set of operating rules and a frameworkfor risk reporting to guide GAP in its activities. The Major Material Risk Advisory Framework was finalised in late2013 by GAP and the IFRC as the agreed methodology to identify, report and manage MMR in National SocietyBlood Services.The Self-assessment process conducted in the Asia Pacific and Middle East & Northern Africa regions in2013-2014 provided the first opportunity for use of the new MMR framework. In accordance with the framework,GAP was required to follow-up with a number of National Society Blood Services in response to the answers providedto particular questions in the Self-assessment which may indicate a potential MMR situation exists. Individual countryfollow-up was progressed by the GAP Secretariat in conjunction with the Asia Pacific Zone Coordinators, and inaccordance with the agreed MMR framework.Following the first in-practice use of the framework for the follow-up of Self-assessment results in the AsiaPacific region in 2013/2014, the framework was reviewed by the GAP Executive Board. The review highlightedthat application of the agreed MMR framework to the Self-assessment responses received from the region wouldrequire GAP to follow up with many National Society Blood Services that may not have a true MMR. It was agreedthat the MMR process flowchart contained within the IFRC Major Material Risk Advisory Framework would berevised to further clarify the process.Self-assessment QuestionnaireThe Self-assessment questionnaire was also reviewed in 2014 to include additional questions (see table below)to ensure that it does not trigger an unspecified MMR, but will trigger a demonstrable and specific incident whichrequires the attention of the IFRC. By specifically requesting further information from the National Society BloodService within the questionnaire, the need for unnecessary follow-up will be circumvented wherea true MMR does not exist. A summary of these questions is provided below.An Indian sub-regional meeting will be held in 2015 to discuss the results. The GAP Executive Board willdetermine an appropriate strategy for further action, if required, once further clarity on the scale and scopeof the Red Cross Blood Service in India is known. This may include the further distribution of theSelf-assessment to additional centres.Additional Self-assessment questionsExplanation1.2.1If YES or Partially:Have these policies been implemented?What is the level of VNRBD in your country?Are there steps in place to increase VNRBD?1.2.2If NO:What is the level of VNRBD in your country?Are there steps in place to increase VNRBD?1.4.1If not, Why?Are plans in place to change this?These questions request additional information if the blood service indicates that they do not havea long-term sufficient and sustainable source of revenue.1.5Does the Blood Service have sufficient of the following resources to meet regulatory requirements(facilities, supplies, equipment, trained staff/volunteers)?If the blood service selects No, slight shortage or No, significant shortage a prompt for furtherinformation has been added and a caution that a negative response may indicate a potential MMR.4.1If NO, which agency provides support for these recipientsThis question asks for further information if the blood service states that they (or the health department)do not have a mechanism for providing support to recipients of infected blood.Are you participating in any bilateral support programmes for your blood service?Part BAre you receiving any funds from other sources to support bilateral arrangements?These questions prompt the blood service to provide additional information in regards to a national policyof securing supply of safe blood through voluntary non-remunerated blood donation (VNRBD).These questions request further information from the blood service regarding any existingsupport arrangements.910GAPANNUAL REPORT 2014GAPANNUAL REPORT 20147.PROJECTSAfrica Zone (IFRC Funding 2013 2014)GAP sought to increase its level of support in the Africa and MENA (Middle East & Northern Africa) Zonethrough the completion of the Self-assessment process and efforts to attract and train a Zone Coordinator(ZC) for the region.The responses from the Africa Zone to the GAP global mapping survey in 2014 did not identify a NationalSociety with current involvement in blood activity at Level A or B. Two level C National Societies were identified Madagascar and Sudan. This indicated that a request for a representative to consider the role of GAP ZoneCoordinator (ZC) in the Africa region was not warranted at this time given the absence of Level A and B activity.GAP Priority Country (Nepal) Joint IFRC and Hong Kong Red Cross Funding (2013-2014)A collaborative initiative between the Hong Kong Red Cross Blood Transfusion Service (HKRC BTS), Nepal RedCross Society National Blood Transfusion Service (NRCS NBTS) and GAP, this project aimed to build capacityin the Nepal BTS through provision of support in three key areas:1.Procurement and installation of critical equipment;2.Providing technical support by developing a risk management frameworkand providing training on donor care and counselling;3.Improving national coordination of the blood program by holding a developmentforum with key stakeholders.Following an extensive procurement process by the project steering committee, the equipment was purchasedin July 2014 from Insignia International (New Delhi) and was delivered to the Nepal Red Cross Society CentralBlood Transfusion Service on 25th August 2014. This supplier was chosen due to their proximity to Nepal(reduced transport costs), competitive pricing and excellent service and communication. Plaques were placedon the equipment acknowledging the funding from the Hong Kong Red Cross.The in country support component of the project was undertaken from August 25th 29th 2014. The teamincluded GAP Asia Pacific Zone Coordinator and HKRC BTS technical expert Dr Che Kit Lin, Ms Michelle Wsolakand Ms Emily Tonks from the GAP Secretariat and Australian Red Cross Blood Service risk management expertsMr Christopher Wheatley and Mr Mathew Manning.The week long programme included training workshops, a high level development forum and a number of meetingswith key stakeholders in Nepal including Dr Manita Rajkarnikar (Director of the NRCS NBTS), the Secretary Generalof the Nepal Red Cross Society, representatives of the governments National Public Health Laboratories, WHO andthe US Embassy. The meetings included discussions on the progress, challenges and future plans of the NRCSNBTS including the strategic plan developed with GAP.A review of the progress of the Blood Service to key challenges was undertaken and significant policy changesand issues were discussed, primarily including the revised national blood policy which permits new entrants toprovide blood in Nepal a significant shift in national direction. The role of the Ministry of Health in blood centreregulation and oversight, and the role of the Nepal Red Cross Society, in ensuring appropriate funding and selfsufficiency were discussed together with the recent WHO Essential medicines listing of blood and blood products.The team visited: Nepal Red Cross Society Central Blood Transfusion Service A district blood centre operated by the NRCS NBTS Tribhuvan University Teaching Hospital Blood Bank Centre Grande Private Hospital Blood BankThe equipment was funded by the Hong Kong Red Cross and was comprised of: Vertical Autoclave 100L (1) Manual Plasma Extractors (5) Stainless Steel sample racks, 48 tube capacity (25) Centrifuge Balance (1) Blood Refrigerator, 150 bag capacity (3)Dr Che Kit Lin (HKRC BTS) andDr Manita Rajkarnikar (Director,NRCS NBTS) showing the plaquesacknowledging equipment fundingfrom the Hong Kong Red Cross1112GAPANNUAL REPORT 2014GAPANNUAL REPORT 2014Training WorkshopsTwo training workshops were held for Nepal Red Cross Society Blood Service staff. The training participantsincluded technical representatives from the central, district and remote regional blood centres, and also includedparticipants from the Nepal Red Cross Society executive and management teams.Workshop 1: Blood donor care and counselling.The GAP delegation provided presentations to 28 participants on the donation process and targeted donor careand counselling recommendations, led by Dr Che Kit Lin. Participants performed donor counselling role playexercises, practising the techniques highlighted in the theory sessions. Each participant was provided with ahandbook outlining the material covered during the theory session together with additional reference information.It is intended that the handbooks may be circulated widely or used to base future internal training sessions withinthe NRCS NBTS and throughout the district and regional centres.Dr Che Kit Lin presenting at the training workshops in NepalWorkshop 2: The Risk Management Planning WorkshopThe workshop, which was attended by 47 participants, assisted the NRCS NBTS with the developmentof an appropriate risk management system by identifying key organisational risks which were capturedinto a risk register. A theoretical session on risk management was provided, followed by worked examplesand practical application of the risk management system to identify, prioritise and prepare treatment plansfor NRCS NBTS risks. Practical sessions were conducted in groups to assist in working through theprocess for risk management based on each particular area of technical expertise. A handbook outliningthe risk management system for further development and tailoring by the NRCS NBTS was providedto all participants, together with relevant reference material. The outcomes of the practical sessionsand group work were captured into a risk register, which was provided to the blood service Director.Development ForumA development forum was held where the 42 attendees (from NRCS NBTS executive/management,Nepals national Public Health Laboratories, IFRC, Nepal Red Cross Society, World Health Organisation,various embassies and UNICEF) were provided with presentations on National Blood System requirements,emerging policy issues, the progress of the national strategic plan, additional elements required for bestpractice and any current barriers to implementation. Group sessions and discussions were facilitated toengage the participants in the sessions, and to seek opportunities to leverage support and assistancefor the NRCS NBTS in achieving their strategic plan, and enabling delivery of an effective national bloodprogram for the people of Nepal.FeedbackParticipants at the training workshops in NepalDr Rajkarnikar reported at the GAP AsiaPacific regional meeting in September2014 that the training provided was highlyvalued and thanked GAP and the HongKong Red Cross for providing the bloodservice with this support. It was suggestedthat the materials provided during thetraining were so well regarded that theyshould be placed on the GAP websiteas a resource for other countries toaccess. As a result, the presentationshave been added to the GAP websiteand are available on the public pages.GAP team in Nepal with Dr ManitaRajkarnikar (Director, NRCS NBTS)ai1314GAPANNUAL REPORT 2014GAPANNUAL REPORT 20148.PRIORITY COUNTRIESNepalThe collaborative project between the Hong Kong Red Cross, Nepal Red Cross Society National Blood TransfusionService and GAP, completed during 2014, aimed to improve blood service capability through the provision of criticalequipment and staff training as well as guidance in the development of a risk management framework andimprovements to national policy and planning.In conjunction with the World Health Organisation (WHO) and Dr Che Kit Lin (GAP Asia Pacific Zonal Coordinator)and building on the outcomes of the 2014 Nepal training workshops, the Secretariat is coordinating a potential visitfor the Nepal Minister of Health and Nepal Red Cross Society Secretary General to visit Hong Kong and Australia.The purpose of the visit is to review well-functioning models within the region where National Society Blood Servicesoperate a single national blood program with government funding support*. The visit will enable the Nepal Ministryof Health and Secretary General to gain a detailed understanding of the governance, structural and operationalarrangements which support such models and which ensure effective and close cooperation with government.Nepals status as a GAP priority country will continue to be reviewed by the GAP Executive Board.The GAP website homepageGAP Website (IFRC Funding 2013-2014)The GAP website was developed to support GAP member, blood service and public access to materials,resources and tools and to provide users with direct links to GAP contacts and information.The development of the website was guided by member input from a user requirements survey which providedvaluable information on the content of the website that would be most useful to members. A detailed comparisonof potential website developers was undertaken, including consideration of critical factors such as security, cost,provision of ongoing maintenance, support and hosting arrangements, developer responsiveness, reputationand reliability.The Secretariat worked closely with the website developer during 2014 to finalise the design, features, content,security and access requirements.The GAP website was launched on 17th February 2015. Members were notified of the GAP website location,www.globaladvisorypanel.org and given their unique login to access the restricted member only pages on thesite. A link to the GAP website has been created on the IFRC Fednet website on the Blood Donation page.The website has: Public pages (open access) information about GAP and public events/tools GAP member pages (login required) restricted access documents, events and tools. Discussion forum - for members.15* The Nepal Government recently revised its blood policy to now permit agencies other than the Nepal Red Cross Society to provide blood.A number of national changes to the organisation, regulation and oversight of blood centres will be implemented in the near future and theaim of the visit is to show the Minister examples of effective models whereby the national blood program is delivered by RC/RC but fundedby government.BangladeshBangladesh was selected as a GAP priority country in May 2014, on the basis of their GAPSelf-assessment results in 2013, which identified a number of areas of potential significant risk.GAP delegates Dr Wolfgang Mayr and Ms Michelle Wsolak conducted an initial scoping visitof the Bangladesh Red Crescent Blood Service (BRCBS) from 24th 27th November, 2014.The purpose of the visit was to increase GAPs understanding of the Blood Service situationin Bangladesh, including the operational context of the Blood Service within the broader healthsector and coordination with other agencies, to assess and prioritise the key risk management and corporategovernance needs of the BRCBS in the provision of its blood program and to develop recommendations anda proposal for a future programme of GAP support to Bangladesh Red Crescent Blood Service for consideration.During the visit, the GAP delegates met key stakeholders in Bangladesh including: Dr Tarique Mehedi - Deputy Director and In-Charge BRCBS; Representatives from the Safe Blood Transfusion Expert Committee; WHO consultant - Dr Murad Sultan; Secretary General Bangladesh Red Crescent Society - BMM Mozharul Huq; IFRC country delegation Programme Coordinator Mr David Easson and Manager Health - Dr Abu Faruq.16GAPANNUAL REPORT 2014GAPANNUAL REPORT 2014HaitiThe priority country status of Haiti is currently on hold pending completion of their bilateral support programmes.IndonesiaThe priority country status of Indonesia is currently on hold pending completion of their bilateral support programmes.VietnamThe priority country status of Vietnam has been closed on the basis of information provided by the VietnamRed Cross that they are not involved in a Level A blood programme.Laboratory in HondurasGAP delegates in Bangladeshwith Bangladesh Red Crescent BloodService Deputy Director & In-ChargeDr Mehedi and WHO representative.The delegates also toured the BRCBS Dhaka Blood Centre Facility, a major maternity hospital blood bank(Mohammadbpur Fertility Services and Training Centre Dhaka) and attended a Voluntary Blood DonorCamp at Karwan Bazar sponsored by Bank Asia.A full report of the visit was provided to the BRCBS, including a number of prioritised recommendationsfor action, and proposed options for GAP support to BRCBS to assist in managing these key risk areas.The recommendations for the future of GAP support to Bangladesh are currently being finalised by GAPand the BRCBS Director.HondurasIn October 2013, a second workshop was held with Honduran Red Cross (HRC), Swiss Red Cross (SRC),and GAP to clarify the roles and responsibilities of HRC and prepare an action plan. Workshop outcomesincluded the development of a proposed new governing and organisational structure for the HonduranRed Cross National Society. In January 2014, GAP received advice from the Honduran Red Cross that theyhave adapted their governing structure according to GAPs recommendations, signalling significant progressin addressing this area of key risk. GAP has written to the HRC to formally endorse the proposed structure.GAP member Dr Rudolf Schwabe continues to support the bilateral project with Honduras, through the SwissRed Cross, to assist in strengthening the technical, administrative and governance capacity of the HonduranRed Crosss National Blood Program.1718GAPANNUAL REPORT 2014GAPANNUAL REPORT 20149. FINANCIAL REPORTGAP Income and Expenditure for period 1 January 2014 to 31 December 2014Opening balance at 1 January 2014NotesAUD accountCHF accountTotal CHFGAP accountsAustralian Account291,411Swiss Account236,693107,922107,922369,868107,922408,340AUD accountCHF accountTotal CHFIFRC Funding accountAustralian AccountCombined opening balance at 1 January 201478,457*Income63,7252014 Member ContributionsAmerica26,27721,343Australia26,34621,399Finland23,80919,339Israel24,96620,278Japan24,65420,025Switzerland25,29220,543Germany24,01019,502Austria24,81420,155Belgium25,34620,587Thailand24,99420,301250,508203,47177,58463,016Hong Kong - special statusHonduras - exemptsubtotal2014 IFRC funding IncomeIncome2014 Interest IncomeInterest- GAP Australian account11,555Interest - GAP Swiss account9,38544Interest - IFRC funding account2,805subtotal14,36023,831442,2784411,707Other IncomePayment from HKRC for Nepal Joint Project ContributionTotal IncomeExpenditure19,356366,28344297,550AUD AccountCHF AccountTotal CHFSecretariatSelf Assessment costsSecretariat costs#(40,354)(32,777)(89,906)(73,024)(125)(101)Specialist AdviceTranslation- Self assessment reports, GAP manual, questionnaireProfessional expertise eg legalStakeholder meetings (e.g. IFRC, WHO, ISBT)Travel & accommodationOther meeting expensesRegional meetingsMeeting costs269219(10,815)(8,785)Travel & accommodation(2,275)(1,848)Meeting venue/catering(3,457)(2,808)(907)(737)(3,324)(2,700)(16,637)(13,513)(21,413)(17,393)Participant costsAnnual General MeetingGAP networking events (dinner)Other expensesExecutive Board Meeting(s)Meeting venue/catering and travel accommodationTeleconferencesNepal (priority NS)GAP-HKRC Joint Project for Nepal - IFRC Funded ExpenditureGAP-HKRC Joint Project for Nepal - HKRC Funded ExpenditureHonduras (priority NS)Travel & accommodation(8,919)(8,919)Insurance(1,000)(1,000)Bank fees(72)(72)Other ExpensesContingency fundsIFRC funding expenditurePriority Country Support - Bangladesh(9,969)(8,097)(29,228)(23,740)Translation Costs(1,352)(1,098)Website Development(9,553)(7,759)Project SupportPriority Country Support - Nepal (Joint GAP Project with HKRC) refer aboveTotal Expenditure**(239,047)(9,991)Surplus/(Deficit)127,236(9,947)93,398Closing balance at 31 December 2014497,10497,975501,73819(204,152)Notes* Exchange rate as per XE Currency converter website 31 Dec 2014: 1 AUD = 0.8122324904 CHF** Cost Accrual not yet shown but fully expended. A further 6,476 CHF for Project Support will be incurred in January 2015.# Secretariat costs include salary and oncosts, phone, training, office supplies, postage, rent, other secretariat sundry expenses Cost incurred were for AUD 21,413 and invoice raised in Nov 2014 was for USD 20,132.47. Amount received in Dec 2014 wasfor AUD 23,831 as a result of exchange rate fluctuation as at date of payment.20
GAP Self-assessment (Spanish)
Grupo Mundial de Asesores en materia de estructura institucional y gestión de riesgo para las sociedades de la Cruz Roja y de la Media Luna Roja que participan en programas de sangre (GAP) Autoevaluación del GAP Versión 4.1 Diseñado para las Sociedades Nacionales que cuentan con servicios de sangre (nivel A) [INSERT MONTH ] de 2014 Si desea obtener más información y leer las instrucciones, consulte las guías de autoevaluación del GAP. País: Nombre del servicio de sangre: Nombre (s) persona (s) que completa la encuesta: Posición: Fecha en la que la completa: Una vez que la complete, envíe un correo electrónico a GAPSelfAssessment@redcrossblood.org.au (opción preferible) o envíela por fax al +61 8 6213 5949 Contenido Lista de acrónimos Sección A: cuestiones clave Cuestión clave Nº 1: condiciones mínimas Cuestión clave Nº 2: requisitos organizativos esenciales Cuestión clave Nº 3: protección contra los reclamos por daños y perjuicios Cuestión clave Nº 4: apoyo a las personas que reciben sangre infectada Cuestión clave Nº 5: la seguridad frente a los Cuestión clave Nº 6: financiación Cuestión clave Nº 7: información sobre los riesgos y las consecuencias relacionados con la sangre  Cuestión clave Nº 8: habilidades de gestión Cuestión clave Nº 9: fraccionamiento Sección B: generalidades sobre las actividades del servicio de Autosuficiencia del plasma Acuerdos bilaterales Próximos pasos recomendados Comentarios finales Lista de acrónimos AABB CdE Asociación American de Bancos de Sangre Consejo de Europa (Comité Europeo (acuerdo parcial) de transfusión sanguínea (CD-P-TS)) GAP Grupo Mundial de Asesores en materia de estructura institucional y gestión de riesgo de las sociedades de la Cruz Roja y de la Media Luna Roja que participan en programas de sangre Federación Internacional de sociedades de la Cruz Roja y de la Media Luna Roja Sociedad Nacional Autoevaluación del GAP Donación de sangre voluntaria y no remunerada Organización Mundial de la Salud FICR SN AE DSVNR OMS Sección A: Cuestiones clave Cuestión clave Nº 1: condiciones mínimas Aclaración: • Es importante que la gestión del servicio de sangre se base en los principios fundamentales de la FICR. • Las relaciones con las autoridades competentes del gobierno nacional y local deben estar claramente definidas para garantizar que el servicio de sangre siga siendo independiente. • La donación de sangre voluntaria y no remunerada es una política de la FICR; todos los servicios de sangre de las Sociedades Nacionales deberían contar con sistemas sanguíneos que se la DSVNR. • La implementación de un servicio de sangre debe incluir fuentes de ingresos sustentables y a largo plazo, así como instalaciones, suministros, equipo, personal y voluntarios suficientes que satisfagan las necesidades operativas. 1.1 ¿Se han establecido claramente las funciones y responsabilidades entre el servicio de sangre y Parcialment e (indique Sí No No se conoce No se aplica los detalles) el gobierno nacional los gobiernos locales la Sociedad Nacional Otras partes interesadas (por favor, especifique): por ejemplo, los hospitales Sírvase dar detalles: 1.1.1 Si la respuesta es SÍ, cómo se definen? (Seleccione todas las que apliquen) Memorando de entendimiento Contrato u Otros otro acuerdo (especifique a por escrito continuación) No se aplica el gobierno nacional los gobiernos locales la Sociedad Nacional Otras partes interesadas (por favor, especifique): por ejemplo, los hospitales Otro; especificar: 1.1.2 Si la respuesta es SÍ o Parcialmente: ¿las partes que se enumeran a continuación, asumen estas responsabilidades en forma activa? Sí Parcialment e (indique los detalles) No No se conoce No se aplica No No se conoce No se aplica el gobierno nacional los gobiernos locales la Sociedad Nacional Otras partes interesadas (por favor, especifique): por ejemplo, los hospitales Sírvase dar detalles: 1.2 ¿El gobierno de su país cuenta con una política nacional orientada a garantizar el suministro de sangre segura a través de la donación de sangre voluntaria y no remunerada (DSVNR)? Sí Parcialment e (indique los detalles) Sírvase dar detalles: 1.2.1 Si Contestó SI o Parcialmente Se han implementado estas políticas?  Cuál es el nivel de la DVNRS en su país?  Existen iniciativas para incrementar la DVNRS? Sírvase dar detalles: 1.2.2 Si Contestó NO:  Cuál es el nivel de la DVNRS en su país?  Existen iniciativas para incrementar la DVNRS? Sírvase dar detalles: Cuestión clave Nº 1: condiciones mínimas (cont.) 1.3 ¿El servicio de sangre es una entidad legal independiente de la Sociedad Nacional? Sí Parcialment e (indique los detalles) No No se conoce No se aplica Sírvase dar detalles: 1.4 Si el gobierno no financia completamente su servicio de sangre, ¿usted cuenta con una fuente de ingresos a largo plazo, suficiente y sustentable? Sí No No se conoce Sírvase dar detalles: 1.4.1 Si no,  Porqué?  Existen planes para cambiar esto? Sírvase dar detalles: 1.5 ¿El servicio de sangre cuenta con los recursos suficientes de las categorías que se enumeran a continuación como para cumplir con los requisitos reglamentarios? Sí, son suficientes No, escasez No, escasez considerable leve (*Sírvase (*Sírvase proporcionar proporcionar más más información) información) No se conoce instalaciones *Si la respuesta es No, escasez leve o No, escasez considerable, esto podría indicar un riesgo considerable en relación con los materiales, así que le solicitamos que a continuación brinde información más detallada en lo que respecta a la escasez de instalaciones y si se han desarrollado planes para mejorar esto. suministros *Si la respuesta es No, escasez leve o No, escasez considerable, esto podría indicar un riesgo considerable en relación con los materiales, así que le solicitamos que a continuación brinde información más detallada en lo que respecta a la escasez de suministros y si se han desarrollado planes para mejorar esto. equipo *Si la respuesta es No, escasez leve o No, escasez considerable, esto podría indicar un riesgo considerable en relación con los materiales, así que le solicitamos que a continuación brinde información más detallada en lo que respecta a la escasez de equipo y si se han desarrollado planes para mejorar esto. personal/voluntarios capacitados *Si la respuesta es No, escasez leveoNo, escasez considerable, esto podría indicar un riesgo considerable en relación con los materiales, así que le solicitamos que a continuación brinde información más detallada en lo que respecta a la escasez de personal/voluntarios capacitados y si se han desarrollado planes para mejorar esto. Cuestión clave Nº 1: condiciones mínimas (cont.) 1.6 ¿El servicio de sangre es capaz de garantizar la plena privacidad y confidencialidad de la información relacionada con los donantes? Sí Parcialment e (indique los detalles) Sírvase dar detalles: Si lo desea, puede incluir otros comentarios o información adicional para aclarar sus respuestas con respecto a esta sección: No No se conoce No se aplica Cuestión clave Nº 2: requisitos organizativos esenciales Aclaración: El GAP recomienda que las Sociedades Nacionales que ofrecen un programa de sangre deben establecer un servicio de sangre separado que cuente con una junta profesional de gobierno al que se le haya delegado la responsabilidad de llevar a cabo las tareas de dirección estratégica y la supervisión del desempeño operativo. Las habilidades y los conocimientos particularmente útiles para los miembros de la junta incluyen los que se relacionan con la gestión médico-científica y las áreas económico-financiera, política y legal. 2.1 ¿La Sociedad Nacional cuenta con una junta de gobierno separada para el servicio de sangre a la que le hayan delegado responsabilidades y el control de la planificación estratégica y la gestión operativa, y que le hayan conferido la autoridad financiera sobre el programa de sangre? Sí Parcialme nte (indique los detalles) No No se conoce No se aplica No No se conoce No se aplica No No se conoce No se aplica No No se conoce No No se conoce Sírvase dar detalles: 2.1.1 Si la respuesta es SÍ, ¿La Sociedad Nacional tiene un sistema bien definido para delegar tareas que es claro en lo que respecta a la autoridad y la responsabilidad entre: Sí Parcialme nte (indique los detalles) la Sociedad Nacional y las juntas del servicio de sangre? la junta de los servicios de sangre y la gerencia de los servicios de sangre? Sírvase dar detalles: 2.1.2 Si la respuesta es SÍ, ¿Su servicio de sangre tiene las habilidades y los conocimientos para implementar y gestionar el cambio, mantener las funciones y responsabilidades estrictas y cumplir con sus responsabilidades según el Q2.1? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: 2.2 Existe una estructura organizativa apropiada para la junta de gobierno del servicio de sangre? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: 2.2.1 Si la respuesta es SÍ, Su servicio de sangre, ¿se basa en un modelo de organización a escala nacional? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: Si lo desea, puede incluir otros comentarios o información adicional para aclarar sus respuestas con respecto a esta sección: Cuestión clave Nº 3: protección contra los reclamos por daños y perjuicios Aclaración: • Se prefiere que las Sociedades Nacionales cuenten con una cobertura de seguros para las actividades del programa de sangre. • Los servicios de sangre deben tener una definición clara de su relación con el gobierno y el papel que desempeña el gobierno en lo que respecta a proteger la Sociedad Nacional contra llos reclamos y los daños. • El cuidado adecuado de los pacientes que sufren efectos adversos como resultado de la terapia de transfusión de sangre representa un problema importante para la • Lo ideal es que los servicios de sangre participen en la capacitación de la población acerca de los posibles riesgos de las transfusiones. • Asimismo, deben llevar registros precisos y conservarlos de manera segura. 3.1 La protección del gobierno (legal/financiera), ¿prevé la prestación de servicios de sangre o de los bancos de sangre y tejidos? Sí Parcialme nte (indique los detalles) No No se conoce No se aplica No No se conoce No se aplica No No se conoce No se aplica No No se conoce No se aplica No No se conoce No se aplica No No se conoce No se aplica Sírvase dar detalles: 3.2 ¿Se ha establecido una estructura corporativa separada entre la Sociedad Nacional y el servicio Sí de sangre para proteger los fondos de la Sociedad Nacional contra los daños relacionados con la (especifiqu prestación de los servicios de sangre? e los detalles) 3.2a Si la respuesta es SÍ, o PARCIALMENTE: Parcialme nte (indique los detalles) Sírvase dar detalles: 3.3 ¿El servicio de sangre funciona de acuerdo con las normas internacionales (por ejemplo, OMS, AABB, CdE) en relación con los programas de sangre? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: 3.3.1 Si la respuesta es SÍ, o PARCIALMENTE, ¿qué norma(s) utiliza el servicio de sangre? Sírvase dar detalles: 3.4 Cuando el servicio de sangre no cumple con las normas internacionales en cuanto a la ejecución de los programas de sangre, ¿se documenta el motivo? Sí Parcialme nte (indique los Sírvase dar detalles: 3.5 Cuando el servicio de sangre no cumple con las normas internacionales en cuanto a la ejecución de los programas de la sangre, ¿el gobierno reconoce y acepta el motivo? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: 3.6 ¿El servicio de sangre realiza campañas con el objetivo de aumentar la conciencia pública acerca de: Sí Parcialme nte (indique los detalles) 1. el hecho de que no es posible tener un riesgo cero con la terapia de transfusión de sangre? 2. la necesidad de equilibrar el riesgo de transfusión con el riesgo de no realizar la transfusión? 3. los logros en lo que respecta a la mitigación de los riesgos y los riesgos restantes? Sírvase dar detalles: Cuestión clave Nº 3: protección contra los reclamos por daños y perjuicios (cont.) 3.6.1 Si la respuesta es SÍ, ¿Con qué frecuencia se llevan a cabo las campañas? Sírvase dar detalles: 3.7 ¿El servicio de sangre desarrolló los sistemas para informar a los médicos sobre los posibles riesgos de las transfusiones? Si la respuesta es afirmativa, ¿cómo? Sí Parcialme nte (indique los detalles) No No se conoce No se aplica No No se conoce No se aplica No No se conoce No se aplica No No se conoce No se aplica Sí, Sí, por lo periódicam menos una ente. vez por año. No No se conoce Parcialme nte (indique los detalles) No No se conoce Información en el sitio web Folletos Redes clínicas informales Reuniones regionales Participación en los comités de transfusión hospitalarios otro; especificar: Sírvase dar detalles: 3.8 ¿El servicio de sangre cuenta con una política de retención de registros de donantes y de donaciones? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: 3.9 ¿El servicio de sangre, cuenta con una cobertura de seguros contra las posibles responsabilidades que figuran a continuación? Sí Parcialme nte (indique los detalles) pérdida de la propiedad responsabilidad civil responsabilidad en relación con la sangre y los hemoderivados responsabilidad de directores y funcionarios responsabilidad profesional fraude interno lesión de los donantes manipulación maliciosa del producto Sírvase dar detalles: 3.10 Si la respuesta es SÍ, ¿la cobertura del seguro es suficiente? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: 3.11 ¿El servicio de sangre recibe asesoramiento profesional acerca de los niveles y los tipos de coberturas de seguros? 3.12 ¿El servicio de sangre recibe protección comercial o gubernamental en relación con las enfermedades que se transmiten a través de la sangre? Sí Sírvase dar detalles: Si lo desea, puede incluir otros comentarios o información adicional para aclarar sus respuestas con respecto a esta sección: No se aplica Cuestión clave Nº 4: apoyo a las personas que reciben sangre infectada Aclaración: : las Sociedades de la Cruz Roja y de la Media Luna Roja deben demostrar compasión por todas las personas que reciben sangre infectada. El servicio de sangre no se hace responsable del riesgo de infección, que es inherente a los productos sanguíneos. Sin embargo, es apropiado que la Sociedad Nacional les brinde apoyo a las personas que sufren este tipo de complicaciones. Esto puede incluir asistencia financiera, psicológica, médica o social. 4.1 ¿El servicio de sangre o el departamento de salud cuentan con un mecanismo para brindar asistencia a las personas que reciben sangre infectada? Sí Parcialme nte (indique los No No se conoce No se aplica No No se conoce No se aplica No No se conoce No se aplica No No se conoce No se aplica No No se conoce No se aplica Sírvase dar detalles: 4.1.1 Si contestó No, que agencia les brinda apoyo a estos Sírvase dar detalles: receptores? 4.2 ¿El servicio de sangre o el departamento de salud brindan una compensación económica a las personas que reciben sangre infectada? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: 4.3 ¿El servicio de sangre o el departamento de salud brindan apoyo psicológico profesional a las personas que reciben sangre infectada? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: 4.4 ¿El servicio de sangre o el departamento de salud proporcionan asistencia médica a las personas que reciben sangre infectada? Sí Parcialme nte (indique los Sírvase dar detalles: 4.5 ¿El servicio de sangre o el departamento de salud brindan apoyo social a las personas que reciben sangre infectada? Por ejemplo, en las conversaciones de apoyo acerca de los seguros de salud Sí Parcialme nte (indique los Sírvase dar detalles: Si lo desea, puede incluir otros comentarios o información adicional para aclarar sus respuestas con respecto a esta Cuestión clave Nº 5: La seguridad frente a los costos Aclaración: • Estas preguntas abordan cuestiones relacionadas con el equilibrio entre la seguridad, el costo y la disponibilidad. • A pesar de que hay una tendencia continua hacia la mejora de la seguridad de los productos sanguíneos, es importante asegurarse de que no se esté reemplazando un riesgo pequeño con un riesgo desconocido que posiblemente sea mayor. Además, los esfuerzos para aumentar la seguridad pueden afectar la disponibilidad de productos sanguíneos en general. • Estar pendiente de las amenazas emergentes y de la capacitación de los organismos gubernamentales en lo que se refiere a las nuevas medidas de seguridad representan funciones importantes del servicio de sangre. • Los mecanismos de revisión para rastrear el uso del producto y asegurar que los componentes de la sangre se utilicen de manera adecuada dentro de los hospitales constituyen otra preocupación clave. 5.1 ¿El servicio de sangre realiza un análisis de costos de todas las nuevas propuestas destinadas a mejorar la seguridad? Sí Parcialme nte (indique los detalles) No No se conoce No No se conoce No No se conoce No No se conoce Sírvase dar detalles: 5.2 ¿El servicio de sangre informa activamente a los organismos gubernamentales acerca de la importancia de contar con una financiación adecuada para las nuevas iniciativas vinculadas con la seguridad de la sangre y las consecuencias de no financiarlas? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: 5.3 ¿El servicio de sangre cuenta con sistemas para controlar las nuevas amenazas a la seguridad del suministro de sangre (por ejemplo, control de las enfermedades de la región)? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: 5.4 ¿El servicio de sangre implementó sistemas para asegurar que se cumpla con los siguientes cuatro aspectos de la seguridad relacionados con las transfusiones de sangre (y asegurar el mejor resultado para el paciente): Sí Parcialme nte (indique los detalles) Se brinda la sangre correcta. Se brinda el producto al paciente correcto. Se brinda el producto en el momento correcto. Se cuenta con el mecanismo de revisión correcto. Sírvase dar detalles: Cuestión clave Nº 5: la seguridad frente a los costos (cont.) 5.5 ¿El servicio de sangre tiene como objetivo influir sobre el uso adecuado del producto, o acerca de su almacenamiento, tratamiento, desperdicio mínimo, etc.? Sí Parcialme nte (indique los detalles) No No se conoce No No se conoce Sírvase dar detalles: 5.5.1 Si la respuesta es SÍ, ¿Cómo? Especifique: indique el porcentaje de usuarios finales en relación con los cuales hay un acuerdo por escrito. 5.6 ¿Los hospitales que utilizan productos sanguíneos que provienen de su servicio de sangre cuentan con un comité multidisciplinario activo de transfusiones? Sí Parcialme nte (indique los detalles) Hospitales públicos Hospitales privados Hospitales sin fines de lucro Clínicas Fuerzas armadas otro; especificar: Sírvase dar detalles: 5.6a ¿Qué porcentaje del total nacional representan los siguientes usuarios: Hospitales públicos Hospitales privados Hospitales sin fines de lucro Clínicas Fuerzas armadas otro; especificar: 5.6.1 Si la respuesta es SÍ o PARCIALMENTE, ¿El servicio de sangre participa % % % % % % Sí No No se conoce Parcialme nte (indique los detalles) No comités? 5.7 ¿El servicio de sangre participa en el desarrollo de regulaciones, junto con las autoridades sanitarias competentes? Sí Sírvase dar detalles: 5.8 Aproximadamente, ¿qué porcentaje de su suministro de sangre proviene de donantes DSVNR? % No se conoce Cuestión clave Nº 5: la seguridad frente a los costos (cont.) Si lo desea, puede incluir otros comentarios o información adicional para aclarar sus respuestas con respecto a esta sección: Cuestión clave Nº 6: financiación Aclaración: Se deben implementar acuerdos financieros suficientes y  a largo plazo que debe revisar la sociedad local de la Cruz Roja o de la Media Luna Roja antes de iniciar o seguir participando en un programa de sangre. La mejor manera de asegurar finanzas sustentables es a través de la recuperación de los costos o la financiación del gobierno, aunque en algunas áreas se aceptaría el uso de donaciones. La transferencia de fondos entre las Sociedades Nacionales y los servicios de sangre deben realizarse en el marco de los acuerdos de servicio adecuados. La existencia de acuerdos financieros transparentes y sustentables dentro de los servicios de sangre, y entre el servicio de la sangre y de la sociedad de la Cruz Roja o de Media Luna Roja constituye una prioridad. 6.1 ¿Qué porcentaje de su presupuesto total de servicios de sangre proviene: Especifique el porcentaje en cada caso: 6.1.1 del gobierno % 6.1.2 de los hospitales % 6.1.3 la refacturación de los costos a los usuarios finales % 6.1.4 de las actividades de financiamiento internas % 6.1.5 de su Sociedad Nacional % 6.1.6 de otras Sociedades Nacionales % 6.1.7 de las ONG (organizaciones no gubernamentales) y los fondos internacionales % 6.1.8 del sistema de seguro de salud público/privado % 6.1.9 Otro (especificar): % 6.2 ¿El servicio de sangre asegura que ni las organizaciones sin fines de lucro ni los proveedores tienen participación alguna en el capital o en el control de la gestión del programa de sangre? Sí Parcialme nte (indique los detalles) No No se conoce No No se conoce No No se conoce Sírvase dar detalles: 6.3 ¿El servicio de sangre cuenta con una política para asegurar que no exista un conflicto de intereses con: Sí Parcialme nte (indique los detalles) los miembros de la junta el personal profesional los voluntarios Sírvase dar detalles: 6.4 ¿El servicio de sangre cuenta con una política para asegurar que no exista un conflicto de intereses en relación con los principales proveedores? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: Cuestión clave Nº 6: Financiación (cont.) 6.5 ¿Existe un acuerdo formal para gestionar el acceso de la Sociedad Nacional a los fondos del servicio de sangre? 6.6 Sí; la SN no puede acceder a los fondos. Sí; el acuerdo formal le permite acceder a los fondos a la la SN, según corresponda. No No se conoce Otro : (Especifique los detalles a continuación) No se aplica Sírvase dar detalles: ¿Se separaron los fondos del servicio de sangre para que el servicio de sangre los utilice? Sí Parcialme nte (indique los detalles) No No se conoce No se aplica No No se conoce No se aplica No No se conoce No se aplica Sírvase dar detalles: 6.7 ¿La Sociedad Nacional subsidia el servicio de sangre? Parcialme Sí nte (especifiq (indique ue los los detalles) detalles) Sírvase dar detalles: 6.8 ¿Los fondos del servicio de sangre se destinan a otras actividades de la Cruz Roja que no se relacionan con el servicio de sangre? Parcialme Sí nte (especifiq (indique ue los los detalles) detalles) Sírvase dar detalles: Cuestión clave Nº 6: Financiación (cont.) 6.9 ¿La Sociedad Nacional y el servicio de sangre llevan sistemas de contabilidad separados? Sí Parcialme nte (indique los detalles) No No se conoce Sírvase dar detalles: Si lo desea, puede incluir otros comentarios o información adicional para aclarar sus respuestas con respecto a esta sección: No se aplica Cuestión clave Nº 7: información sobre los riesgos y las consecuencias relacionados con la sangre Aclaración: : Es importante que los servicios de sangre de las Sociedades de la Media Luna Roja y de la Cruz Roja capaciten adecuadamente tanto al público en general como a las otras partes, tales como la  Sociedad Nacional, el gobierno, las universidades de medicina y el personal de los servicios de sangre con el fin de que comprendan mejor cuáles son los riesgos inherentes a las transfusiones de sangre. 7.1 ¿Los pacientes tienen que dar su consentimiento informado y por escrito antes de la transfusión? Sí Parcialme nte (indique los detalles) No No se conoce No se aplica No No se conoce No se aplica No No se conoce No No se conoce Sírvase dar detalles: 7.1.1 ¿El servicio de sangre trabaja junto con los hospitales para asegurar la iplementación de una política o de procedimientos que exijan que los pacientes den su consentimiento informado y por escrito antes de la transfusión? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: 7.2 ¿El servicio de sangre desarrolló e implementó estrategias destinadas a mejorar la información que recibe el público en relación con la seguridad de los riesgos de la donación y las transfusiones de sangre? Sí Parcialme nte (indique los detalles) Programas escolares Medios (incluidos los medios de comunicación social) Información en el sitio web Folletos Redes informales La capacitación de los donantes La ubicación de representantes en los órganos adecuados de toma de Otro (especificar): Sírvase dar detalles: 7.2.1 ¿Las estrategias mencionadas se están implementando? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: Cuestión clave Nº 7: información sobre los riesgos y las consecuencias relacionados con la sangre (cont.) 7.3 ¿El servicio de sangre brinda capacitación sobre los riesgos de la transfusión de sangre a otras partes interesadas, tales como: Sí Parcialme nte (indique los detalles) No No se conoce No No se conoce la Sociedad Nacional del gobierno universidades de medicina personal del servicio de sangre Otro (especificar): Sírvase dar detalles: 7.4 ¿El servicio de sangre realiza campañas periódicas para educar al público acerca de la necesidad de donar sangre con regularidad? Parcialme Sí nte (especifiq (indique ue los los detalles) detalles) Sírvase dar detalles: Si lo desea, puede incluir otros comentarios o información adicional para aclarar sus respuestas con respecto a esta sección: Cuestión clave Nº 8: Habilidades de gestión Aclaración: Con el fin de lograr y mantener un buen nivel de gestión en los servicios de sangre de la Sociedad Nacional, se debe contar con una visión y una misión claras, objetivos estratégicos, así como medios para medir el progreso hacia la consecución de estos objetivos. 8.1 ¿El servicio de sangre tiene lo siguiente? Sí Parcialme nte (indique los detalles) No No se conoce No No se conoce No No se conoce una visión clara una misión clara un plan estratégico objetivos estratégicos Sírvase dar detalles: 8.2 Si los hay, ¿los objetivos estratégicos del servicio de sangre: Sí Parcialme nte (indique los detalles) establecen responsabilidades claras abordan las necesidades del donante abordan las necesidades del receptor abordan las necesidades del médico Sírvase dar detalles: 8.3 ¿Se han establecido y puesto en práctica objetivos e indicadores clave de desempeño (por ejemplo, porcentaje de disminución en el tiempo de lesiones del personal, porcentaje de disminución del desperdicio del producto)? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: Cuestión clave Nº 8: habilidades de gestión (cont.) 8.4 ¿Existen programas de capacitación orientados a mantener y desarrollar las habilidades de gestión y liderazgo? Sí Parcialme nte (indique los detalles) No No se conoce Sírvase dar detalles: Si lo desea, puede incluir otros comentarios o información adicional para aclarar sus respuestas con respecto a esta sección: Cuestión clave Nº 9: fraccionamiento Aclaración: • En los países desarrollados, no es conveniente que la Cruz Roja / Media Luna Roja comience a realizar actividades de fraccionamiento por el riesgo de descartes masivo, a menos que la escala de la operaciones en ese país permita que sea viable. • En los países en desarrollo, la Sociedad Nacional puede considerar la posibilidad de llevar a cabo el fraccionamiento si esta es la única manera de obtener productos derivados del plasma, pero solo si se obtiene el apoyo adecuado de la autoridad gubernamental. • Si se debe descartar el plasma, se les debe advertir a los donantes. • Antes de que las Sociedades Nacionales fraccionen o tercericen la tarea a otros fraccionadores, las autoridades gubernamentales competentes deben aprobar la fabricación y los procesos de comercialización del producto. • La posición de la FICR es que la autosuficiencia de un país es un asunto de la política del gobierno de ese país. 9.1 ¿El gobierno cuenta con una política nacional de autosuficiencia en relación con los productos sanguíneos que incluye los productos de plasma? Sí Parcialme nte (indique los detalles) No No se conoce No No se conoce No No se conoce No No se conoce Sírvase dar detalles: 9.2 ¿El servicio de sangre opera una o más plantas de fraccionamiento? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: 9.2.1 ¿El servicio de sangre o la Sociedad Nacional planean participar de alguna manera en la operación de plantas de fraccionamiento en el futuro inmediato? Sí Parcialme nte (indique los Sírvase dar detalles: 9.3 ¿El servicio de sangre o la Sociedad Nacional envían plasma para que un fraccionador externo lo fraccione? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: Cuestión clave 9: Fraccionamiento (cont.) 9.3.1 Si la respuesta es la respuesta es No, ¿el servicio de sangre o la Sociedad Nacional planea comenzar a enviar plasma para su fraccionamiento? Sí Parcialme nte (indique los detalles) No No se conoce No No se conoce No No se conoce No No se conoce Sírvase dar detalles: 9.4 Si el servicio de la sangre o la Sociedad Nacional llevan a cabo actividades de fraccionamiento de plasma, ¿el servicio de sangre informa a los donantes cuando se desecha el plasma? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: 9.5 Si el servicio de sangre o la Sociedad Nacional llevan a cabo actividades de fraccionamiento de plasma, ¿se trata de una actividad transparente y se rinde cuentas frente a los donantes? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: 9.5.1 Si la respuesta es SÍ o PARCIALMENTE, ¿qué hace el servicio de sangre Sírvase dar detalles: para garantizar la transparencia y la rendición de cuentas? 9.6 Si el servicio de sangre o la Sociedad Nacional llevan a cabo actividades de fraccionamiento de plasma o envían plasma para su fraccionamiento a una planta de fraccionamiento externa, ¿se cuenta con la aprobación oficial del gobierno con respecto al proceso de fabricación o comercialización? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: Si lo desea, puede incluir otros comentarios o información adicional para aclarar sus respuestas con respecto a esta sección: Sección B: Generalidades sobre las actividades del servicio de sangre  Por favor proporcione una breve descripción de su servicio de sangre y los datos más recientes a los que usted tenga acceso. Esta sección le ayudará a establecer un panorama general de las actividades relacionadas con la sangre en su Sociedad Nacional, y ayudar a evaluar el progreso en el tiempo. País Nombre de la organización Año de inicio del servicio de sangre Número de empleados de la Sociedad Nacional involucrados en el servicio de sangre (no los miembros del personal del hospital) Presupuesto anual actual Especifique año al que se refiere este presupuesto (especificar mes y año de inicio y de finalización) 0 0 [Especificar la moneda] a Desde Si hay otros proveedores de servicios de sangre en su país, sírvase enumerarlos (por ejemplo, los cinco proveedores principales)       junto con el porcentaje aproximado de participación en la cobertura del servicio en general: Nombre                         % de participación 1. 2. 3. 4. 5. Por favor adjunte su: estructura de gobierno organigrama Socios que prestan apoyo técnico (especificar) Número de lugares fijos Número de lugares móviles Número total de tomas por año* Cantidad de sangre total por año * De corresponder, indique el número de extracciones de aféresis: -> Plasma (unidades de aféresis de plasma al año) -> Plaquetas Unidades ml por unidad -> Los glóbulos rojos (unidades de aféresis de plaquetas/año) De corresponder, especifique la cantidad anual de plasma destinado al fraccionamiento* (en toneladas): * Si el año de las extracciones difiere al del presupuesto, especifique el año al que se refieren las extracciones [Insertar el mes/el año] [Insertar el mes/el año] a: a Autosuficiencia del plasma ¿La cantidad de plasma para fraccionamiento es suficiente para satisfacer las necesidades de su país? Sí No Si la respuesta es No,, Por favor indique los 5 productos de fraccionamiento principales por fuente: Producto 1. 2. 3. 4. 5. Importado de País Empresa Sección B: generalidades sobre las actividades de los servicios de sangre (cont.) ¿Usted tiene un excedente de plasma o productos de plasma?             Si la respuesta es SÍ, ¿qué ocurre con los productos excedentes? descartado vendido a [Especificar el país] [Especificar el país] vendido a Otro; especificar:       Si se venden diferentes productos a diferentes países, especifique a continuación: Sí No para recuperar el costo para obtener una gan       ¿Su servicio de sangre participa actualmente de cualquiera de las siguientes terapias con células o tejidos? Sí No Células madre del cordón umbilical Células madre de sangre periférica Células madre de médula ósea Trasplante de órganos macizos Hueso Córnea Otro (especificar): Si la respuesta es SÍ, indique el nivel y tipo de actividad y el alcance de la participación (por ejemplo, Registry Collection / cosecha, el procesamiento, el almacenamiento, las pruebas) ¿Su servicio de sangre está planificando participar en cualquiera de las siguientes terapias de células o tejidos en los próximos uno a dos años? Sí No Células madre del cordón umbilical Células madre de sangre periférica Células madre de médula ósea Trasplante de órganos macizos Hueso Córnea Otro (especificar): Si la respuesta es SÍ, indique los detalles de la actividad prevista y el alcance de la participación (por ejemplo, Registry Collection / cosecha, el procesamiento, el almacenamiento, las pruebas) Sección B: generalidades sobre las actividades de los servicios de sangre (cont.) Acuerdos bilaterales ¿Participa de algún programa de apoyo bilateral en relación con su servicio de sangre? Sí No Si SÍ, indique los detalles: ¿Recibe fondos de otras fuentes para respaldar los acuerdos bilaterales? Sí No Si la respuesta es SÍ, indique los detalles: Historias de éxito ¿Estaría dispuesto a compartir algunas de sus historias de éxito local con otros servicios de sangre de la Cruz Roja Media Luna Roja? Sí No Próximos pasos Próximos pasos recomendados El objetivo de la autoevaluación es permitirles a las Sociedades Nacionales y sus servicios de salud que identifiquen los problemas a los que se les debe prestar más atención. Cada pregunta de la AE describe una condición que, si no se cumple, representa un riesgo para el servicio de sangre y su SN. Un plan que aborde cada una de las condiciones que no se cumplen, comenzando con aquellas que se incluyen en la cuestión clave Nº 1, deberían reducir considerablemente el nivel de riesgo del servicio de sangre y de la Sociedad Nacional. Para ayudar al servicio de sangre a enfrentar los riesgos que se identificaron, el GAP le brindará un informe de autoevaluación individual que contenga recomendaciones para gestionar los riesgos. Mientras tanto, el GAP recomendó una variedad de “próximos pasos” para que tenga en cuenta el servicio de sangre: Gobierno y gerencia  Establecer un grupo de trabajo junto con la Sociedad Nacional o con el servicio de sangre para revisar la estructura de gobierno y la gerencia actuales, y preparar un plan estratégico.  Pensar en la posibilidad de obtener asistencia o asesoramiento especializado en relación con cuestiones de gobernanza y gerencia de parte de otras Sociedades Nacionales o servicios de sangre, o contratar un asesor externo especializado en la materia.  El grupo de trabajo o el asesor podrían considerar lo siguiente: ○ si la estructura actual ofrece la supervisión adecuada y si las responsabilidades están claramente definidas; ○ si debería separarse la gerencia del servicio de sangre y la de la Sociedad Nacional; ○ si el servicio de sangre debería formar parte de una entidad legal separada de la Sociedad Nacional; ○ una estructura que incluya una junta de supervisión (que cuente con funciones de supervisión estratégica); ○ un máximo responsable ejecutivo (responsable de las gestiones diarias y de presentar informes ante la junta) y ○ un equipo de gerentes experimentados (que responda ante el máximo responsable ejecutivo) podría funcionar. Gestión de problemas legales y riesgos  Identificar las bases legislativas y normativas que rigen las operaciones del servicio de sangre. Evaluar si las leyes y normas actuales: ○ establecen con precisión cuál es la relación entre la gerencia del servicio de sangre y las autoridades gubernamentales; ○ regulan las actividades del servicio de manera adecuada; ○ le brindan alguna protección o indemnización frente a los reclamos legales.  Considerar si es necesario modificar las leyes y cuál es la mejor manera de lograr tales modificaciones.  Considerar la posibilidad de conversar con el gobierno y con las autoridades sanitarias competentes con el fin de obtener su apoyo en relación con esas propuestas.  Crear un equipo de gestión de riesgos dentro del servicio de sangre con el objetivo de que evalúen las actividades del servicio y preparen las políticas para identificar, minimizar y eliminar riesgos. Financiación y seguro  Revisar cuáles son las fuentes de financiación y los posibles flujos de ingresos. Evaluar si los contratos de servicios actuales (si los hubiera) con la Sociedad Nacional y los organismos públicos son suficientes o si es necesario modificarlos.  Solicitar asesoramiento acerca de la disponibilidad y el costo de obtener una cobertura de riesgos integral para el servicio y el personal. Políticas y estándares  Realizar una auditoría operativa con el fin de evaluar el grado de cumplimiento con los estándares de los programas de sangre internacionales. Identificar cuáles son los pasos que se deben realizar para mejorar el cumplimiento.  Revisar las políticas operativas (por ejemplo, las políticas para seleccionar y capacitar al personal, conservar documentos, las relacionadas con el consentimiento fundamentado de los pacientes, la información que se le brinda al público y las relaciones con los medios de comunicación, entre otros).  Establecer prioridades y revisar de manera sistemática las cuestiones y los puntos clave de la autoevaluación e incorporarlos en la política y los materiales de planificación.  Repetir la autoevaluación en forma periódica para verificar el avance. Comentarios finales Comentarios finales: El Grupo Mundial de Asesores agradece los comentarios relacionados con el proceso de completar esta autoevaluación. Estamos interesados ​en conocer quiénes participaron, recibir sugerencias o cualquier comentario adicional. GRACIAS Muchas gracias por su participación en la autoevaluación. Si usted tiene alguna otra información o retroalimentación que usted desea ofrecer, por favor, dirigirse por correo electrónico a: GAPSelfAssessment@redcrossblood.org.au Recibirá su informe de comentarios individual una vez que se termine el proceso de autoevaluación dentro de su región.
GAP Self-assessment (Arabic)
‫اﻟﻔرﯾﻖ اﻻﺳﺗﺷﺎري اﻟﻌﺎﻟﻣﻲ )‪ (GAP‬ﻋﻠﻰ ﺣوﻛﻣﺔ اﻟﺷرﻛﺎت وإدارة اﻟﻣﺧﺎطر ﻟﺧدﻣﺎت اﻟدم ﻓﻲ ﺟﻣﻌﯾﺎت اﻟﺻﻠﯾب‬ ‫اﻷﺣﻣر واﻟﮭﻼل اﻷﺣﻣر‬ ‫اﻟﺗﻘﯾﯾم اﻟذاﺗﻲ ‪GAP‬‬ ‫اﻹﺻدار ‪4.1‬‬ ‫ﻣﺻﻣﻣﺔ ﻟﻠﺟﻣﻌﯾﺎت اﻟوطﻧﯾﺔ اﻟﻌﺎﻣﻠﺔ ﻓﻲ ﺧدﻣﺎت اﻟدم )اﻟﻣﺳﺗوى أ(‬ ‫]إدراج ﺷﮭر[ ‪2014‬‬ ‫ﯾرﺟﻰ اﻟرﺟوع إﻟﻰ إرﺷﺎدات اﻟﺗﻘﯾﯾم اﻟذاﺗﻲ ‪ GAP‬ﻟﻠﻣﻌﻠوﻣﺎت اﻟﻌﺎﻣﺔ واﻟﺗﻌﻠﯾﻣﺎت‬ ‫اﻟدوﻟﺔ‪:‬‬ ‫اﺳم ﺧدﻣﺔ اﻟدم‪:‬‬ ‫اﺳم )اﺳﻣﺎء( اﻷﺷﺧﺎص اﻟذﯾن ﯾﺳﺗﻛﻣﻠون اﻻﺳﺗﺑﯾﺎن‪:‬‬ ‫اﻟﻣﻧﺻب‪:‬‬ ‫ﺗﺎرﯾﺦ اﻹﻧﺗﮭﺎء‪:‬‬ ‫وﺑﻣﺟرد اﻻﻧﺗﮭﺎء‪،‬‬ ‫ﯾرﺟﻰ إرﺳﺎﻟﮫ ﻋﺑر اﻟﺑرﯾد اﻹﻟﻛﺗروﻧﻲ ‪) GAPSelfassessment@redcrossblood.org.au‬ﯾُﻔﺿل(‬ ‫أو اﻟﻔﺎﻛس إﻟﻰ ‪5949 6213 8 61+‬‬ ‫اﻟﻣﺣﺗوﯾﺎت‬ ‫ﻗﺎﺋﻣﺔ اﻻﺧﺗﺻﺎرات‬ ‫اﻟﻘﺳم أ ‪ -‬اﻟﻘﺿﺎﯾﺎ اﻟرﺋﯾﺳﯾﺔ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :1‬اﻟﺣد اﻷدﻧﻰ ﻣن اﻟﺷروط‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :2‬اﻟﻣﺗطﻠﺑﺎت اﻟﺗﻧظﯾﻣﯾﺔ اﻷﺳﺎﺳﯾﺔ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :3‬ﺣﻣﺎﯾﺔ ﺿد اﻟﻣطﺎﻟﺑﺎت ﻋن اﻷﺿرار‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :4‬اﻟدﻋم ﻟﻠﻣﺗﻠﻘﯾن ﻟﻠدم اﻟﻣﻠوث‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :5‬اﻟﺳﻼﻣﺔ ﻣﻘﺎﺑل اﻟﺗﻛﻠﻔﺔ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :6‬اﻟﺗﻣوﯾل‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :7‬اﻟﻣﻌرﻓﺔ ﺑﺷﺄن ﻣﺧﺎطر اﻟدم وﻋواﻗﺑﮫ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :8‬اﻟﻣﮭﺎرات اﻹدارﯾﺔ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :9‬اﻟﺗﻘﺳﯾم‬ ‫اﻟﻘﺳم ب ‪ -‬ﻧظرة ﻋﺎﻣﺔ ﻋﻠﻰ أﻧﺷطﺔ ﺧدﻣﺎت اﻟدم‬ ‫اﻻﻛﺗﻔﺎء اﻟذاﺗﻲ ﻟﻠﺑﻼزﻣﺎ‬ ‫اﻻﺗﻔﺎﻗﯾﺎت اﻟﺛﻧﺎﺋﯾﺔ‬ ‫اﻟﺧطوات اﻟﻣﻘﺑﻠﺔ اﻟﻣوﺻﻰ ﺑﮭﺎ‬ ‫اﻟﺗﻌﻠﯾﻘﺎت اﻟﻧﮭﺎﺋﯾﺔ‬ ‫ﻗﺎﺋﻣﺔ اﻻﺧﺗﺻﺎرات‬ ‫‪AABB‬‬ ‫‪CofE‬‬ ‫اﻟﺟﻣﻌﯾﺔ اﻷﻣرﯾﻛﯾﺔ ﻟﺑﻧوك اﻟدم‬ ‫ﻣﺟﻠس أوروﺑﺎ )اﻟﻠﺟﻧﺔ اﻷوروﺑﯾﺔ )اﻻﺗﻔﺎق اﻟﺟزﺋﻲ( ﻋﻠﻰ ﻧﻘل اﻟدم )‪((CD-P-TS‬‬ ‫‪GAP‬‬ ‫اﻟﻔرﯾﻖ اﻻﺳﺗﺷﺎري اﻟﻌﺎﻟﻣﻲ ﻟﺣوﻛﻣﺔ اﻟﺷرﻛﺎت وإدارة ﻣﺧﺎطر‬ ‫ﺧدﻣﺎت اﻟدم ﻓﻲ ﺟﻣﻌﯾﺎت اﻟﺻﻠﯾب اﻷﺣﻣر واﻟﮭﻼل اﻷﺣﻣر‬ ‫اﻻﺗﺣﺎد اﻟدوﻟﻲ ﻟﺟﻣﻌﯾﺎت اﻟﺻﻠﯾب اﻷﺣﻣر واﻟﮭﻼل اﻷﺣﻣر‬ ‫اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ‬ ‫اﻟﺗﻘﯾﯾم اﻟذاﺗﻲ ‪GAP‬‬ ‫اﻟﺗﺑرع ﺑﺎﻟدم طوﻋﺎ وﺑدون ﻣﻘﺎﺑل‬ ‫ﻣﻧظﻣﺔ اﻟﺻﺣﺔ اﻟﻌﺎﻟﻣﯾﺔ‬ ‫‪IFRC‬‬ ‫‪NS‬‬ ‫‪SA‬‬ ‫‪VNRBD‬‬ ‫‪WHO‬‬ ‫اﻟﻘﺳم أ ‪ -‬اﻟﻘﺿﺎﯾﺎ اﻟرﺋﯾﺳﯾﺔ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ - 1‬اﻟﺣد اﻷدﻧﻰ ﻣن اﻟﺷروط‬ ‫ﻣﻼﺣظﺔ ﺗوﺿﯾﺣﯾﺔ‪:‬‬ ‫• ﻣن اﻟﻣﮭم أن إدارة ﺧدﻣﺎت ﻧﻘل اﻟدم ﺗﻌﺗﻣد ﻋﻠﻰ اﻟﻣﺑﺎدئ اﻷﺳﺎﺳﯾﺔ ﻟﻼﺗﺣﺎد اﻟدوﻟﻲ ﻟﺟﻣﻌﯾﺎت اﻟﺻﻠﯾب اﻷﺣﻣر واﻟﮭﻼل اﻷﺣﻣر ‪.IFRC‬‬ ‫• اﻟﻌﻼﻗﺔ ﻣﻊ اﻟﺳﻠطﺔ اﻟﺣﻛوﻣﯾﺔ اﻟوطﻧﯾﺔ واﻟﻣﺣﻠﯾﺔ ذات اﻟﺻﻠﺔ ﯾﻧﺑﻐﻲ أن ﺗﺣدد ﺑوﺿوح ﻟﺿﻣﺎن ﺑﻘﺎء ﺧدﻣﺔ ﻧﻘل اﻟدم ﻣﺳﺗﻘﻠﺔ‪.‬‬ ‫• ﯾﻌد اﻟﺗﺑرع ﺑﺎﻟدم طوﻋﺎ وﺑدون ﻣﻘﺎﺑل )‪ (VNRBD‬ﺳﯾﺎﺳﺔ ﻣن ﺳﯾﺎﺳﺎت اﻻﺗﺣﺎد اﻟدوﻟﻲ ﻟﺟﻣﻌﯾﺎت اﻟﺻﻠﯾب اﻷﺣﻣر واﻟﮭﻼل اﻷﺣﻣر ‪ ،IFRC‬وﯾﻧﺑﻐﻲ أن ﯾﻛون ﻟدى ﺟﻣﯾﻊ ﺧدﻣﺎت اﻟدم اﻟﺗﺎﺑﻌﺔ ﻟﻠﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ ﻧظم‬ ‫ﻧﻘل اﻟدم ﻋﻠﻰ أﺳﺎس ‪.VNRBD‬‬ ‫• ﯾﻧﺑﻐﻲ أن ﯾﺷﻣل إﻧﺷﺎء داﺋرة ﻧﻘل اﻟدم ﻣﺻﺎدر ﻋﻠﻰ اﻟﻣدى اﻟطوﯾل وﻣﺳﺗداﻣﺔ ﻟﻠدﺧل‪ ،‬ﻓﺿﻼ ﻋن ﻣراﻓﻖ ﻛﺎﻓﯾﺔ وإﻣدادات وﻣﻌدات وﻣوظﻔﯾن وﻣﺗطوﻋﯾن ﻟﺗﻠﺑﯾﺔ اﻻﺣﺗﯾﺎﺟﺎت اﻟﺗﺷﻐﯾﻠﯾﺔ‪.‬‬ ‫‪ 1.1‬ھل اﻷدوار واﻟﻣﺳؤوﻟﯾﺎت ﻗد ﺗم ﺗوﺿﯾﺣﮭﺎ ﺑﯾن ﺧدﻣﺔ ﻧﻘل اﻟدم و‬ ‫ﻧﻌم‬ ‫اﻟﺣﻛوﻣﺔ اﻟوطﻧﯾﺔ‬ ‫اﻟﺣﻛوﻣﺎت اﻟﻣﺣﻠﯾﺔ‬ ‫اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ‬ ‫اﻟﺟﮭﺎت اﻟﻣﻌﻧﯾﺔ اﻷﺧرى )ﯾرﺟﻰ اﻟﺗﺣدﯾد(‪ :‬ﻋﻠﻰ ﺳﺑﯾل اﻟﻣﺛﺎل‪ ،‬اﻟﻣﺳﺗﺷﻔﯾﺎت‬ ‫‪1.1.1‬‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم‪ ,‬ﻛﯾف ﯾﺗم ﺗﺣدﯾدھﺎ؟ )ﯾرﺟﻰ اﺧﺗﯾﺎر ﻛل ﻣﺎ ﯾﻧطﺑﻖ(‬ ‫اﻟﺣﻛوﻣﺔ اﻟوطﻧﯾﺔ‬ ‫اﻟﺣﻛوﻣﺎت اﻟﻣﺣﻠﯾﺔ‬ ‫اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ‬ ‫اﻟﺟﮭﺎت اﻟﻣﻌﻧﯾﺔ اﻷﺧرى )ﯾرﺟﻰ اﻟﺗﺣدﯾد(‪ :‬ﻋﻠﻰ ﺳﺑﯾل اﻟﻣﺛﺎل‪ ،‬اﻟﻣﺳﺗﺷﻔﯾﺎت‬ ‫‪1.1.2‬‬ ‫ﻣذﻛرة اﻟﺗﻔﺎھم‬ ‫‪1.2‬‬ ‫ﻋﻘد أو اﺗﻔﺎق‬ ‫آﺧر ﻣﻛﺗوب‬ ‫ﻏﯾر ذﻟك )ﯾرﺟﻰ ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﺗﺣدﯾد ذﻟك أدﻧﺎه( ﻟﻠﺗطﺑﯾﻖ‬ ‫ﻏﯾر ذﻟك )ﯾرﺟﻰ ﺗﺣدﯾد ذﻟك(‪:‬‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم‪ ,‬أو ﺟزﺋﯾﺎ‪ :‬ھل ﯾﺗﻌﯾن اﻟﺗﻘﯾد ﺑﮭذه اﻷدوار واﻟﻣﺳؤوﻟﯾﺎت ﺑﺷﻛل ﻓﻌﺎل‪:‬‬ ‫ھل ﻟدى ﺣﻛوﻣﺔ ﺑﻠدﻛم ﺳﯾﺎﺳﺔ وطﻧﯾﺔ ﻟﺗﺄﻣﯾن إﻣدادات اﻟدم اﻟﻣﺄﻣون ﻣن ﺧﻼل اﻟﺗﺑرع ﺑﺎﻟدم طوﻋﺎ وﺑدون‬ ‫ﻣﻘﺎﺑل )‪?(VNRBD‬‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‬ ‫ﻧﻌم‬ ‫اﻟﺣﻛوﻣﺔ اﻟوطﻧﯾﺔ‬ ‫اﻟﺣﻛوﻣﺎت اﻟﻣﺣﻠﯾﺔ‬ ‫اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ‬ ‫اﻟﺟﮭﺎت اﻟﻣﻌﻧﯾﺔ اﻷﺧرى )ﯾرﺟﻰ اﻟﺗﺣدﯾد(‪ :‬ﻋﻠﻰ ﺳﺑﯾل اﻟﻣﺛﺎل‪ ،‬اﻟﻣﺳﺗﺷﻔﯾﺎت‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء ﺗﻔﺎﺻﯾل(‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء ﺗﻔﺎﺻﯾل( ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء ﺗﻔﺎﺻﯾل( ﻻ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ - 1‬اﻟﺣد اﻷدﻧﻰ ﻣن اﻟﺷروط )ﻣﺗﺎﺑﻌﺔ(‬ ‫‪1.2.1‬‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم‪ ,‬أو ﺟزﺋﯾﺎ‪:‬‬ ‫ھل ﻗد ﺗم ﺗﻧﻔﯾذ ھذه اﻟﺳﯾﺎﺳﺎت؟‬ ‫‪ ‬ﻣﺎ ھو ﻣﺳﺗوى اﻟﺗﺑرع ﺑﺎﻟدم طوﻋﺎ وﺑدون ﻣﻘﺎﺑل )‪ (VNRBD‬ﻓﻲ ﺑﻠدﻛم؟‬ ‫‪ ‬ھل ھﻧﺎك ﺧطوات ﻣطﺑﻘﺔ ﻟزﯾﺎدة اﻟﺗﺑرع ﺑﺎﻟدم طوﻋﺎ وﺑدون ﻣﻘﺎﺑل )‪(VNRBD‬؟‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫‪1.2.2‬‬ ‫إذا ﻛﺎﻧت اﻹﺟﺎﺑﺔ ﺑﻼ‪:‬‬ ‫‪ ‬ﻣﺎ ھو ﻣﺳﺗوى اﻟﺗﺑرع ﺑﺎﻟدم طوﻋﺎ وﺑدون ﻣﻘﺎﺑل )‪ (VNRBD‬ﻓﻲ ﺑﻠدﻛم؟‬ ‫‪ ‬ھل ھﻧﺎك ﺧطوات ﻣطﺑﻘﺔ ﻟزﯾﺎدة اﻟﺗﺑرع ﺑﺎﻟدم طوﻋﺎ وﺑدون ﻣﻘﺎﺑل )‪(VNRBD‬؟‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫‪1.3‬‬ ‫ھل ﺧدﻣﺔ ﻧﻘل اﻟدم ﻛﯾﺎن ﻗﺎﻧوﻧﻲ ﻣﻧﻔﺻل ﻋن اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ؟‬ ‫‪1.4‬‬ ‫إذا ﻛﺎﻧت اﻟﺣﻛوﻣﺔ ﻻ ﺗﻣول ﺑﺎﻟﻛﺎﻣل ﺧدﻣﺔ ﻧﻘل اﻟدم اﻟﺧﺎﺻﺔ ﺑك‪ ،‬ھل ﻟدﯾك ﻣﺻدر طوﯾل اﻷﻣد وﻛﺎف‬ ‫وﻣﺳﺗدام ﻟﻠدﺧل؟‬ ‫‪1.4.1‬‬ ‫إن ﻟم ﯾﻛن‪،‬‬ ‫‪ ‬ﻟﻣﺎذا؟‬ ‫‪ ‬ھل ھﻧﺎك ﺧطط ﻣطﺑﻘﺔ ﻟﺗﻐﯾﯾر ھذا؟‬ ‫‪1.5‬‬ ‫ھل ﻟدى ﺧدﻣﺔ ﻧﻘل اﻟدم ﻣﺎ ﯾﻛﻔﻲ ﻣن اﻟﻣوارد اﻟﺗﺎﻟﯾﺔ ﻟﺗﻠﺑﯾﺔ اﻟﻣﺗطﻠﺑﺎت اﻟﺗﻧظﯾﻣﯾﺔ؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء ﺗﻔﺎﺻﯾل( ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‪ ،‬ﻛﺎﻓﯾﺔ‬ ‫ﻻ‪ ،‬ﻧﻘص طﻔﯾف‬ ‫) *ﯾرﺟﻰ ﺗﻘدﯾم‬ ‫ﻣزﯾد ﻣن‬ ‫اﻟﻣﻌﻠوﻣﺎت(‬ ‫ﻻ‪ ،‬ﻧﻘص ﻛﺑﯾر‬ ‫) *ﯾرﺟﻰ ﺗﻘدﯾم‬ ‫ﻣزﯾد ﻣن‬ ‫اﻟﻣﻌﻠوﻣﺎت(‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫اﻟﻣراﻓﻖ‬ ‫*إذا "ﻛﺎﻧت اﻹﺟﺎﺑﺔ ﺑﻼ‪ ,‬ﻧﻘص طﻔﯾف" أو "ﻻ‪ ,‬ﻧﻘص ﻛﺑﯾر"‪ ,‬وھذا ﯾﻣﻛن أن ﯾﺷﯾر إﻟﻰ وﺟود ﻣﺧﺎطر ﻣﺣﺗﻣﻠﺔ ﻟﻠﻣواد‬ ‫اﻟرﺋﯾﺳﯾﺔ )‪ ،(MMR‬ﻟذا ﯾرﺟﻰ ﺗﻘدﯾم ﻣﻌﻠوﻣﺎت أﻛﺛر ﺗﻔﺻﯾﻼ أدﻧﺎه ﺑﺧﺻوص ﻧﻘص اﻟﻣراﻓﻖ وﻋﻣﺎ إذا ﻛﺎﻧت ھﻧﺎك‬ ‫ﺧطط ﻣﻌﻣول ﺑﮭﺎ ﻟﺗﺣﺳﯾن ھذا‪.‬‬ ‫اﻹﻣدادات‬ ‫*إذا "ﻛﺎﻧت اﻹﺟﺎﺑﺔ ﺑﻼ‪ ,‬ﻧﻘص طﻔﯾف" أو "ﻻ‪ ,‬ﻧﻘص ﻛﺑﯾر"‪ ,‬وھذا ﯾﻣﻛن أن ﯾﺷﯾر إﻟﻰ وﺟود ﻣﺧﺎطر ﻣﺣﺗﻣﻠﺔ ﻟﻠﻣواد‬ ‫اﻟرﺋﯾﺳﯾﺔ )‪ ،(MMR‬ﻟذا ﯾرﺟﻰ ﺗﻘدﯾم ﻣﻌﻠوﻣﺎت أﻛﺛر ﺗﻔﺻﯾﻼ أدﻧﺎه ﺑﺧﺻوص ﻧﻘص اﻹﻣدادات وﻋﻣﺎ إذا ﻛﺎﻧت ھﻧﺎك‬ ‫ﺧطط ﻣﻌﻣول ﺑﮭﺎ ﻟﺗﺣﺳﯾن ھذا‪.‬‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ - 1‬اﻟﺣد اﻷدﻧﻰ ﻣن اﻟﺷروط )ﻣﺗﺎﺑﻌﺔ(‬ ‫‪1.5‬‬ ‫)ﻣﺗﺎﺑﻌﺔ(‬ ‫ھل ﻟدى ﺧدﻣﺔ ﻧﻘل اﻟدم ﻣﺎ ﯾﻛﻔﻲ ﻣن اﻟﻣوارد اﻟﺗﺎﻟﯾﺔ ﻟﺗﻠﺑﯾﺔ اﻟﻣﺗطﻠﺑﺎت اﻟﺗﻧظﯾﻣﯾﺔ؟‬ ‫ﻧﻌم‪ ،‬ﻛﺎﻓﯾﺔ‬ ‫اﻟﺗﺟﮭﯾزات‬ ‫ﻻ‪ ،‬ﻧﻘص طﻔﯾف‬ ‫) *ﯾرﺟﻰ ﺗﻘدﯾم‬ ‫ﻣزﯾد ﻣن‬ ‫اﻟﻣﻌﻠوﻣﺎت(‬ ‫ﻻ‪ ،‬ﻧﻘص ﻛﺑﯾر‬ ‫) *ﯾرﺟﻰ ﺗﻘدﯾم‬ ‫ﻣزﯾد ﻣن‬ ‫اﻟﻣﻌﻠوﻣﺎت(‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫*إذا "ﻛﺎﻧت اﻹﺟﺎﺑﺔ ﺑﻼ‪ ,‬ﻧﻘص طﻔﯾف" أو "ﻻ‪ ,‬ﻧﻘص ﻛﺑﯾر"‪ ,‬وھذا ﯾﻣﻛن أن ﯾﺷﯾر إﻟﻰ وﺟود ﻣﺧﺎطر ﻣﺣﺗﻣﻠﺔ ﻟﻠﻣواد‬ ‫اﻟرﺋﯾﺳﯾﺔ )‪ ،(MMR‬ﻟذا ﯾرﺟﻰ ﺗﻘدﯾم ﻣﻌﻠوﻣﺎت أﻛﺛر ﺗﻔﺻﯾﻼ أدﻧﺎه ﺑﺧﺻوص ﻧﻘص اﻟﺗﺟﮭﯾزات وﻋﻣﺎ إذا ﻛﺎﻧت ھﻧﺎك‬ ‫ﺧطط ﻣﻌﻣول ﺑﮭﺎ ﻟﺗﺣﺳﯾن ھذا‪.‬‬ ‫اﻟﻣوظﻔون‪/‬اﻟﻣﺗطوﻋون اﻟﻣدرﺑون‬ ‫*إذا "ﻛﺎﻧت اﻹﺟﺎﺑﺔ ﺑﻼ‪ ,‬ﻧﻘص طﻔﯾف" أو "ﻻ‪ ,‬ﻧﻘص ﻛﺑﯾر"‪ ,‬وھذا ﯾﻣﻛن أن ﯾﺷﯾر إﻟﻰ وﺟود ﻣﺧﺎطر ﻣﺣﺗﻣﻠﺔ ﻟﻠﻣواد‬ ‫اﻟرﺋﯾﺳﯾﺔ )‪ ،(MMR‬ﻟذا ﯾرﺟﻰ ﺗﻘدﯾم ﻣﻌﻠوﻣﺎت أﻛﺛر ﺗﻔﺻﯾﻼ أدﻧﺎه ﺑﺧﺻوص ﻧﻘص اﻟﻣوظﻔﯾن‪/‬اﻟﻣﺗطوﻋﯾن اﻟﻣدرﺑﯾن‬ ‫وﻋﻣﺎ إذا ﻛﺎﻧت ھﻧﺎك ﺧطط ﻣﻌﻣول ﺑﮭﺎ ﻟﺗﺣﺳﯾن ھذا‪.‬‬ ‫‪1.6‬‬ ‫ھل ﯾﻣﻛﻧك اﻟﺗﻌﮭد ﺑﺎﻟﺧﺻوﺻﯾﺔ و اﻟﺳرﯾﺔ اﻟﻛﺎﻣﻠﺔ ﻟﻠﻣﻌﻠوﻣﺎت اﻟﻣﺎﻧﺣﺔ?‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء ﺗﻔﺎﺻﯾل( ﻻ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻻ ﺗﺗردد ﻓﻲ ﺗﻘدﯾم ﺗﻌﻠﯾﻘﺎت أﺧرى أو ﻣزﯾد ﻣن اﻟﻣﻌﻠوﻣﺎت ﻟﺗوﺿﯾﺢ ردودﻛم ﻋﻠﻰ ھذا اﻟﻘﺳم‪:‬‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :2‬اﻟﻣﺗطﻠﺑﺎت اﻟﺗﻧظﯾﻣﯾﺔ اﻷﺳﺎﺳﯾﺔ‬ ‫ﻣﻼﺣظﺔ ﺗوﺿﯾﺣﯾﺔ‪ :‬ﯾوﺻﻲ اﻟﻔرﯾﻖ اﻻﺳﺗﺷﺎري اﻟﻌﺎﻟﻣﻲ )‪ (GAP‬ﺑﺄن اﻟﺟﻣﻌﯾﺎت اﻟوطﻧﯾﺔ اﻟﺗﻲ ﺗﻘدم ﺑرﻧﺎﻣﺞ اﻟدم‪ ،‬ﯾﺟب ﻋﻠﯾﮭﺎ إﻧﺷﺎء ﺧدﻣﺔ ﻟﻧﻘل اﻟدم ﻣﻧﻔﺻﻠﺔ ﺑواﺳطﺔ ﻣﺟﻠس إدارة ﻣﮭﻧﻲ ﺑﻣﺳؤوﻟﯾﺔ ﻣﻔوﺿﺔ ﻋن‬ ‫اﻟﺗوﺟﯾﮫ اﻻﺳﺗراﺗﯾﺟﻲ واﻟرﻗﺎﺑﺔ ﻋﻠﻰ اﻷداء اﻟﺗﺷﻐﯾﻠﻲ‪ .‬ﻣﮭﺎرات وﻣﻌرﻓﺔ ﻣﻔﯾدة ﻟﻠﻐﺎﯾﺔ ﻷﻋﺿﺎء ﻣﺟﻠس اﻹدارة ﺗﺷﻣل اﻟﺗﻘﻧﯾﺔ اﻟﺣﯾوﯾﺔ واﻹدارة اﻟطﺑﯾﺔ‪ /‬اﻟﻌﻠﻣﯾﺔ‪ ،‬واﻻﻗﺗﺻﺎدﯾﺔ‪ /‬اﻟﻣﺎﻟﯾﺔ واﻟﺳﯾﺎﺳﯾﺔ واﻟﻘﺎﻧوﻧﯾﺔ‪.‬‬ ‫‪2.1‬‬ ‫ھل ﻟدى اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ ﻣﺟﻠس إدارة ﻣﻧﻔﺻل ﻟﺧدﻣﺔ ﻧﻘل اﻟدم‪ ،‬ﺑﻣﺳؤوﻟﯾﺔ ﻣﻔوﺿﺔ وإﺷراف ﻋﻠﻰ اﻟﺗﺧطﯾط‬ ‫اﻻﺳﺗراﺗﯾﺟﻲ واﻹدارة اﻟﺗﻧﻔﯾذﯾﺔ واﻟﺳﻠطﺔ اﻟﻣﺎﻟﯾﺔ اﻟﻣﻔوﺿﺔ ﻋﻠﻰ ﺑرﻧﺎﻣﺞ اﻟدم؟‬ ‫‪2.1.1‬‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم‪ ,‬ھل اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ ﻟدﯾﮭﺎ ﻧظﺎم واﺿﺢ اﻟﻣﻌﺎﻟم ﻟﻠﺗﻔوﯾض‪ ،‬وﺗوﻓﯾر اﻹﯾﺿﺎح ﺑﺷﺄن اﻟﺳﻠطﺔ‬ ‫واﻟﻣﺳﺎءﻟﺔ ﺑﯾن‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﻣﺟﺎﻟس اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ وﺧدﻣﺔ ﻧﻘل اﻟدم؟‬ ‫ﻣﺟﻠس وإدارة ﺧدﻣﺔ ﻧﻘل اﻟدم؟‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫‪2.1.2‬‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم‪ ,‬ﻓﮭل ﻟدى ﺧدﻣﺔ ﻧﻘل اﻟدم اﻟﻣﮭﺎرات واﻟﻣﻌرﻓﺔ اﻟﻼزﻣﺔ ﻟﺗﻧﻔﯾذ وإدارة اﻟﺗﻐﯾﯾر‪ ،‬واﻟﺣﻔﺎظ ﻋﻠﻰ‬ ‫اﻷدوار واﻟﻣﺳؤوﻟﯾﺎت اﻟﺻﺎرﻣﺔ وﻏﯾر ذﻟك أداء ﻣﺳؤوﻟﯾﺎﺗﮭﺎ وﻓﻘﺎ ﻟﺳؤال ‪2.1‬؟‬ ‫‪2.2‬‬ ‫ھل ھﻧﺎك ھﯾﻛل إداري ﺗﻧظﯾﻣﻲ ﻣﻧﻔﺻل ﻟﺧدﻣﺔ ﻧﻘل اﻟدم؟‬ ‫‪2.2.1‬‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم‪ ,‬ھل ﺧدﻣﺔ ﻧﻘل اﻟدم اﻟﺧﺎﺻﺔ ﺑك ﻋﻠﻰ أﺳﺎس ﻧﻣوذج ﺗﻧظﯾﻣﻲ وطﻧﻲ؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻻ ﺗﺗردد ﻓﻲ ﺗﻘدﯾم ﺗﻌﻠﯾﻘﺎت أﺧرى أو ﻣزﯾد ﻣن اﻟﻣﻌﻠوﻣﺎت ﻟﺗوﺿﯾﺢ ردودﻛم ﻋﻠﻰ ھذا اﻟﻘﺳم‪:‬‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :3‬ﺣﻣﺎﯾﺔ ﺿد اﻟﻣطﺎﻟﺑﺎت ﻋن اﻷﺿرار‬ ‫ﻣﻼﺣظﺔ ﺗوﺿﯾﺣﯾﺔ‪:‬‬ ‫• وﻣن اﻷﻓﺿل ﺗﻣﺎﻣﺎ أن ﯾﻛون ﻟدى اﻟﺟﻣﻌﯾﺎت اﻟوطﻧﯾﺔ ﺗﻐطﯾﺔ ﺗﺄﻣﯾﻧﯾﺔ ﻷﻧﺷطﺔ ﺑرﻧﺎﻣﺞ ﻧﻘل اﻟدم‪.‬‬ ‫• ﯾﻧﺑﻐﻲ أن ﯾﻛون ﻟدى ﺧدﻣﺎت ﻧﻘل اﻟدم ﺗﻌرﯾف واﺿﺢ ﻟﻌﻼﻗﺗﮭﺎ ﻣﻊ اﻟﺣﻛوﻣﺔ ودور اﻟﺣﻛوﻣﺔ ﻓﻲ ﺣﻣﺎﯾﺔ اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ ﺿد اﻟﻣطﺎﻟﺑﺎت واﻟﺧﺳﺎﺋر‪.‬‬ ‫• ﺗﻣﺛل اﻟرﻋﺎﯾﺔ اﻟﺳﻠﯾﻣﺔ ﻟﻠﻣرﺿﻰ اﻟذﯾن ﯾﻌﺎﻧون ﻣن أﺣداث ﻣﻧﺎوﺋﺔ ﻧﺗﯾﺟﺔ ﻟﻌﻼج ﻧﻘل اﻟدم ﻗﺿﯾﺔ ھﺎﻣﺔ ﺑﺎﻟﻧﺳﺑﺔ ﻟﻠﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ‪.‬‬ ‫• وﻣن اﻟﻧﺎﺣﯾﺔ اﻟﻣﺛﺎﻟﯾﺔ‪ ،‬ﯾﻧﺑﻐﻲ أن ﺗﺷﺎرك ﺧدﻣﺎت ﻧﻘل اﻟدم ﻓﻲ ﺗﺛﻘﯾف اﻟﺟﻣﮭور ﺣول اﻟﻣﺧﺎطر اﻟﻣﺣﺗﻣﻠﺔ ﻓﻲ ﻧﻘل اﻟدم‪.‬‬ ‫• ﻛﻣﺎ ﯾﺟب ﻋﻠﯾﮭﺎ اﻻﺣﺗﻔﺎظ ﺑﺄﻣن ودﻗﺔ اﻟﺳﺟﻼت‪.‬‬ ‫‪3.1‬‬ ‫ھل ﯾﺗم ﺗوﻓﯾر ﺣﻣﺎﯾﺔ ﺣﻛوﻣﯾﺔ )ﻗﺎﻧوﻧﯾﺔ‪/‬ﻣﺎﻟﯾﺔ( ﻟﺗﻘدﯾم ﺧدﻣﺎت ﻧﻘل اﻟدم و‪ /‬أو ﺑﻧوك اﻟدم واﻷﻧﺳﺟﺔ؟‬ ‫‪3.2‬‬ ‫ھل ﻗد ﺗم إﻧﺷﺎء ھﯾﻛل ﻣؤﺳﺳﻲ ﻣﻧﻔﺻل ﺑﯾن اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ وﺧدﻣﺔ ﻧﻘل اﻟدم ﻟﺗﻣﻛﯾن ﺣﻣﺎﯾﺔ أﻣوال اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ ﻣن اﻷﺿرار‬ ‫اﻟﻣﺗﻌﻠﻘﺔ ﺑﺗﻘدﯾم ﺧدﻣﺎت اﻟدم؟‬ ‫‪3.2‬أ‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم‪ ,‬أو ﺟزﺋﯾﺎ‪:‬‬ ‫‪3.3‬‬ ‫ھل ﺗﻌﻣل ﺧدﻣﺔ ﻧﻘل اﻟدم وﻓﻘﺎ ﻟﻠﻣﻌﺎﯾﯾر اﻟدوﻟﯾﺔ )ﻣﺛل ﻣﻧظﻣﺔ اﻟﺻﺣﺔ اﻟﻌﺎﻟﻣﯾﺔ ‪ ،WHO‬اﻟﺟﻣﻌﯾﺔ اﻷﻣرﯾﻛﯾﺔ ﻟﺑﻧوك اﻟدم ‪ ،AABB‬ﻣﺟﻠس‬ ‫أوروﺑﺎ ‪ (CoE‬ﻓﻲ ﺑراﻣﺞ اﻟدم ؟‬ ‫‪3.3.1‬‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم أو ﺟزﺋﯾﺎ‪ ,‬أي اﻟﻣﻌﺎﯾﯾر ﺗﺳﺗﺧدﻣﮭﺎ ﺧدﻣﺔ ﻧﻘل اﻟدم?‬ ‫‪3.4‬‬ ‫ﻓﻲ ﺣﺎﻟﺔ ﻋدم إﺳﺗﯾﻔﺎء ﺧدﻣﺔ ﻧﻘل اﻟدم اﻟﻣﻌﺎﯾﯾر اﻟدوﻟﯾﺔ ﻓﻲ ﺗﻧﻔﯾذ ﺑراﻣﺞ ﻧﻘل اﻟدم‪ ،‬ھل اﻟﺳﺑب ﻣوﺛﻖ؟‬ ‫‪3.5‬‬ ‫ﻓﻲ ﺣﺎﻟﺔ ﻋدم إﺳﺗﯾﻔﺎء ﺧدﻣﺔ ﻧﻘل اﻟدم اﻟﻣﻌﺎﯾﯾر اﻟدوﻟﯾﺔ ﻓﻲ ﺗﻧﻔﯾذ ﺑراﻣﺞ ﻧﻘل اﻟدم‪ ،‬ھل اﻟﺳﺑب ﻣﻌﺗرف ﺑﮫ وﻣﻘﺑول ﻣن ﻗﺑل اﻟﺣﻛوﻣﺔ؟‬ ‫‪3.6‬‬ ‫ھل ﺗﺟري ﺧدﻣﺔ ﻧﻘل اﻟدم ﺣﻣﻼت ﺑﮭدف زﯾﺎدة اﻟوﻋﻲ اﻟﻌﺎم‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﻻ‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﻻ‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﻻ‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﻻ‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﻻ‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫‪ .1‬ﺣﻘﯾﻘﺔ أن اﻧﻌدام اﻟﺧطر ﻏﯾر ﻣﻣﻛﻧﺔ ﻣﻊ ﻋﻼج ﻧﻘل اﻟدم؟‬ ‫‪ .2‬اﻟﺣﺎﺟﺔ إﻟﻰ ﺗﺣﻘﯾﻖ اﻟﺗوازن ﺑﯾن ﻣﺧﺎطر ﻧﻘل اﻟدم ﻣﻘﺎﺑل ﻣﺧﺎطر ﻋدم ﻧﻘل اﻟدم؟‬ ‫‪ .3‬اﻹﻧﺟﺎزات اﻟﺗﻲ ﺗﺣﻘﻘت ﻓﻲ اﻟﺗﺧﻔﯾف ﻣن اﻟﻣﺧﺎطر‪ ،‬وأي ﻣﺧﺎطر ﺑﺎﻗﯾﺔ؟‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ - 3‬ﺣﻣﺎﯾﺔ ﺿد اﻟﻣطﺎﻟﺑﺎت ﻋن اﻷﺿرار )ﻣﺗﺎﺑﻌﺔ(‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫‪3.6.1‬‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم‪ ,‬ﻛﯾف ﺗ ُﺟرى ﻏﺎﻟﺑﺎ اﻟﺣﻣﻼت?‬ ‫‪3.7‬‬ ‫ھل ﻗﺎﻣت ﺧدﻣﺔ ﻧﻘل اﻟدم ﺑﺗطوﯾر اﻷﻧظﻣﺔ ﻹﺑﻼغ اﻷطﺑﺎء ﺣول اﻟﻣﺧﺎطر اﻟﻣﺣﺗﻣﻠﺔ ﻟﻠﻧﻘل؟ إذا ﻛﺎن اﻷﻣر ﻛذﻟك‪ ،‬ﻛﯾف؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫اﻻطﻼع ﻋﻠﻰ ﻣوﻗﻌﻧﺎ‬ ‫اﻟﻛﺗﯾﺑﺎت ‪ /‬ﻣﻧﺷورات‬ ‫اﻟﺷﺑﻛﺎت اﻟﺳرﯾرﯾﺔ ﻏﯾر اﻟرﺳﻣﯾﺔ‬ ‫اﻻﺟﺗﻣﺎﻋﺎت اﻟﻣﺣﻠﯾﺔ‬ ‫اﻟﻣﺷﺎرﻛﺔ ﻓﻲ ﻟﺟﺎن اﻟﻧﻘل ﺑﺎﻟﻣﺳﺗﺷﻔﻰ‬ ‫ﻏﯾر ذﻟك )ﯾرﺟﻰ ﺗﺣدﯾد ذﻟك(‪:‬‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫‪3.8‬‬ ‫ھل ﻟدى ﺧدﻣﺔ ﻧﻘل اﻟدم ﺳﯾﺎﺳﺔ ﻟﻼﺣﺗﻔﺎظ ﺑﺳﺟﻼت اﻟﻣﺗﺑرﻋﯾن واﻟﺗﺑرع؟‬ ‫‪3.9‬‬ ‫ھل ﺗﺣﺗﻔظ ﺧدﻣﺔ ﻧﻘل اﻟدم ﺑﺗﻐطﯾﺔ ﺗﺄﻣﯾﻧﯾﺔ ﺿد اﻟﺣوادث اﻟﺗﺎﻟﯾﺔ اﻟﻣﺣﺗﻣﻠﺔ؟‬ ‫‪3.10‬‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم‪ ,‬ھل اﻟﺗﻐطﯾﺔ اﻟﺗﺄﻣﯾﻧﯾﺔ ﻛﺎﻓﯾﺔ؟‬ ‫‪3.11‬‬ ‫ھل ﺗﺗﻠﻘﻰ ﺧدﻣﺔ ﻧﻘل اﻟدم اﻟﻣﺷورة اﻟﻣﮭﻧﯾﺔ ﺑﺧﺻوص ﻣﺳﺗوﯾﺎت وﻧوع اﻟﺗﻐطﯾﺔ اﻟﺗﺄﻣﯾﻧﯾﺔ؟‬ ‫‪3.12‬‬ ‫ھل ﺗﻧﻌم ﺧدﻣﺔ ﻧﻘل اﻟدم ﺑﺄي ﺣﻣﺎﯾﺔ إﻣﺎ ﺗﺟﺎرﯾﺔ أو ﺗﻌوﯾض ﻣن اﻟﺣﻛوﻣﺔ ﻣن اﺣﺗﻣﺎل ﺣدوث أﻣراض ﻣﻧﻘوﻟﺔ ﻋن طرﯾﻖ اﻟدم؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫اﻟﺧﺳﺎﺋر ﻓﻲ اﻟﻣﻣﺗﻠﻛﺎت‬ ‫اﻟﻣﺳؤوﻟﯾﺔ اﻟﻌﺎﻣﺔ‬ ‫ﻣﺳؤوﻟﯾﺔ اﻟﻘﺎﻧوﻧﯾﺔ ﻋن أﺿرار اﻟدم وﻣﻧﺗﺟﺎﺗﮫ‬ ‫ﻣﺳؤوﻟﯾﺔ اﻟﻣدﯾرﯾن واﻟﻣوظﻔﯾن‬ ‫اﻟﺗﻌوﯾض اﻟﻣﮭﻧﻲ‬ ‫اﻻﺣﺗﯾﺎل اﻟداﺧﻠﻲ‬ ‫إﺻﺎﺑﺔ اﻟﻣﺗﺑرع‬ ‫اﻟﺗﻼﻋب اﻟﺧﺑﯾث ﺑﺎﻟﻣﻧﺗﺞ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‪ ،‬ﻋﻠﻰ‬ ‫اﻷﻗل ﺳﻧوﯾﺎ‬ ‫ﻧﻌم‪ ،‬دورﯾﺎ‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫‪‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻻ ﺗﺗردد ﻓﻲ ﺗﻘدﯾم ﺗﻌﻠﯾﻘﺎت أﺧرى أو ﻣزﯾد ﻣن اﻟﻣﻌﻠوﻣﺎت ﻟﺗوﺿﯾﺢ ردودﻛم ﻋﻠﻰ ھذا اﻟﻘﺳم‪:‬‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :4‬اﻟدﻋم ﻟﻠﻣﺗﻠﻘﯾن ﻟﻠدم اﻟﻣﻠوث‬ ‫ﻣﻼﺣظﺔ ﺗوﺿﯾﺣﯾﺔ‪ :‬ﯾﺟب ﻋﻠﻰ ﺟﻣﻌﯾﺎت اﻟﮭﻼل اﻷﺣﻣر‪ /‬اﻟﺻﻠﯾب اﻷﺣﻣر إظﮭﺎر اﻟﺗﻌﺎطف ﻣﻊ ﺟﻣﯾﻊ اﻟﻣﺗﻠﻘﯾن ﻟﻠدم اﻟﻣﻠوث‪ .‬ﻻ ﯾﻣﻛن ﻟﺧدﻣﺔ ﻧﻘل اﻟدم أن ﺗﺗﺣﻣل ﻣﺳؤوﻟﯾﺔ ﺧطر اﻟﻌدوى‬ ‫اﻟﻛﺎﻣن ﻓﻲ ﻣﻧﺗﺟﺎت اﻟدم‪ .‬وﻣﻊ ذﻟك‪ ،‬ﻓﺈﻧﮫ ﻣن اﻟﻣﻧﺎﺳب ﻟﻠﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ ﻟﺧدﻣﺎت ﻧﻘل اﻟدم ﺗوﻓﯾر اﻟدﻋم ﻟﻣﺗﻠﻘﻲ ﻧﻘل اﻟدم اﻟﻣﺻﺎب‪ .‬وھذا ﻗد ﯾﺷﻣل اﻟدﻋم اﻟﻣﺎﻟﻲ واﻟﻧﻔﺳﻲ واﻟطﺑﻲ‬ ‫واﻻﺟﺗﻣﺎﻋﻲ‪.‬‬ ‫‪ 4.1‬ھل ﻟدى ﺧدﻣﺔ ﻧﻘل اﻟدم أو وزارة اﻟﺻﺣﺔ آﻟﯾﺔ ﻟﺗﻘدﯾم اﻟدﻋم ﻟﻠﻣﺗﻠﻘﯾن ﻟﻠدم اﻟﻣﻠوث؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫‪ 4.1.1‬إذا ﻛﺎﻧت اﻹﺟﺎﺑﺔ ﺑﻼ‪ ,‬ﻣﺎ اﻟوﻛﺎﻻت اﻟﺗﻲ ﺗﻘدم اﻟدﻋم ﻟﻠﻣﺗﻠﻘﯾن?‬ ‫‪4.2‬‬ ‫ھل ﻟدى ﺧدﻣﺔ ﻧﻘل اﻟدم أو وزارة اﻟﺻﺣﺔ آﻟﯾﺔ ﻟﺗﻘدﯾم ﺗﻌوﯾﺿﺎت ﻣﺎﻟﯾﺔ ﻟﻣﺗﻠﻘﻲ اﻟدم اﻟﻣﻠوث؟‬ ‫‪4.3‬‬ ‫ھل ﻟدى ﺧدﻣﺔ ﻧﻘل اﻟدم أو وزارة اﻟﺻﺣﺔ آﻟﯾﺔ ﻟﺗﻘدﯾم اﻟدﻋم اﻟﻧﻔﺳﻲ اﻟﻣﮭﻧﻲ ﻟﻣﺗﻠﻘﻲ اﻟدم اﻟﻣﻠوث؟‬ ‫‪4.4‬‬ ‫ھل ﻟدى ﺧدﻣﺔ ﻧﻘل اﻟدم أو وزارة اﻟﺻﺣﺔ آﻟﯾﺔ ﻟﺗﻘدﯾم اﻟدﻋم اﻟطﺑﻲ ﻟﻣﺗﻠﻘﻲ اﻟدم اﻟﻣﻠوث؟‬ ‫‪4.5‬‬ ‫ھل ﻟدى ﺧدﻣﺔ ﻧﻘل اﻟدم أو وزارة اﻟﺻﺣﺔ آﻟﯾﺔ ﻟﺗﻘدﯾم اﻟدﻋم اﻻﺟﺗﻣﺎﻋﻲ ﻟﻣﺗﻠﻘﻲ اﻟدم اﻟﻣﻠوث؟‬ ‫ﻋﻠﻰ ﺳﺑﯾل اﻟﻣﺛﺎل اﻟدﻋم ﻓﻲ ﻣﺣﺎدﺛﺎت اﻟﺗﺄﻣﯾن اﻟﺻﺣﻲ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻻ ﺗﺗردد ﻓﻲ ﺗﻘدﯾم ﺗﻌﻠﯾﻘﺎت أﺧرى أو ﻣزﯾد ﻣن اﻟﻣﻌﻠوﻣﺎت ﻟﺗوﺿﯾﺢ ردودﻛم ﻋﻠﻰ ھذا اﻟﻘﺳم‪:‬‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :5‬اﻟﺳﻼﻣﺔ ﻣﻘﺎﺑل اﻟﺗﻛﻠﻔﺔ‬ ‫ﻣﻼﺣظﺔ ﺗوﺿﯾﺣﯾﺔ‪:‬‬ ‫• ﺗﺗﻧﺎول ھذه اﻷﺳﺋﻠﺔ اﻟﻣﺳﺎﺋل اﻟﻣﺗﻌﻠﻘﺔ ﺑﺎﻟﺗوازن ﺑﯾن اﻟﺳﻼﻣﺔ واﻟﺗﻛﻠﻔﺔ واﻟﺗواﻓر‪.‬‬ ‫• ﻋﻠﻰ اﻟرﻏم ﻣن وﺟود ﺧطوة ﻣﺳﺗﻣرة ﻧﺣو ﺗﺣﺳﯾن ﺳﻼﻣﺔ ﻣﻧﺗﺟﺎت اﻟدم‪ ،‬إﻻ أﻧﮫ ﻣن اﻟﻣﮭم اﻟﺗﺄﻛد ﻣن أن اﻟﺧطر اﻟﺻﻐﯾر اﻟﻣﻌروف ﻻ ﯾﺗم اﺳﺗﺑداﻟﮫ ﺑﺧطر أﻛﺑر ﻣﺟﮭول ﻣﺣﺗﻣل اﻟﺣدوث‪ .‬أﯾﺿﺎ‪،‬‬ ‫ﯾﻣﻛن أن ﯾﻛون ﻟدى اﻟﺟﮭود اﻟﻣﺑذوﻟﺔ ﻟزﯾﺎدة اﻟﺳﻼﻣﺔ ﺗﺄﺛﯾرا ﻋﻠﻰ ﺗواﻓر ﻣﻧﺗﺟﺎت اﻟدم ﺑﺷﻛل ﻋﺎم‪.‬‬ ‫• إن ﻟﻠوﻋﻲ اﻟﻣﺳﺗﻣر ﺑﺎﻟﺗﮭدﯾدات اﻟﻧﺎﺷﺋﺔ‪ ،‬وﺗﺛﻘﯾف اﻟوﻛﺎﻻت اﻟﺣﻛوﻣﯾﺔ ﺣول ﺗداﺑﯾر اﻟﺳﻼﻣﺔ اﻟﺟدﯾدة دورا ھﺎﻣﺎ ﻓﻲ ﺧدﻣﺔ ﻧﻘل اﻟدم‪.‬‬ ‫• ﻛﻣﺎ أن آﻟﯾﺎت ﻣراﺟﻌﺔ اﻟﻣﺎﺿﻲ ﻟﺗﻌﻘب اﺳﺗﺧدام اﻟﻣﻧﺗﺞ واﻟﺗﺄﻛد ﻣن أن ﻣﻛوﻧﺎت اﻟدم ﺗﺳﺗﺧدم ﺑﺷﻛل ﻣﻧﺎﺳب داﺧل اﻟﻣﺳﺗﺷﻔﯾﺎت ﻣﺛﺎر ﻗﻠﻖ ﺑﺎﻟﻎ‪.‬‬ ‫‪5.1‬‬ ‫ھل ﺗﻘوم ﺧدﻣﺔ ﻧﻘل اﻟدم ﺑﺈﺟراء ﺗﺣﻠﯾل ﻟﻠﺗﻛﻠﻔﺔ‪ /‬اﻟﻣﻧﻔﻌﺔ ﻟﺟﻣﯾﻊ اﻟﻣﻘﺗرﺣﺎت اﻟﺟدﯾدة ﻟﺗﻌزﯾز اﻟﺳﻼﻣﺔ؟‬ ‫‪5.2‬‬ ‫ھل ﺗﻘوم ﺧدﻣﺔ ﻧﻘل اﻟدم ﺑﺈﺷراك اﻟوﻛﺎﻻت اﻟﺣﻛوﻣﯾﺔ ﺑﺷﻛل ﻓﻌﺎل ﻓﻲ أھﻣﯾﺔ اﻟﺗﻣوﯾل اﻟﻛﺎﻓﻲ ﻟﻠﻣﺑﺎدرات‬ ‫اﻟﺟدﯾدة ﻟﺳﻼﻣﺔ اﻟدم وﻋواﻗب ﻋدم ﺗﻣوﯾﻠﮭﺎ؟‬ ‫‪5.3‬‬ ‫ھل ﻟدى ﺧدﻣﺔ ﻧﻘل اﻟدم أﻧظﻣﺔ ﻣطﺑﻘﺔ ﻟرﺻد اﻟﺗﮭدﯾدات اﻟﻧﺎﺷﺋﺔ ﻟﺳﻼﻣﺔ إﻣدادات اﻟدم )ﻣﺛل ﻣراﻗﺑﺔ اﻷﻣراض‬ ‫اﻹﻗﻠﯾﻣﯾﺔ(؟‬ ‫‪5.4‬‬ ‫ھل ﻟدى ﺧدﻣﺔ ﻧﻘل اﻟدم أﻧظﻣﺔ ﻣطﺑﻘﺔ ﻟﺿﻣﺎن اﺳﺗﯾﻔﺎء اﻟﺟواﻧب اﻷرﺑﻌﺔ اﻟﺗﺎﻟﯾﺔ ﻟﺳﻼﻣﺔ ﻧﻘل اﻟدم )ﻟﺿﻣﺎن‬ ‫ﻧﺗﺎﺋﺞ أﻓﺿل ﻟﻠﻣرﺿﻰ(‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﯾﺗم ﺗوﻓﯾر ﻧوع اﻟدم اﻟﺻﺣﯾﺢ‪.‬‬ ‫ﯾﺗم إﻋطﺎء اﻟﻣﻧﺗﺞ إﻟﻰ اﻟﻣرﯾض اﻟﺻﺣﯾﺢ‪.‬‬ ‫ﯾﺗم إﻋطﺎء اﻟﻣﻧﺗﺞ ﻓﻲ اﻟوﻗت اﻟﺻﺣﯾﺢ‪.‬‬ ‫اﻵﻟﯾﺔ اﻟﻣدﻣﺟﺔ اﻟﺻﺣﯾﺣﺔ ﻟﻣراﺟﻌﺔ اﻟﻣﺎﺿﻲ‪.‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :5‬اﻟﺳﻼﻣﺔ ﻣﻘﺎﺑل اﻟﺗﻛﻠﻔﺔ )ﻣﺗﺎﺑﻌﺔ(‬ ‫‪ 5.5‬ھل ﺗﺳﻌﻰ ﺧدﻣﺔ ﻧﻘل اﻟدم إﻟﻰ اﻟﺗﺣﻛم ﻓﻲ اﻻﺳﺗﺧدام اﻟﻣﻧﺎﺳب ﻟﻠﻣﻧﺗﺞ‪ ،‬واﻟﺗﺧزﯾن‪ /‬اﻟﻣﻌﺎﻟﺟﺔ‪ ،‬واﻟﺣد اﻷدﻧﻰ ﻣن‬ ‫اﻟﮭدر وﻣﺎ إﻟﻰ ذﻟك؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫‪5.5.1‬‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم‪,‬‬ ‫ﻛﯾف ?‬ ‫ﯾرﺟﻰ اﻟﺗﺣدﯾد‪:‬‬ ‫اﻟﻧﺳﺑﺔ اﻟﻣﺋوﯾﺔ ﻟﻠﻣﺳﺗﺧدﻣﯾن اﻟﻧﮭﺎﺋﯾﯾن ﺣﯾث ﯾوﺟد اﺗﻔﺎق ﻣطﺑﻖ ﻣﻛﺗوب؟‬ ‫‪5.6‬‬ ‫ھل ﻟدى اﻟﻣﺳﺗﺷﻔﯾﺎت اﻟﺗﻲ ﺗﺳﺗﺧدم ﻣﻧﺗﺟﺎت اﻟدم ﻣن ﺧدﻣﺔ ﻧﻘل اﻟدم اﻟﺧﺎﺻﺔ ﺑك ﻟﺟﻧﺔ ﻧﻘل ﻓﻌﺎﻟﺔ ﻣﺗﻌددة‬ ‫اﻟﺗﺧﺻﺻﺎت?‬ ‫ﻧﻌم‬ ‫اﻟﻣﺳﺗﺷﻔﯾﺎت اﻟﻌﺎﻣﺔ‬ ‫اﻟﻣﺳﺗﺷﻔﯾﺎت اﻟﺧﺎﺻﺔ‬ ‫اﻟﻣﺳﺗﺷﻔﯾﺎت ﻏﯾر اﻟﮭﺎدﻓﺔ ﻟﻠرﺑﺢ‬ ‫اﻟﻌﯾﺎدات‬ ‫اﻟﻘوات اﻟﻣﺳﻠﺣﺔ‬ ‫ﻏﯾر ذﻟك )ﯾرﺟﻰ ﺗﺣدﯾد ذﻟك(‪:‬‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫‪5.6‬أ‬ ‫ﻣﺎ اﻟﻧﺳﺑﺔ اﻟﻣﺋوﯾﺔ ﻣن اﻹﺟﻣﺎﻟﻰ اﻟوطﻧﻰ اﻟﺗﻲ ﺗﻣﺛل ھؤﻻء اﻟﻣﺳﺗﺧدﻣﯾن‪:‬‬ ‫‪5.6.1‬‬ ‫ﻏﯾر ذﻟك )ﯾرﺟﻰ ﺗﺣدﯾد ذﻟك(‪:‬‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم أو ﺟزﺋﯾﺎ‪ ,‬ھل ﺗﺷﺎرك ﺧدﻣﺔ ﻧﻘل اﻟدم ﻓﻲ‬ ‫اﻟﻠﺟﺎن؟‬ ‫‪5.7‬‬ ‫ھل ﺗﺷﺎرك ﺧدﻣﺔ ﻧﻘل اﻟدم ﻣﻊ اﻟﺳﻠطﺎت اﻟﺻﺣﯾﺔ اﻟﻣﺧﺗﺻﺔ ﻓﻲ ﺗطوﯾر اﻟﻣﻌﺎﯾﯾر اﻟوطﻧﯾﺔ؟‬ ‫‪5.8‬‬ ‫ﺗﻘرﯾﺑﺎ ﻣﺎ ھﻲ اﻟﻧﺳﺑﺔ اﻟﻣﺋوﯾﺔ ﻹﻣدادات اﻟدم اﻟﺧﺎﺻﺔ ﺑك اﻟﺗﻲ ﺗﺄﺗﻲ ﻣن ﻣﺎﻧﺣﻲ اﻟﺗﺑرع ﺑﺎﻟدم طوﻋﺎ وﺑدون‬ ‫ﻣﻘﺎﺑل )‪(VNRBD‬؟‬ ‫اﻟﻣﺳﺗﺷﻔﯾﺎت اﻟﻌﺎﻣﺔ‬ ‫اﻟﻣﺳﺗﺷﻔﯾﺎت اﻟﺧﺎﺻﺔ‬ ‫اﻟﻣﺳﺗﺷﻔﯾﺎت ﻏﯾر اﻟﮭﺎدﻓﺔ ﻟﻠرﺑﺢ‬ ‫اﻟﻌﯾﺎدات‬ ‫اﻟﻘوات اﻟﻣﺳﻠﺣﺔ‬ ‫‪%‬‬ ‫‪%‬‬ ‫‪%‬‬ ‫‪%‬‬ ‫‪%‬‬ ‫‪%‬‬ ‫ﻧﻌم‬ ‫ﻧﻌم‬ ‫ﻻ‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫‪%‬‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :5‬اﻟﺳﻼﻣﺔ ﻣﻘﺎﺑل اﻟﺗﻛﻠﻔﺔ )ﻣﺗﺎﺑﻌﺔ(‬ ‫ﻻ ﺗﺗردد ﻓﻲ ﺗﻘدﯾم ﺗﻌﻠﯾﻘﺎت أﺧرى أو ﻣزﯾد ﻣن اﻟﻣﻌﻠوﻣﺎت ﻟﺗوﺿﯾﺢ ردودﻛم ﻋﻠﻰ ھذا اﻟﻘﺳم‪:‬‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :6‬اﻟﺗﻣوﯾل‬ ‫ﻣﻼﺣظﺔ ﺗوﺿﯾﺣﯾﺔ‪ :‬ﯾﺟب أن ﺗﻛون اﻻﺳﺗﻌدادات اﻟﻣﺎﻟﯾﺔ اﻟﻛﺎﻓﯾﺔ وطوﯾﻠﺔ اﻷﺟل ﻣطﺑﻘﺔ وﯾﺗم ﻣراﺟﻌﺗﮭﺎ ﻣن ﻗﺑل ﺟﻣﻌﯾﺔ اﻟﺻﻠﯾب اﻷﺣﻣر‪ /‬اﻟﮭﻼل اﻷﺣﻣر اﻟﻣﺣﻠﯾﺔ ﻗﺑل اﻟﺑدء أو اﻟﺑﻘﺎء ﻓﻲ أي ﺑرﻧﺎﻣﺞ‬ ‫ﻧﻘل ﻟﻠدم‪ .‬إن أﻓﺿل ﺗﺄﻣﯾن ﻟﻠﺗﻣوﯾل اﻟﻣﺳﺗدام ﻣن ﺧﻼل إﻣﺎ اﺳﺗرداد اﻟﺗﻛﺎﻟﯾف أو اﻟﺗﻣوﯾل اﻟﺣﻛوﻣﻲ‪ ،‬ﻋﻠﻰ اﻟرﻏم ﻣن أن اﺳﺗﺧدام ﺑﻌض اﻟﻣﻧﺎطﻖ ﻟﻠﺗﺑرﻋﺎت اﻟﻌﺎﻣﺔ ﻣن ﺷﺄﻧﮫ أن ﯾدﻋم‪ .‬ﯾﺟب أن ﯾﻛون‬ ‫ﺗﺣوﯾل اﻷﻣوال ﺑﯾن اﻟﺟﻣﻌﯾﺎت اﻟوطﻧﯾﺔ وﺧدﻣﺎت ﻧﻘل اﻟدم ﻓﻲ ﺳﯾﺎق اﻻﺗﻔﺎﻗﺎت اﻟﻣﻧﺎﺳﺑﺔ ﻋﻠﻰ ﻣﺳﺗوى اﻟﺧدﻣﺔ‪ .‬ﯾﻧظر إﻟﻰ اﻻﺳﺗﻌدادات اﻟﻣﺎﻟﯾﺔ اﻟﺷﻔﺎﻓﺔ واﻟﻣﺳﺗداﻣﺔ ﺿﻣن ﺧدﻣﺎت ﻧﻘل اﻟدم وﺑﯾن ﺧدﻣﺔ‬ ‫ﻧﻘل اﻟدم وﺟﻣﻌﯾﺔ اﻟﺻﻠﯾب اﻷﺣﻣر‪ /‬اﻟﮭﻼل اﻷﺣﻣر ﻛﺄوﻟوﯾﺔ‪.‬‬ ‫‪ 6.1‬ﻣﺎ ھﻲ اﻟﻧﺳﺑﺔ اﻟﻣﺋوﯾﺔ ﻹﺟﻣﺎﻟﻲ ﻣﯾزاﻧﯾﺔ ﺧدﻣﺔ ﻧﻘل اﻟدم اﻟﺧﺎﺻﺔ ﺑك اﻟﺗﻲ ﺗﺄﺗﻲ ﻣن‪:‬‬ ‫‪6.1.1‬‬ ‫اﻟﺣﻛوﻣﺔ‬ ‫‪6.1.2‬‬ ‫اﻟﻣﺳﺗﺷﻔﯾﺎت‬ ‫‪6.1.3‬‬ ‫ﺗﻛﻠﻔﺔ رﺳوم اﻻﺳﺗرداد ﻟﻠﻣﺳﺗﺧدﻣﯾن اﻟﻧﮭﺎﺋﯾﯾن‬ ‫‪6.1.4‬‬ ‫أﻧﺷطﺔ اﻟﺗﻣوﯾل اﻟداﺧﻠﯾﺔ‬ ‫‪6.1.5‬‬ ‫اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ اﻟﺧﺎﺻﺔ ﺑك‬ ‫‪6.1.6‬‬ ‫اﻟﺟﻣﻌﯾﺎت اﻟوطﻧﯾﺔ اﻷﺧرى‬ ‫‪6.1.7‬‬ ‫‪) NGOs‬اﻟﻣﻧظﻣﺎت ﻏﯾر اﻟﺣﻛوﻣﯾﺔ( واﻟﺻﻧﺎدﯾﻖ اﻟدوﻟﯾﺔ‬ ‫‪6.1.8‬‬ ‫ﻧظﺎم اﻟﺗﺄﻣﯾن اﻟﺻﺣﻲ اﻟﻌﺎم واﻟﺧﺎص‬ ‫‪6.1.9‬‬ ‫ﻏﯾر ذﻟك )ﯾرﺟﻰ ﺗﺣدﯾد ذﻟك(‪:‬‬ ‫‪:‬‬ ‫‪6.2‬‬ ‫اﻟﻣوردﯾن ﻟﯾس ﻟدﯾﮭم أي أﺳﮭم ﻋﺎدﯾﺔ أو رﻗﺎﺑﺔ‬ ‫ھل ﺗﺿﻣن ﺧدﻣﺔ ﻧﻘل اﻟدم أن اﻟﻣﻧظﻣﺎت "اﻟرﺑﺣﯾﺔ" أو‬ ‫إدارﯾﺔ ﻓﻲ ﺑرﻧﺎﻣﺞ ﻧﻘل اﻟدم؟‬ ‫ﯾرﺟﻰ إﻋطﺎء‪ ٪‬ﻟﻛل ﻣﻧﮭﺎ‪:‬‬ ‫‪%‬‬ ‫‪%‬‬ ‫‪%‬‬ ‫‪%‬‬ ‫‪%‬‬ ‫‪%‬‬ ‫‪%‬‬ ‫‪%‬‬ ‫‪%‬‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫ﻧﻌم‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫‪6.3‬‬ ‫ھل ﻟدى ﺧدﻣﺔ ﻧﻘل اﻟدم ﺳﯾﺎﺳﺔ ﻟﺿﻣﺎن ﻋدم وﺟود ﺗﺿﺎرب ﻓﻲ اﻟﻣﺻﺎﻟﺢ ﻟـ‪:‬‬ ‫‪6.4‬‬ ‫ھل ﻟدى ﺧدﻣﺔ ﻧﻘل اﻟدم ﺳﯾﺎﺳﺔ ﻟﺿﻣﺎن ﻋدم وﺟود ﺗﺿﺎرب ﻓﻲ اﻟﻣﺻﺎﻟﺢ ﻋﻧد اﻟﺗﻌﺎﻣل ﻣﻊ اﻟﻣوردﯾن‬ ‫اﻟرﺋﯾﺳﯾﯾن؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫أﻋﺿﺎء ﻣﺟﻠس اﻹدارة‬ ‫ﻛﺑﺎر اﻟﻣوظﻔﯾن‬ ‫اﻟﻣﺗطوﻋون‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :6‬اﻟﺗﻣوﯾل )ﻣﺗﺎﺑﻌﺔ(‬ ‫‪6.5‬‬ ‫ھل ھﻧﺎك اﺗﻔﺎق رﺳﻣﻲ ﻣطﺑﻖ ﻹدارة وﺻول اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ ﻟﺻﻧﺎدﯾﻖ ﺧدﻣﺔ ﻧﻘل اﻟدم؟‬ ‫‪6.6‬‬ ‫ھل ﺗم ﻓرض ﺣﺟرا ﺻﺣﯾﺎ ﻋﻠﻰ اﺳﺗﺧدام ﺻﻧﺎدﯾﻖ ﺧدﻣﺔ ﻧﻘل اﻟدم ﻣن ﻗﺑل ﺧدﻣﺎت ﻧﻘل اﻟدم؟‬ ‫‪6.7‬‬ ‫ھل ﺗﻘدم اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ اﻟدﻋم اﻟﻣﺎﻟﻲ ﻟﺧدﻣﺔ ﻧﻘل اﻟدم؟‬ ‫‪6.8‬‬ ‫ھل ﺗﺳﺎھم اﻟﺻﻧﺎدﯾﻖ ﻣن ﺧدﻣﺔ ﻧﻘل اﻟدم ﻓﻲ أﻧﺷطﺔ ﻟﻠﺻﻠﯾب اﻷﺣﻣر ﻏﯾر ﺧدﻣﺔ ﻧﻘل اﻟدم؟‬ ‫ﻧﻌم ‪ -‬ﻻ ﯾﻣﻛن ﻟﻠﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ اﻟوﺻول إﻟﻰ اﻟﺻﻧﺎدﯾﻖ‬ ‫ﻧﻌم ‪ -‬ﯾﺳﻣﺢ اﻻﺗﻔﺎق اﻟرﺳﻣﻲ ﻟﻠﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ ﺑﺎﻟوﺻول إﻟﻰ‬ ‫اﻟﺻﻧﺎدﯾﻖ ﻋﻧد اﻟﻠزوم‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻏﯾر ذﻟك ‪) :‬ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل أدﻧﺎه(‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم )ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم )ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :6‬اﻟﺗﻣوﯾل )ﻣﺗﺎﺑﻌﺔ(‬ ‫‪6.9‬‬ ‫ھل ھﻧﺎك ﻧظم ﻣﺣﺎﺳﺑﯾﺔ ﻣﻧﻔﺻﻠﺔ ﻟﻠﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ وﺧدﻣﺔ ﻧﻘل اﻟدم؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻻ ﺗﺗردد ﻓﻲ ﺗﻘدﯾم ﺗﻌﻠﯾﻘﺎت أﺧرى أو ﻣزﯾد ﻣن اﻟﻣﻌﻠوﻣﺎت ﻟﺗوﺿﯾﺢ ردودﻛم ﻋﻠﻰ ھذا اﻟﻘﺳم‪:‬‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :7‬اﻟﻣﻌرﻓﺔ ﺑﺷﺄن ﻣﺧﺎطر اﻟدم وﻋواﻗﺑﮫ‬ ‫ﻣﻼﺣظﺔ ﺗوﺿﯾﺣﯾﺔ‪ :‬ﻣن اﻟﻣﮭم أن ﺗﻘدم ﺧدﻣﺎت ﻧﻘل اﻟدم اﻟﺗﺎﺑﻌﺔ ﻟﺟﻣﻌﯾﺔ اﻟﺻﻠﯾب اﻷﺣﻣر‪ /‬اﻟﮭﻼل اﻷﺣﻣر اﻟﺗﻌﻠﯾم اﻟﻣﻧﺎﺳب ﻟﻛل ﻣن ﻋﻣوم اﻟﻧﺎس وﻏﯾرھم ﻣن اﻟﺷرﻛﺎء ﻣﺛل اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ‬ ‫واﻟﺣﻛوﻣﺔ واﻟﻛﻠﯾﺎت اﻟطﺑﯾﺔ وﻣوظﻔﻲ ﺧدﻣﺎت ﻧﻘل اﻟدم ﻣن أﺟل ﻧﻘل ﻓﮭم أﻓﺿل ﻟﻠﻣﺧﺎطر اﻟﻛﺎﻣﻧﺔ ﻓﻲ ﻧﻘل اﻟدم‪.‬‬ ‫‪7.1‬‬ ‫ھل ﯾﺟب ﻋﻠﻰ اﻟﻣرﺿﻰ ﺗﻘدﯾم ﻣواﻓﻘﺔ ﻣﺳﺑﻘﺔ ﺧطﯾﺔ ﻋن ﻋﻠم ﻗﺑل ﻧﻘل اﻟدم؟‬ ‫‪7.1.1‬‬ ‫ھل ﺗﻌﻣل ﺧدﻣﺔ ﻧﻘل اﻟدم ﻣﻊ اﻟﻣﺳﺗﺷﻔﯾﺎت ﻟﺿﻣﺎن وﺟود ﺳﯾﺎﺳﺔ أو إﺟراءات ﻣﻧﻔذة ﺗطﻠب ﻣن اﻟﻣرﺿﻰ‬ ‫ﺗﻘدﯾم ﻣواﻓﻘﺔ ﺧطﯾﺔ ﻋن ﻋﻠم ﻗﺑل اﻟﻧﻘل؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫‪ 7.2‬ھل ﻗﺎﻣت ﺧدﻣﺔ ﻧﻘل اﻟدم ﺑﺗطوﯾر وﺗﻧﻔﯾذ اﺳﺗراﺗﯾﺟﯾﺎت ﺗﮭدف إﻟﻰ ﺗﺣﺳﯾن اﻟﺗﻌﻠﯾم اﻟﻌﺎم ﻓﯾﻣﺎ ﯾﺗﻌﻠﻖ ﺑﺳﻼﻣﺔ‬ ‫إﻣدادات اﻟدم ﻣن ﻣﺧﺎطر ﻧﻘل اﻟدم؟‬ ‫ﻏﯾر ذﻟك )ﯾرﺟﻰ اﻟﺗﺣدﯾد(‪:‬‬ ‫‪7.2.1‬‬ ‫ﻧﻌم‬ ‫اﻟﺑراﻣﺞ اﻟﻣدرﺳﯾﺔ‬ ‫وﺳﺎﺋل اﻹﻋﻼم )ﺑﻣﺎ ﻓﻲ ذﻟك وﺳﺎﺋل اﻟﺗواﺻل اﻻﺟﺗﻣﺎﻋﻲ(‬ ‫اﻻطﻼع ﻋﻠﻰ ﻣوﻗﻌﻧﺎ‬ ‫اﻟﻛﺗﯾﺑﺎت ‪ /‬ﻣﻧﺷورات‬ ‫اﻟﺷﺑﻛﺎت ﻏﯾر اﻟرﺳﻣﯾﺔ‬ ‫ﺗﻌﻠﯾم اﻟﻣﺗﺑرﻋﯾن‬ ‫وﺿﻊ اﻟﻣﻣﺛﻠﯾن ﻓﻲ ھﯾﺋﺎت ﻣﻧﺎﺳﺑﺔ ﻟﺻﻧﻊ اﻟﻘرار‬ ‫‪:‬‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ھل اﻻﺳﺗراﺗﯾﺟﯾﺎت اﻟﻣذﻛورة أﻋﻼه ﺗم ﺗﻧﻔﯾذھﺎ؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :7‬اﻟﻣﻌرﻓﺔ ﺑﺷﺄن ﻣﺧﺎطر اﻟدم وﻋواﻗﺑﮫ )ﻣﺗﺎﺑﻌﺔ(‬ ‫‪7.3‬‬ ‫ھل ﺗوﻓر ﺧدﻣﺔ ﻧﻘل اﻟدم اﻟﺗﻌﻠﯾم ﺑﺷﺄن ﻣﺧﺎطر ﻧﻘل اﻟدم إﻟﻰ ﻏﯾرھﺎ ﻣن اﻟﺟﮭﺎت اﻟﻣﻌﻧﯾﺔ‪ ،‬ﺑﻣﺎ ﻓﻲ ذﻟك‪:‬‬ ‫ﻧﻌم‬ ‫اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ‬ ‫اﻟﺣﻛوﻣﺔ‬ ‫اﻟﻛﻠﯾﺎت اﻟطﺑﯾﺔ‬ ‫ﻣوظﻔﻲ ﺧدﻣﺔ ﻧﻘل اﻟدم‬ ‫ﻏﯾر ذﻟك )ﯾرﺟﻰ اﻟﺗﺣدﯾد(‪:‬‬ ‫‪7.4‬‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫‪:‬‬ ‫ھل ﺗﻘوم ﺧدﻣﺔ ﻧﻘل اﻟدم ﺑﺈﺟراء ﺣﻣﻼت ﻣﻧﺗظﻣﺔ ﻟﺗﺛﻘﯾف اﻟﺟﻣﮭور ﺑﺷﺄن اﻟﺣﺎﺟﺔ إﻟﻰ اﻟﺗﺑرع ﺑﺎﻟدم ﺑﺎﻧﺗظﺎم؟‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم )ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻻ ﺗﺗردد ﻓﻲ ﺗﻘدﯾم ﺗﻌﻠﯾﻘﺎت أﺧرى أو ﻣزﯾد ﻣن اﻟﻣﻌﻠوﻣﺎت ﻟﺗوﺿﯾﺢ ردودﻛم ﻋﻠﻰ ھذا اﻟﻘﺳم‪:‬‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :8‬اﻟﻣﮭﺎرات اﻹدارﯾﺔ‬ ‫ﻣﻼﺣظﺔ ﺗوﺿﯾﺣﯾﺔ‪ :‬ﻣن أﺟل ﺗﺣﻘﯾﻖ واﻟﻣﺣﺎﻓظﺔ ﻋﻠﻰ ﻣﺳﺗوى ﺟﯾد ﻟﻺدارة ﻓﻲ ﺧدﻣﺎت ﻧﻘل اﻟدم اﻟﺗﺎﺑﻌﺔ ﻟﻠﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ‪ ،‬ﯾﺟب أن ﯾﻛون ھﻧﺎك رؤﯾﺔ واﺿﺣﺔ ﻣﺑﯾﻧﺔ ورﺳﺎﻟﺔ وﺧطﺔ اﺳﺗراﺗﯾﺟﯾﺔ‬ ‫وأھداف اﺳﺗراﺗﯾﺟﯾﺔ ﻣﻊ وﺳﯾﻠﺔ ﻟﻘﯾﺎس اﻟﺗﻘدم اﻟﻣﺣرز ﻧﺣو ﺗﺣﻘﯾﻖ ھذه اﻷھداف‪.‬‬ ‫‪8.1‬‬ ‫ھل ﻣﺎ ﯾﻠﻲ ﻣطﺑﻖ ﻟدى ﺧدﻣﺔ ﻧﻘل اﻟدم؟‬ ‫‪8.2‬‬ ‫إذا ﻛﺎن ذﻟك ﻣطﺑﻘﺎ‪ ،‬ھل ﺗﻘوم اﻷھداف اﻻﺳﺗراﺗﯾﺟﯾﺔ ﻟﺧدﻣﺔ ﻧﻘل اﻟدم ﺑـ‪:‬‬ ‫ﻧﻌم‬ ‫رؤﯾﺔ واﺿﺣﺔ‬ ‫ﻣﮭﻣﺔ واﺿﺣﺔ‬ ‫ﺧطﺔ اﺳﺗراﺗﯾﺟﯾﺔ‬ ‫أھداف اﺳﺗراﺗﯾﺟﯾﺔ‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺗﺣدﯾد اﻟﻣﺳؤوﻟﯾﺔ اﻟواﺿﺣﺔ‬ ‫ﻣﻌﺎﻟﺟﺔ اﺣﺗﯾﺎﺟﺎت اﻟﻣﺗﺑرع‬ ‫ﻣﻌﺎﻟﺟﺔ اﺣﺗﯾﺎﺟﺎت اﻟﻣﺗﻠﻘﻲ‬ ‫ﻣﻌﺎﻟﺟﺔ اﺣﺗﯾﺎﺟﺎت اﻟطﺑﯾب‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫‪ 8.3‬ھل ﻗد ﺗم إﻧﺷﺎء وﺗﻧﻔﯾذ أھداف اﻷداء اﻟرﺋﯾﺳﯾﺔ )ﻣﺛل اﻧﺧﻔﺎض‪ ٪‬ﻓﻲ اﻟوﻗت اﻟﻣﺣﺗﺳب ﺑدل اﻟﺿﺎﺋﻊ‬ ‫ﻟﻠﻣوظﻔﯾن‪ ،‬واﻧﺧﻔﺎض ‪ ٪‬ﻓﻲ ﻓﻘد اﻟﻣﻧﺗﺞ(؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :8‬اﻟﻣﮭﺎرات اﻹدارﯾﺔ )ﻣﺗﺎﺑﻌﺔ(‬ ‫‪8.4‬‬ ‫ھل ﺑراﻣﺞ اﻟﺗدرﯾب ﻣطﺑﻘﺔ ﻟﺣﻔظ وﺗطوﯾر اﻟﻣﮭﺎرات اﻹدارﯾﺔ واﻟﻘﯾﺎدﯾﺔ؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻻ ﺗﺗردد ﻓﻲ ﺗﻘدﯾم ﺗﻌﻠﯾﻘﺎت أﺧرى أو ﻣزﯾد ﻣن اﻟﻣﻌﻠوﻣﺎت ﻟﺗوﺿﯾﺢ ردودﻛم ﻋﻠﻰ ھذا اﻟﻘﺳم‪:‬‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :9‬اﻟﺗﻘﺳﯾم‬ ‫ﻣﻼﺣظﺔ ﺗوﺿﯾﺣﯾﺔ‪:‬‬ ‫• ﻓﻲ اﻟﺑﻠدان اﻟﻣﺗﻘدﻣﺔ‪ ،‬ﻓﺈﻧﮫ ﻟﯾس ﻣن اﻟﻣرﻏوب ﻓﯾﮫ ﻟﻠﺻﻠﯾب اﻷﺣﻣر ‪ /‬اﻟﮭﻼل اﻷﺣﻣر ﺑدء أﻧﺷطﺔ ﺗﺟزﺋﺔ ﺑﺳﺑب ﺧطر اﻟﮭدر اﻟﮭﺎﺋل‪ ،‬إﻻ إذا ﻛﺎن ﻧطﺎق اﻟﻌﻣﻠﯾﺎت ﻓﻲ ذﻟك اﻟﺑﻠد ﯾﺟﻌﻠﮭﺎ ﻗﺎﺑﻠﺔ ﻟﻠﺗطﺑﯾﻖ‪.‬‬ ‫• ﻓﻲ اﻟﺑﻠدان اﻟﻧﺎﻣﯾﺔ ﯾﺟوز ﻟﻠﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ اﻟﻧظر ﻓﻲ اﻟﺗﺟزﺋﺔ إذا ﻛﺎن ھذا ھو اﻟﺳﺑﯾل اﻟوﺣﯾد ﻟﻣﺻدر اﻟﻣﻧﺗﺟﺎت اﻟﻣﺷﺗﻘﺔ ﻣن اﻟﺑﻼزﻣﺎ‪ ،‬وﻟﻛن ﻓﻘط إذا ﺗم ﺗﺄﻣﯾن اﻟدﻋم واﻟﺳﻠطﺔ اﻟﺣﻛوﻣﯾﺔ اﻟﻣﻧﺎﺳﺑﺔ‪.‬‬ ‫• إذا ﻛﺎن ﻟﯾﺗم اﻟﺗﺧﻠص ﻣن اﻟﺑﻼزﻣﺎ‪ ،‬ﯾﻧﺑﻐﻲ ﻧﺻﺢ اﻟﻣﺗﺑرﻋﯾن‪.‬‬ ‫• ﻗﺑل أن ﺗﻘوم اﻟﺟﻣﻌﯾﺎت اﻟوطﻧﯾﺔ إﻣﺎ ﺑﺎﻟﺗﺟزﺋﺔ أو اﻻﺳﺗﻌﺎﻧﺔ ﺑﻣﺻﺎدر ﺧﺎرﺟﯾﺔ ﻟﻠﻣﺟزﺋﺎت أﺧرى‪ ،‬ﯾﺟب ﻋﻠﻰ اﻟﺳﻠطﺎت اﻟﺣﻛوﻣﯾﺔ اﻟﻣﺧﺗﺻﺔ اﻟﻣواﻓﻘﺔ ﻋﻠﻰ ﺗﺻﻧﯾﻊ اﻟﻣﻧﺗﺟﺎت وﻋﻣﻠﯾﺎت اﻟﺗﺳوﯾﻖ‪.‬‬ ‫• ﻣوﻗف ﺟﻣﻌﯾﺎت اﻟﺻﻠﯾب اﻷﺣﻣر واﻟﮭﻼل اﻷﺣﻣر ‪ IFRC‬ھو أن اﻻﻛﺗﻔﺎء اﻟذاﺗﻲ اﻟوطﻧﻲ ﻣﺳﺄﻟﺔ ﺗﺧص ﺳﯾﺎﺳﺔ اﻟﺣﻛوﻣﺔ ﻓﻲ ھذا اﻟﺑﻠد‪.‬‬ ‫‪9.1‬‬ ‫ھل ﻟدى اﻟﺣﻛوﻣﺔ ﺳﯾﺎﺳﺔ اﻻﻛﺗﻔﺎء اﻟذاﺗﻲ اﻟوطﻧﻲ ﻟﻣﻧﺗﺟﺎت اﻟدم اﻟﺗﻲ ﺗﺷﻣل ﻣﻧﺗﺟﺎت اﻟﺑﻼزﻣﺎ؟‬ ‫‪9.2‬‬ ‫ھل ﺗﻘوم ﺧدﻣﺔ ﻧﻘل اﻟدم ﺑﺗﺷﻐﯾل واﺣد أو أﻛﺛر ﻣن ﻣﺣطﺔ ﺗﺟزﺋﺔ؟‬ ‫‪9.2.1‬‬ ‫ھل ﻟدى ﺧطﺔ ﺧدﻣﺔ ﻧﻘل اﻟدم‪ /‬اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ أي ﺗدﺧل ﻓﻲ ﺗﺷﻐﯾل ﻣﺣطﺎت اﻟﺗﺟزﺋﺔ ﻓﻲ اﻟﻣﺳﺗﻘﺑل اﻟﻘرﯾب؟‬ ‫‪9.3‬‬ ‫ھل ﺗرﺳل ﺧدﻣﺔ ﻧﻘل اﻟدم‪ /‬اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ اﻟﺑﻼزﻣﺎ ﻟﻠﺗﺟزﺋﺔ إﻟﻰ ﻣﺟزئ ﺧﺎرﺟﻲ؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :9‬ﻣﺗﺎﺑﻌﺔ اﻟﺗﺟزﺋﺔ‬ ‫‪9.3.1‬‬ ‫إذا ﻛﺎﻧت اﻹﺟﺎﺑﺔ ﺑﻼ‪ ,‬ھل ﺗﺧطط ﺧدﻣﺔ ﻧﻘل اﻟدم‪ /‬اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ ﻟﺑدء إرﺳﺎل اﻟﺑﻼزﻣﺎ ﻟﻠﺗﺟزﺋﺔ؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫‪ 9.4‬إذا ﻛﺎﻧت ﺧدﻣﺔ ﻧﻘل اﻟدم‪ /‬اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ ﺗﺗوﻟﻰ أﻧﺷطﺔ ﺗﺟزﺋﺔ اﻟﺑﻼزﻣﺎ‪ ،‬ھل ﺗﻘدم ﺧدﻣﺔ ﻧﻘل اﻟدم اﻟﻣﺷورة‬ ‫ﻟﻠﻣﺗﺑرﻋﯾن ﻋﻧدﻣﺎ ﯾﺗم اﻟﺗﺧﻠص ﻣن اﻟﺑﻼزﻣﺎ؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫‪ 9.5‬إذا ﻛﺎﻧت ﺧدﻣﺔ ﻧﻘل اﻟدم‪ /‬اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ ﺗﺗوﻟﻰ أﻧﺷطﺔ ﺗﺟزﺋﺔ اﻟﺑﻼزﻣﺎ‪ ،‬ھل ھﻲ ﺷﻔﺎﻓﺔ وﺧﺎﺿﻌﺔ ﻟﻠﻣﺳﺎءﻟﺔ‬ ‫ﻟﻠﻣﺗﺑرﻋﯾن؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫‪9.5.1‬‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم أو ﺟزﺋﯾﺎ‪ ,‬ﻣﺎ اﻟذي ﺗﻘوم ﺑﮫ ﺧدﻣﺔ ﻧﻘل اﻟدم ﻟﺿﻣﺎن اﻟﺷﻔﺎﻓﯾﺔ واﻟﻣﺳﺎءﻟﺔ؟‬ ‫‪9.6‬‬ ‫إذا ﻛﺎﻧت ﺧدﻣﺔ ﻧﻘل اﻟدم‪ /‬اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ ﺗﺗوﻟﻰ أﻧﺷطﺔ ﺗﺟزﺋﺔ اﻟﺑﻼزﻣﺎ أو ﺗرﺳل اﻟﺑﻼزﻣﺎ ﻟﻠﺗﺟزﺋﺔ إﻟﻰ ﻣﺻﻧﻊ‬ ‫ﺗﺟزﺋﺔ ﺧﺎرﺟﻲ‪ ،‬ھل ھﻧﺎك ﻣواﻓﻘﺔ رﺳﻣﯾﺔ ﻣن اﻟﺣﻛوﻣﺔ ﻋﻠﻰ ﻋﻣﻠﯾﺔ اﻟﺗﺻﻧﯾﻊ و‪ /‬أو اﻟﺗﺳوﯾﻖ؟‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻻ ﺗﺗردد ﻓﻲ ﺗﻘدﯾم ﺗﻌﻠﯾﻘﺎت أﺧرى أو ﻣزﯾد ﻣن اﻟﻣﻌﻠوﻣﺎت ﻟﺗوﺿﯾﺢ ردودﻛم ﻋﻠﻰ ھذا اﻟﻘﺳم‪:‬‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫اﻟﻘﺳم ب ‪ -‬ﻧظرة ﻋﺎﻣﺔ ﻋﻠﻰ أﻧﺷطﺔ ﺧدﻣﺎت ﻧﻘل اﻟدم‬ ‫ﯾرﺟﻰ ﺗﻘدﯾم ﻟﻣﺣﺔ ﻣوﺟزة ﻋن ﺧدﻣﺔ ﻧﻘل اﻟدم اﻟﺧﺎﺻﺔ ﺑك‪ ،‬ﻣﻊ أﺣدث اﻟﺑﯾﺎﻧﺎت اﻟﻣﺗﺎﺣﺔ ﻟك‪.‬‬ ‫ﺳوف ﯾﺳﺎﻋد ھذا اﻟﻘﺳم ﻓﻲ ﺗﺣدﯾد ﺻورة ﺷﺎﻣﻠﺔ ﻷﻧﺷطﺔ اﻟدم ﻓﻲ اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ اﻟﺧﺎﺻﺔ ﺑك‪،‬‬ ‫واﻟﻣﺳﺎﻋدة ﻓﻲ ﺗﻘﯾﯾم اﻟﺗﻘدم اﻟﻣﺣرز ﺑﻣرور اﻟوﻗت‪.‬‬ ‫‪0‬‬ ‫‪0‬‬ ‫اﻟدوﻟﺔ‬ ‫اﺳم اﻟﻣﻧظﻣﺔ‬ ‫ﻋﺎم ﺑدء ﺧدﻣﺔ ﻧﻘل اﻟدم‬ ‫ﻋدد ﻣوظﻔﻲ اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ‬ ‫اﻟﻣﺷﺎرﻛﯾن ﻓﻲ ﺧدﻣﺔ ﻧﻘل اﻟدم )وﻟﯾس ﻣوظﻔﻲ‬ ‫اﻟﻣﺳﺗﺷﻔﻰ(‬ ‫اﻟﻣﯾزاﻧﯾﺔ اﻟﺳﻧوﯾﺔ اﻟﺣﺎﻟﯾﺔ‬ ‫ﺗﺣدﯾد اﻟﻌﺎم اﻟذي ﺗﺷﯾر إﻟﯾﮫ ھذه اﻟﻣﯾزاﻧﯾﺔ )ﺗﺣدﯾد ﻣن ﺷﮭر‪ /‬ﺳﻧﺔ إﻟﻰ ﺷﮭر‪ /‬ﻣن‬ ‫ﺳﻧﺔ(‬ ‫]ﺗﺣدﯾد اﻟﻌﻣﻠﺔ[‬ ‫إﻟﻰ‬ ‫إذا ﻛﺎن ھﻧﺎك ﻣﻘدﻣﯾن آﺧرﯾن ﻟﺧدﻣﺎت ﻧﻘل اﻟدم ﻓﻲ ﺑﻠدك‪ ،‬رﺟﺎء ﺗﻘدﯾم ﻗﺎﺋﻣﺔ ﺑﮭم )ﻣﺛل أﻓﺿل ﺧﻣس ﻣﻘدﻣﯾن(‬ ‫‪      ‬ﻣﻊ ﺣﺻﺗﮭم اﻟﺗﻘرﯾﺑﯾﺔ ‪ ٪‬ﻟﺗﻐطﯾﺔ اﻟﺧدﻣﺎت اﻟﻌﺎﻣﺔ‪:‬‬ ‫ﺣﺻﺔ ‪%‬‬ ‫اﻻﺳم‬ ‫‪.1‬‬ ‫‪.2‬‬ ‫‪.3‬‬ ‫‪.4‬‬ ‫‪.5‬‬ ‫ﯾرﺟﻰ إرﻓﺎق‪:‬‬ ‫اﻟﮭﯾﻛل اﻹداري‬ ‫اﻟﮭﯾﻛل اﻟﺗﻧظﯾﻣﻲ‬ ‫ﺷرﻛﺎء اﻟدﻋم اﻟﺗﻘﻧﻲ )ﯾرﺟﻰ ذﻛرھم(‬ ‫ﻋدد ﻣن اﻟﻣواﻗﻊ اﻟﺛﺎﺑﺗﺔ‬ ‫ﻋدد ﻣن اﻟﻣواﻗﻊ اﻟﻣﺗﻧﻘﻠﺔ‬ ‫ﻋدد إﺟﻣﺎﻟﻲ اﻟﻣﺟﻣوﻋﺎت ﺳﻧوﯾﺎ*‬ ‫ﻋدد ﻣﺟﻣوﻋﺎت اﻟدم اﻟﻛﺎﻣﻠﺔ ﺳﻧوﯾﺎ*‬ ‫إذا ﻛﺎن ذﻟك ﻣﻣﻛﻧﺎ‪ ،‬ﻋدد ﻣﺟﻣوﻋﺎت ﻓﺻﺎدة‪:‬‬ ‫< اﻟﺑﻼزﻣﺎ )وﺣدات ﺑﻼزﻣﺎ اﻟﻔﺻﺎدة‪ /‬اﻟﺳﻧﺔ(‬‫‪ <-‬اﻟﺻﻔﺎﺋﺢ اﻟدﻣوﯾﺔ‬ ‫ﻣﻠل ﻟﻛل وﺣدة‬ ‫اﻟوﺣدات‬ ‫< ﺧﻼﯾﺎ اﻟدم اﻟﺣﻣراء )وﺣدات ﻣن اﻟﺻﻔﺎﺋﺢ اﻟدﻣوﯾﺔ ﻟﻠﻔﺻﺎدة‪ /‬اﻟﺳﻧﺔ(‬‫إذا ﻛﺎن ذﻟك ﻣﻣﻛﻧﺎ‪ ،‬ﻛﻣﯾﺔ اﻟﺑﻼزﻣﺎ ﻟﻠﺗﺟزﺋﺔ ﺳﻧوﯾﺎ* )طن(‪:‬‬ ‫* إذا ﻛﺎﻧت ﺳﻧﺔ اﻟﻣﺟﻣوﻋﺎت ﻣﺧﺗﻠﻔﺔ ﻋن ﺳﻧﺔ اﻟﻣﯾزاﻧﯾﺔ‪ ،‬ﯾرﺟﻰ ﺗﺣدﯾد اﻟﺳﻧﺔ اﻟﺗﻲ ﺗﺷﯾر إﻟﯾﮭﺎ اﻟﻣﺟﻣوﻋﺎت‬ ‫]إدراج ﺷﮭر‪ /‬ﺳﻧﺔ[‬ ‫]إدراج ﺷﮭر‪ /‬ﺳﻧﺔ[‬ ‫إﻟﻰ‬ ‫إﻟﻰ‪:‬‬ ‫اﻻﻛﺗﻔﺎء اﻟذاﺗﻲ ﻣن اﻟﺑﻼزﻣﺎ‬ ‫ھل ﻛﻣﯾﺔ اﻟﺑﻼزﻣﺎ ﻟﻠﺗﺟزﺋﺔ ﻛﺎﻓﯾﺔ ﻟﺗﻠﺑﯾﺔ ﻣﺗطﻠﺑﺎت ﺑﻠدك؟‬ ‫ﻧﻌم‬ ‫ﻻ‬ ‫إذا ﻛﺎن اﻟﺟواب ﻻ‪ ,‬ﯾرﺟﻰ ذﻛر أﻋﻠﻰ ‪ 5‬ﻣﻧﺗﺟﺎت ﻟﻠﺗﺟزﺋﺔ ﺣﺳب اﻟﻣﺻدر‪:‬‬ ‫اﻟﻣﻧﺗﺞ‬ ‫‪.1‬‬ ‫‪.2‬‬ ‫‪.3‬‬ ‫‪.4‬‬ ‫‪.5‬‬ ‫ﻣﺳﺗورد ﻣن‬ ‫اﻟدوﻟﺔ‬ ‫اﻟﺷرﻛﺔ‬ ‫اﻟﻘﺳم ب ‪ -‬ﻧظرة ﻋﺎﻣﺔ ﻋﻠﻰ أﻧﺷطﺔ ﺧدﻣﺎت ﻧﻘل اﻟدم )ﻣﺗﺎﺑﻌﺔ(‬ ‫ھل ﻟدﯾك ﻓﺎﺋض ﻣن اﻟﺑﻼزﻣﺎ أو ﻣﻧﺗﺟﺎت اﻟﺑﻼزﻣﺎ؟‬ ‫ﻧﻌم‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم ﻣﺎذا ﯾﺣدث ﻟﻠﻔﺎﺋض ﻣن اﻟﻣﻧﺗﺟﺎت؟‬ ‫اﻟﺗﺧﻠص ﻣﻧﮭﺎ‬ ‫ﺑﯾﻌﮭﺎ إﻟﻰ‬ ‫]ﺗﺣدﯾد اﻟﺑﻠد[‬ ‫]ﺗﺣدﯾد اﻟﺑﻠد[‬ ‫ﺑﯾﻌﮭﺎ إﻟﻰ‬ ‫ﻏﯾر ذﻟك ﯾرﺟﻰ ﺗﺣدﯾد ذﻟك‪:‬‬ ‫ﻻ‬ ‫ﻋﻠﻰ اﺳﺗرداد اﻟﺗﻛﺎﻟﯾف‬ ‫ﺑرﺑﺢ‬ ‫إذا ﺗم ﺑﯾﻊ ﻣﻧﺗﺟﺎت ﻣﺧﺗﻠﻔﺔ ﻟدول ﻣﺧﺗﻠﻔﺔ‪ ،‬ﯾرﺟﻰ اﻟﺗوﺿﯾﺢ أدﻧﺎه‪:‬‬ ‫ھل ﺧدﻣﺔ ﻧﻘل اﻟدم اﻟﺧﺎﺻﺔ ﺑك ﺣﺎﻟﯾﺎ ﺗﺷﺎرك ﻓﻲ أي ﻣن ﻋﻼﺟﺎت اﻟﺧﻼﯾﺎ أو اﻷﻧﺳﺟﺔ اﻟﺗﺎﻟﯾﺔ?‬ ‫ﻧﻌم‬ ‫اﻟﺧﻼﯾﺎ اﻟﺟذﻋﯾﺔ ﻟﻠﺣﺑل اﻟﺳري‬ ‫اﻟﺧﻼﯾﺎ اﻟﺟذﻋﯾﺔ اﻟدﻣوﯾﺔ اﻟﻣﺣﯾطﯾﺔ‬ ‫اﻟﺧﻼﯾﺎ اﻟﺟذﻋﯾﺔ ﻟﻧﺧﺎع اﻟﻌظﺎم‬ ‫زرع اﻷﻋﺿﺎء اﻟﺻﻠﺑﺔ‬ ‫اﻟﻌظﺎم‬ ‫اﻟﻘرﻧﯾﺔ‬ ‫ﻏﯾر ذﻟك )ﯾرﺟﻰ اﻟﺗﺣدﯾد‬ ‫ﻻ‬ ‫(‪:‬‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم‪ ,‬ﯾرﺟﻰ ﺗﻘدﯾم ﺗﻔﺎﺻﯾل ﻋن ﻣﺳﺗوى وﻧوع اﻟﻧﺷﺎط وﻧطﺎق اﻟﻣﺷﺎرﻛﺔ )ﻣﺛل ﺟﻣﻊ‪ /‬ﺣﺻﺎد اﻟﺗﺳﺟﯾل واﻟﻣﻌﺎﻟﺟﺔ واﻟﺗﺧزﯾن واﻻﺧﺗﺑﺎر(‬ ‫ھل ﺧدﻣﺔ ﻧﻘل اﻟدم اﻟﺧﺎﺻﺔ ﺑك ُﺗﺧطط ﻟﻠﻣﺷﺎرﻛﺔ ﻓﻲ أي ﻣن ﻋﻼﺟﺎت اﻟﺧﻼﯾﺎ أو اﻷﻧﺳﺟﺔ اﻟﺗﺎﻟﯾﺔ ﻓﻲ اﻟﺳﻧوات ‪ 2-1‬اﻟﻘﺎدﻣﺔ?‬ ‫ﻧﻌم‬ ‫اﻟﺧﻼﯾﺎ اﻟﺟذﻋﯾﺔ ﻟﻠﺣﺑل اﻟﺳري‬ ‫اﻟﺧﻼﯾﺎ اﻟﺟذﻋﯾﺔ اﻟدﻣوﯾﺔ اﻟﻣﺣﯾطﯾﺔ‬ ‫اﻟﺧﻼﯾﺎ اﻟﺟذﻋﯾﺔ ﻟﻧﺧﺎع اﻟﻌظﺎم‬ ‫زرع اﻷﻋﺿﺎء اﻟﺻﻠﺑﺔ‬ ‫اﻟﻌظﺎم‬ ‫اﻟﻘرﻧﯾﺔ‬ ‫ﻏﯾر ذﻟك )ﯾرﺟﻰ اﻟﺗﺣدﯾد‬ ‫ﻻ‬ ‫(‪:‬‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم‪ ,‬ﯾرﺟﻰ ﺗﻘدﯾم ﺗﻔﺎﺻﯾل ﻋن اﻟﻧﺷﺎط اﻟﻣﺧطط وﻧطﺎق اﻟﻣﺷﺎرﻛﺔ )ﻣﺛل ﺟﻣﻊ‪ /‬ﺣﺻﺎد اﻟﺗﺳﺟﯾل واﻟﻣﻌﺎﻟﺟﺔ واﻟﺗﺧزﯾن واﻻﺧﺗﺑﺎر(‬ ‫اﻟﻘﺳم ب ‪ -‬ﻧظرة ﻋﺎﻣﺔ ﻋﻠﻰ أﻧﺷطﺔ ﺧدﻣﺎت ﻧﻘل اﻟدم )ﻣﺗﺎﺑﻌﺔ(‬ ‫اﻻﺗﻔﺎﻗﯾﺎت اﻟﺛﻧﺎﺋﯾﺔ‬ ‫ھل ﺗﺷﺎرك ﻓﻲ أي ﺑراﻣﺞ دﻋم ﺛﻧﺎﺋﯾﺔ ﻟﺧدﻣﺔ ﻧﻘل اﻟدم اﻟﺧﺎﺻﺔ ﺑك؟‬ ‫ﻧﻌم‬ ‫ﻻ‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم‪ ,‬ﯾرﺟﻰ إﻋطﺎء ﺗﻔﺎﺻﯾل‪:‬‬ ‫ھل ﺗﺗﻠﻘﻲ أﻣوال ﻣن ﻣﺻﺎدر أﺧرى ﻟدﻋم اﻟﺗرﺗﯾﺑﺎت اﻟﺛﻧﺎﺋﯾﺔ؟‬ ‫ﻧﻌم‬ ‫ﻻ‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم‪ ,‬ﯾرﺟﻰ إﻋطﺎء ﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻗﺻص اﻟﻧﺟﺎح‬ ‫ھل ﺳﺗﻛون ﻋﻠﻰ اﺳﺗﻌداد ﻟﻣﺷﺎرﻛﺔ ﺑﻌض اﻟﻧﺟﺎﺣﺎت اﻟﻣﺣﻠﯾﺔ اﻟﺧﺎﺻﺔ ﺑك ﻣﻊ اﻵﺧرﯾن ﺑﺧدﻣﺔ ﻧﻘل اﻟدم ﺑﺎﻟﺻﻠﯾب اﻷﺣﻣر‪ /‬اﻟﮭﻼل اﻷﺣﻣر‬ ‫؟‬ ‫ﻧﻌم‬ ‫ﻻ‬ ‫اﻟﺧطوات اﻟﻣﻘﺑﻠﺔ‬ ‫اﻟﺧطوات اﻟﻣﻘﺑﻠﺔ اﻟﻣوﺻﻰ ﺑﮭﺎ‬ ‫ﯾﮭدف اﻟﺗﻘﯾﯾم اﻟذاﺗﻲ إﻟﻰ ﺗﻣﻛﯾن اﻟﺟﻣﻌﯾﺎت اﻟوطﻧﯾﺔ وﺧدﻣﺎت ﻧﻘل اﻟدم اﻟﺧﺎﺻﺔ ﺑﮭﺎ ﻟﺗﺣدﯾد اﻟﻣﺳﺎﺋل اﻟﺗﻲ ﺗﺗطﻠب ﻣزﯾدا ﻣن اﻻھﺗﻣﺎم‪ .‬ﻛل ﺳؤال ﻓﻲ‬ ‫اﻟﺗﻘﯾﯾم اﻟذاﺗﻲ ‪ SA‬ﯾﺻف ﺷرط واﻟذي‪ ،‬إذا ﻟم ﯾﺗم اﺳﺗﯾﻔﺎؤه‪ ،‬ﯾﻣﻛن أن ﯾﻣﺛل ﺧطرا ﻋﻠﻰ ﺧدﻣﺔ ﻧﻘل اﻟدم وﻋﻠﻰ اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ اﻟﺧﺎﺻﺔ ﺑﮭﺎ‪.‬‬ ‫اﻟﺧطﺔ ﻟﻣواﺟﮭﺔ ﻛل اﻟﺷروط اﻟﺗﻲ ﻟم ﯾﺗم اﺳﺗﯾﻔﺎؤھﺎ ‪ -‬ﺑدءا ﻣن اﻟﺗﻲ ﺗﺣت اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ - 1‬ﯾﺟب أن ﺗﻘﻠل إﻟﻰ ﺣد ﻛﺑﯾر ﻣن ﻣﺳﺗوى اﻟﻣﺧﺎطر‬ ‫ﻟﺧدﻣﺔ ﻧﻘل اﻟدم واﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ اﻟﺧﺎﺻﺔ ﺑﮭﺎ‪.‬‬ ‫ﻟﻠﻣﺳﺎﻋدة ﻓﻲ ﺧدﻣﺔ ﻧﻘل اﻟدم ﻓﻲ ﻣﻌﺎﻟﺟﺔ ﻣﺧﺎطرھﺎ اﻟﻣﺣددة‪ ،‬ﺳوف ‪ GAP‬ﺗزوﯾدھﺎ ﺗﻘﯾﯾم اﻟذاﺗﻲ ﺗﻘرﯾر ردود اﻟﻔﻌل اﻟﻔردي ﻣﻊ ﺗوﺻﯾﺎت إدارة‬ ‫اﻟﻣﺧﺎطر‪.‬‬ ‫ﻓﻲ ﻏﺿون ذﻟك‪ ،‬ﻗد اﻗﺗرح اﻟﻔرﯾﻖ اﻻﺳﺗﺷﺎري اﻟﻌﺎﻟﻣﻲ ‪" GAP‬اﻟﺧطوات اﻟﺗﺎﻟﯾﺔ" اﻟﻣﺧﺗﻠﻔﺔ اﻟﻣﻣﻛﻧﺔ ﻟﻣراﻋﺎة ﺧدﻣﺔ ﻧﻘل اﻟدم أدﻧﺎه‪:‬‬ ‫اﻟﺣﻛم واﻹدارة‬ ‫‪ ‬إﻧﺷﺎء ﻓرﯾﻖ ﻋﻣل ﺑداﺧل اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ و‪ /‬أو ﺧدﻣﺔ ﻧﻘل اﻟدم ﻟﻣراﺟﻌﺔ‬ ‫اﻟﮭﯾﻛل اﻟﺣﺎﻟﻲ ﻟﻠﺣﻛم واﻹدارة اﻟﺗﺎﺑﻊ ﻟﻠﺧدﻣﺔ‪ ،‬وإﻋداد اﻟﺧطﺔ اﻻﺳﺗراﺗﯾﺟﯾﺔ‪.‬‬ ‫‪ ‬اﻟﻧظر ﻓﻲ اﻟﺣﺻول ﻋﻠﻰ اﻟﻣﺳﺎﻋدة اﻟﻣﺗﺧﺻﺻﺔ أو اﻟﻣﺷورة ﺑﺷﺄن ﻗﺿﺎﯾﺎ اﻟﺣﻛم واﻹدارة ﻣن‬ ‫اﻟﺟﻣﻌﯾﺎت اﻟوطﻧﯾﺔ اﻷﺧرى‪ /‬ﺧدﻣﺎت ﻧﻘل اﻟدم‪ ،‬أو ﻣن ﺧﻼل إﺷراك ﻣﺳﺗﺷﺎر ﺧﺎرﺟﻲ ﻣﺗﺧﺻص‪.‬‬ ‫‪ ‬ﯾﻣﻛن ﻟﻔرﯾﻖ اﻟﻌﻣل أو اﻟﻣﺳﺗﺷﺎر اﻟﻧظر ﻓﻲ ﻣﺎ ﯾﻠﻲ‪:‬‬ ‫○ ﯾوﻓر اﻟﮭﯾﻛل اﻟﺣﺎﻟﻲ اﻟرﻗﺎﺑﺔ اﻟﻛﺎﻓﯾﺔ‪ ،‬ووﺿوح اﻟﻣﺳؤوﻟﯾﺔ‬ ‫○ ﯾﺟب ﻓﺻل إدارة ﺧدﻣﺎت ﻧﻘل اﻟدم وإدارة اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ‬ ‫○ ﯾﻧﺑﻐﻲ إﻧﺷﺎء ﺧدﻣﺔ ﻧﻘل اﻟدم ﻛﻛﯾﺎن ﻗﺎﻧوﻧﻲ ﻣﺳﺗﻘل ﻋن اﻟﺟﻣﻌﯾﺔ‬ ‫○اﻟوطﻧﯾﺔ‬ ‫○ اﻟﺑﻧﯾﺔ اﻟﺗﻲ ﺗﻧطوي ﻋﻠﻰ ﻣﺟﻠس اﻹدارة اﻹﺷراﻓﻲ )ﻣﻊ ﻣﮭﺎم اﻟرﻗﺎﺑﺔ اﻻﺳﺗراﺗﯾﺟﯾﺔ(‬ ‫○واﻟرﺋﯾس اﻟﺗﻧﻔﯾذي‬ ‫○) اﻟﻣﺳؤول ﻋن اﻹدارة اﻟﯾوﻣﯾﺔ‪ ،‬وﺗﻘدﯾم اﻟﺗﻘﺎرﯾر إﻟﻰ ﻣﺟﻠس اﻹدارة(‬ ‫○ﻓرﯾﻖ اﻹدارة اﻟﻌﻠﯾﺎ‬ ‫○)ﺗﻘدﯾم اﻟﺗﻘﺎرﯾر إﻟﻰ اﻟرﺋﯾس اﻟﺗﻧﻔﯾذي( ﺳوف ﺗﻛون ﻗﺎﺑﻠﺔ ﻟﻠﺗطﺑﯾﻖ‬ ‫اﻟﻘﺿﺎﯾﺎ اﻟﻘﺎﻧوﻧﯾﺔ وإدارة اﻟﻣﺧﺎطر‬ ‫‪ ‬ﺗﺣدﯾد اﻷﺳﺎس اﻟﺗﺷرﯾﻌﻲ واﻟﺗﻧظﯾﻣﻲ ﻟﻌﻣﻠﯾﺎت ﺧدﻣﺔ ﻧﻘل اﻟدم‪ .‬ﺗﻘﯾﯾم ﻣﺎ إذا اﻟﻘواﻧﯾن واﻟﻠواﺋﺢ اﻟﺣﻛوﻣﯾﺔ اﻟﺣﺎﻟﯾﺔ‪:‬‬ ‫○ ﺗﻧص ﺑدﻗﺔ ﻋﻠﻰ اﻟﻌﻼﻗﺔ ﺑﯾن ﺧدﻣﺔ ﻧﻘل اﻟدم واﻟﺳﻠطﺎت اﻟﺣﻛوﻣﯾﺔ‬ ‫○اﻟﺗﻧظﯾم اﻟﻛﺎف ﻷﻧﺷطﺔ اﻟﺧدﻣﺔ‬ ‫○ ﺗﻘدﯾم ﺧدﻣﺔ ﻧﻘل اﻟدم ﻣﻊ أي ﺣﻣﺎﯾﺔ أو ﺗﻌوﯾض ﻋن اﻟﻣطﺎﻟﺑﺎت اﻟﻘﺎﻧوﻧﯾﺔ‬ ‫‪ ‬اﻟﻧظر ﻓﻲ ﻣﺎ إذا ﻛﺎﻧت اﻟﺗﻐﯾﯾرات اﻟﺗﺷرﯾﻌﯾﺔ ﻻزﻣﺔ‪ ،‬وأﻓﺿل اﻟﺳﺑل ﻟﺗﺣﻘﯾﻖ ﻣﺛل ھذه اﻟﺗﻐﯾﯾرات‪.‬‬ ‫‪ ‬اﻟﻧظر ﻓﻲ اﻟدﻋوة ﻣﻊ اﻟﺣﻛوﻣﺔ‪ ،‬واﻟﺳﻠطﺎت اﻟﺻﺣﯾﺔ اﻟﻌﺎﻣﺔ اﻟﻣﻧﺎﺳﺑﺔ‪ ،‬ﻟﻠﺣﺻول ﻋﻠﻰ اﻟدﻋم ﻟﮭذه اﻟﻣﻘﺗرﺣﺎت‪.‬‬ ‫‪ ‬إﻧﺷﺎء ﻓرﯾﻖ ﻹدارة اﻟﻣﺧﺎطر ﺑداﺧل ﺧدﻣﺔ ﻧﻘل اﻟدم‪ ،‬ﻹﺟراء ﺗﻘﯾﯾم ﻷﻧﺷطﺔ اﻟﺧدﻣﺔ وإﻋداد ﺳﯾﺎﺳﺎت ﻟﺗﺣدﯾد وﺗﻘﻠﯾل واﻟﻘﺿﺎء ﻋﻠﻰ اﻟﻣﺧﺎطر‪.‬‬ ‫اﻟﺗﻣوﯾل واﻟﺗﺄﻣﯾن‬ ‫‪ ‬ﻣراﺟﻌﺔ ﻣﺻﺎدر اﻟﺗﻣوﯾل وﻣﺻﺎدر اﻟدﺧل اﻟﻣﺣﺗﻣﻠﺔ‪ .‬ﺗﻘﯾﯾم ﻣﺎ إذا ﻛﺎﻧت اﺗﻔﺎﻗﯾﺎت اﻟﺧدﻣﺔ اﻟﺣﺎﻟﯾﺔ )إن وﺟدت( ﻣﻊ اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ واﻟﮭﯾﺋﺎت‬ ‫اﻟﻌﺎﻣﺔ ﻛﺎﻓﯾﺔ‪ ،‬أو ﺗﺗطﻠب ﺗﻐﯾﯾرات‪.‬‬ ‫‪ ‬طﻠب اﻟﻣﺷورة ﺣول ﺗواﻓر وﺗﻛﻠﻔﺔ اﻟﺗﺄﻣﯾن اﻟﺷﺎﻣل ﻟﻠﺧدﻣﺔ وﻣوظﻔﯾﮭﺎ‪.‬‬ ‫اﻟﺳﯾﺎﺳﺎت واﻟﻣﻌﺎﯾﯾر‬ ‫‪ ‬إﺟراء ﻣراﺟﻌﺔ ﺗﺷﻐﯾﻠﯾﺔ ﻟﺗﻘﯾﯾم ﻣدى اﻻﻣﺗﺛﺎل ﻟﻣﻌﺎﯾﯾر ﺗﻘدﯾم ﺑرﻧﺎﻣﺞ ﻧﻘل اﻟدم اﻟدوﻟﻲ‪ .‬ﺗﺣدﯾد اﻟﺧطوات ﻟﺗﺣﺳﯾن اﻻﻣﺗﺛﺎل‪.‬‬ ‫‪‬ﻣراﺟﻌﺔ اﻟﺳﯾﺎﺳﺎت اﻟﺗﺷﻐﯾﻠﯾﺔ ) ﻋﻠﻰ ﺳﺑﯾل اﻟﻣﺛﺎل‪ ،‬اﻟﺳﯾﺎﺳﺎت ﻟﺗوظﯾف وﺗدرﯾب اﻟﻣوظﻔﯾن‪ ،‬ﺣﻔظ اﻟوﺛﺎﺋﻖ وﻣواﻓﻘﺔ اﻟﻣرﯾض اﻟﻣﺳﺗﻧﯾرة‪ ،‬واﻟﺗﺛﻘﯾف‬ ‫اﻟﻌﺎم‪ ،‬واﻟﻌﻼﻗﺎت اﻹﻋﻼﻣﯾﺔ‪ ،‬وھﻠم ﺟرا(‪.‬‬ ‫‪ ‬اﻟﻣراﺟﻌﺔ ﺑﻣﻧﮭﺟﯾﺔ وﺗﺣدﯾد أوﻟوﯾﺎت اﻟﻘﺿﺎﯾﺎ اﻟرﺋﯾﺳﯾﺔ واﻟﻧﻘﺎط اﻟرﺋﯾﺳﯾﺔ ﻣن اﻟﺗﻘﯾﯾم اﻟذاﺗﻲ‪ ،‬ودﻣﺟﮭﺎ ﻓﻲ ﻣواد اﻟﺳﯾﺎﺳﺎت واﻟﺗﺧطﯾط‪.‬‬ ‫‪ ‬ﺗﻛرار اﻟﺗﻘﯾﯾم اﻟذاﺗﻲ ﺑﺷﻛل دوري ﻣن أﺟل اﺳﺗﻌراض اﻟﺗﻘدم اﻟﻣﺣرز‪.‬‬ ‫اﻟﺗﻌﻠﯾﻘﺎت اﻟﻧﮭﺎﺋﯾﺔ‬ ‫اﻟﺗﻌﻠﯾﻘﺎت اﻟﻧﮭﺎﺋﯾﺔ‪:‬‬ ‫ﯾرﺣب اﻟﻔرﯾﻖ اﻻﺳﺗﺷﺎري اﻟﻌﺎﻟﻣﻲ ﺑﺎﻟﺗﻌﻠﯾﻘﺎت واﻟﻣﻼﺣظﺎت ﺧﻼل ﻋﻣﻠﯾﺔ اﻻﻧﺗﮭﺎء ﻣن ھذا‬ ‫اﻟﺗﻘﯾﯾم اﻟذاﺗﻲ‪ .‬ﻧﺣن ﻣﮭﺗﻣون ﺑﻣن ﺷﺎرك واﻻﻗﺗراﺣﺎت ﻹﺟراء اﻟﺗﻐﯾﯾرات‪ ،‬أو ﻏﯾرھﺎ ﻣن‬ ‫اﻟﺗﻌﻠﯾﻘﺎت اﻷﺧرى‪.‬‬ ‫ﺷﻛرا ﻟﻛم‬ ‫ﺷﻛرا ﺟزﯾﻼ ﻋﻠﻰ ﻣﺷﺎرﻛﺗﻛم ﻓﻲ اﻟﺗﻘﯾﯾم اﻟذاﺗﻲ‪ .‬إذا ﻛﺎن ﻟدﯾك أي ﻣﻌﻠوﻣﺎت أو ﻣﻼﺣظﺎت أﺧرى ﺗرﻏب ﻓﻲ ﺗﻘدﯾﻣﮭﺎ‪ ،‬ﯾرﺟﻰ إرﺳﺎﻟﮭﺎ ﻋن طرﯾﻖ اﻟﺑرﯾد‬ ‫اﻹﻟﻛﺗروﻧﻲ إﻟﻰ‪:‬‬ ‫‪GAPSelfAssessment@redcrossblood.org.au‬‬ ‫ﯾرﺟﻰ ﺗوﻗﻊ اﻟﺣﺻول ﻋﻠﻰ ﺗﻘرﯾر اﻟﺗﻌﻠﯾﻘﺎت اﻟﻔردﯾﺔ اﻟﺧﺎﺻﺔ ﺑك ﻋﻧد اﻻﻧﺗﮭﺎء ﻣن ﻋﻣﻠﯾﺔ اﻟﺗﻘﯾﯾم اﻟذاﺗﻲ داﺧل ﻣﻧطﻘﺗك‪.‬‬
Introduction to the Global Advisory Panel (Presentation)
Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Introduction to the Global Advisory Panel 20th September 2014 Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Presentation Overview  Background to GAP • Establishment • Vision/mission • Structure/Membership  Global Mapping  Core Activities  GAP Tools & Resources • GAP Manual • Self-Assessment • Knowledge sharing • Priority country Assistance  Contacts Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Who is GAP GAP is an association which provides advice to National Red Cross and Red Crescent Societies, and their affiliated blood services, in matters concerning corporate governance and risk management in the field of national society blood programmes, as well as the IFRC Secretariat and other relevant IFRC bodies. Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies GAP Establishment Nov 2000 - International Federation of Red Cross/Red Crescent (IFRC) ceased technical support to National Society Blood Services (NSBS) and focussed on promotion of VNRBD. May 2001 - GAP was formed from experts from national societies with strong blood programmes. 2011 - IFRC Blood Policy approved by General Assembly July 2012 - GAP established as separate legal entity to IFRC (Association under Swiss civil code) Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies IFRC Blood Policy  November 2011 - IFRC blood policy “Promoting Safe and Sustainable Blood Systems” approved by the General Assembly.  The policy outlines the responsibilities of IFRC, GAP, national societies and blood services in managing the risks associated with operating a blood program  GAP’s primary purpose is to provide advice, tools resources and support to NSBS to assist in managing these risks. Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies GAP Vision and Mission Vision: All Red Cross/Red Crescent blood programmes will be safe, well governed and self sustainable based on the principle of voluntary non remunerated blood donation for the benefit of patients and to safeguard blood donors. Mission: GAP will support Red Cross/Red Crescent blood services in risk management, corporate governance of blood programmes and promote good practices and knowledge exchange. Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies GAP mandate Consider and promote blood programme corporate governance and risk management issues Recommend and promote appropriate risk management structures and processes at a regional level Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies GAP Structure & Membership Formal structure - Election of President and Executive Board GAP Members - Experts drawn widely from the RC/RC global membership, with relevant expertise in blood Current membership – 12 NSBS IFRC permanent observer - links to the IFRC Secretary General and connected to the Federation’s Health and Social Care programs. Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies GAP Member Zones      Asia & Pacific Africa Europe & Central Asia Middle East & Northern Africa Americas – Latin America & The Caribbean  Zone Coordinators provide regional coordination of activities Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies GAP member blood services        America (US) Australia Austria Belgium (President) Finland Germany Honduras  Hong Kong (China)  Israel (MDA)  Japan  Switzerland  Thailand Observers: IFRC Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies National Society involvement in blood programmes LEVEL A. Full Blood Service Provision  Governance  Advocacy for appropriate use  Product distribution  Laboratory testing  Component preparation Donor recruitment  Collection services/donor care  Donor recruitment Promotional campaigns Education and awareness  Promotional campaigns Involvement in WBDD  Education and awareness  Involvement in WBDD LEVEL B. Systematic Blood Donor Recruitment C. Advocacy for VNRBD Promotional campaigns Education and awareness Involvement in WBDD Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Global mapping  New global mapping process conducted 2013/14  71 countries responded. 85% of these NS reported having some involvement in the blood program: 26 Level A - full blood service (37%) 19 level B - recruitment of donors(27%) 15 level C - donor motivation, advocacy (21%) 11 nil - no involvement (15%)  GAP Self Assessment distributed to all Level A NS Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Core GAP Activities  Provide technical advice on corporate governance and risk management  Promote knowledge sharing, networking and partnership among Red Cross and Red Crescent blood services  Develop Blood Service tools, resources and guidelines  Provide priority country support to NS most in need  Focus on level A blood programmes  Support IFRC VNRBD programme Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies GAP Tools & Resources GAP Manual Self-Assessment questionnaire Knowledge Sharing/Networking Priority Country Assistance Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies GAP Manual GAP manual: Development of Safe and Sustainable National Blood Programmes  Provides guidance for national societies (NS) on managing blood program related risks.  Available on IFRC website: https://fednet.ifrc.org/en/resources/heal th-and-care/blood/materials-and-tools Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Self-Assessment Questionnaire  Distributed to NSBS to enable them to identify their corporate governance and risk management issues  Focusses on the fundamental aspects NS should consider when undertaking blood programme activities  GAP collates results and prepares individual feedback reports which are provided to NSBS with advice and suggested strategies to improve risk management and corporate governance Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Self-Assessment Questionnaire Types of risks that may be identified in SA  Lack of government protection for blood borne disease transmission and/or appropriate insurance  Inability to meet regulatory or national standards  Lack of funding and resources – affecting BS ability to manage risks and implement donor and product safety systems/processes  Lack of systems to identify/analyse, evaluate, prioritise and manage risks Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Self-Assessment Questionnaire Types of risks that may be identified in SA  Ineffective government and lack of clear separation of blood service and national society regarding corporate management of blood service activities  Lack of systems to monitor emerging threats to blood supply  Lack of practical support to recipients of infected blood Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Self-Assessment Questionnaire Major Material Risk (MMR) Defined as: “A circumstance in which an individual NS or Blood Service knowingly endangers a high number of donors and/or recipients or acts in contravention to the principles of the Federation, thereby exposing the IFRC or sister NS to potential reputational damage” Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Self-Assessment Questionnaire Major Material Risk (MMR)  GAP has developed a process to identify, manage and monitor and if applicable report MMR in conjunction with the IFRC  GAP support is provided to NSBS most in need, to assist in risk monitoring and strategies for risk mitigation Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Knowledge sharing/networking Regional meetings  Results (de-identified) of the SA are discussed at GAP regional meetings. • Sharing of ideas and strategies to address regional issues • Opportunities for buddying/twinning  Where major material risks are identified, GAP liaises with IFRC  SA Results assist the identification of GAP priority countries requiring further specific support Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Priority Country Assistance  1-2 priority NS identified each year for specific technical assistance  Support provided by GAP in 2012/14 ranged from high level support through to dedicated technical assistance  Current GAP priority NS are: Nepal Haiti Vietnam Honduras Bangladesh Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Priority Country Assistance Examples of some types of support GAP may offer:  Advocacy with governments and Ministries of Health  Provision of best practice examples of key governance documentation – Memorandum of Understanding, Blood Policies, strategic plans  Assistance in the development of appropriate risk management systems and frameworks  Assistance in strategic planning  Provision of training and workshops  Advice on national coordination of the blood program  Coordination of partnering assistance with other NSBS Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Priority Country Assistance High level support - Example:  Assisted NSBS with Government and National Public Health Laboratory regarding appropriate funding for blood donation screening.  Government commitment achieved to fund ELISA testing equipment for screening blood donations for TTI.  Director confirmed all blood donations collected in region now screened for TTI on ELISA. Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Priority Country Assistance Technical support – Example:  Dedicated technical support visit to assist NSBS to develop an operationalised strategic plan. • Key activities prioritised • Deliverables planned over 3 year period • Budgetary requirements for key strategic activities identified  The strategic plan is being used to assist and leverage NSBS applications for external funding to support its future program Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies GAP support to NS blood programmes Video – IFRC Blood policy and GAP Describes the role of GAP in supporting NSBS and the tools and resources available for assistance. Refer: link on IFRC website https://fednet.ifrc.org/en/resources/health-and-care/blood/ Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Conclusion In coordination with partners, GAP will continue to provide support to national society blood services at a global, regional and country level. GAP will continue to : • Provide a networking forum for the sharing of risk management/corporate governance challenges and solutions with NSBS • Provide tools, resources and priority country assistance to those NSBS most in need • Provide advocacy and support to IFRC and NSBS on issues affecting blood programmes • Coordinate disaster response support for blood services • Influence global blood policy in conjunction with its partners Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies How to contact GAP Email gapsecretariat@redcrossblood.org.au Website  Currently in development and will be completed early 2015 Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies GAP Providing advice and support to NSBS on governance and risk management of blood programmes at a global, regional and country level. Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Any Questions
Blood Donor Counselling (Presentation)
Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Blood Donor Counselling A presentation for the Nepal Red Cross Society Blood Transfusion Service Dr Che Kit Lin On behalf of GAP and Hong Kong Red Cross 26th August 2014 Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Purpose and Outcomes of Workshop 1. Clarify the importance of blood donor counselling 2. Discuss when and how to perform counselling 3. Identify opportunities for improvements in your own centres Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies What is blood donor counselling? Counselling is the confidential dialogue between a blood donor and counsellor about issues related to donor health and the donation process1 An important part of donor management and care 1. WHO – Blood Donor Counselling Implementation Guidelines, WHO/IFRC 2013 Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Why counsel donors  Assists donors to give informed consent  Reduces donation by unsuitable donors (decrease wastage)  Promotes healthy lifestyles  May reduce adverse donor reactions  Can improve donor perception of blood service (encourage return) Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Why counsel donors  The blood transfusion service has a responsibility to confirm positive or reactive test results and notify and counsel infected individuals  Counselling donors positive for transfusion transmissible infection (TTI) offers an early entry point to treatment and care  Health impacts extend beyond donors to their families and the general population Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Establishing a National system  Management and counselling of donors is an essential part of the donation process  National health authorities and BTS are responsible for ensuring that policies, guidelines and infrastructure are in place to ensure a reliable counselling system  There should be SOPs and documentation for all stages of donor counselling  Manual or electronic records should exist which ensure confidentiality and traceability (donor records, donor deferral registry)  Provide specific training on communication and counselling for all staff involved in counselling at any stage Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Where to perform counselling     Visual and audible privacy Maintain confidentiality Use room dividers/screens or utilise offices Ensure donor can feel welcome and comfortable answering questions honestly  Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Counselling Skills Counsellors should be trained professionals with an in-depth knowledge of: • • • • • • • Health requirements for safe blood donors Infections that are transfusion transmissible Lifestyle behaviours that increase the risk of TTI Donor selection/deferral Process of donation and potential reactions Blood components and testing performed Availability of donor care services including other health-care providers Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Counselling Skills Careful listening – enables the donor to share Attentive listening - Eye contact, tone of voice, using language “Yes”, “I see” Reflective listening – paraphrasing Using open ended questions Give helpful feedback Maintain focus on the topic of counselling (try to prevent distracted conversation) Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies WHO Blood Donor Counselling – Implementation Guidelines Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies When to perform donor counselling Pre-donation information Pre-donation counselling (questionnaire, interview, health and risk assessment, informed consent) Counselling during blood donation Non-reactive Self-deferral Reactive/Indeterminate (confirmatory testing on same and/or new sample) Blood screening for TTI Post-donation self-deferral Negative Positive/Indeterminate Deferral or self-deferral Retain as regular donor and reinforce healthy lifestyle Post-donation counselling (notification, counselling and/or referral) Healthcare providers for continuing care and management Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Pre-donation information  Information given to donors to allow them to make an informed decision before donation  Can be given by trained blood service staff or volunteers  May be given verbally or in written form using authorised blood service materials Wall posters Booklet Information sheet Verbal information Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Pre-donation information To increase donor awareness of: • Blood Transfusion Service responsibility to maintain confidentiality and health of the donor • The steps in the donation process • Importance of the safety of donated blood • Importance of VNRBD • The purpose of screening for transfusion transmissible infections (TTI) To ensure donor’s trust in the blood service To encourage self-deferral (due to health, TTI, behaviour or travel) Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Pre-donation information should include: The importance of VNRBD Donor’s rights and responsibilities and options to withdraw at any time Blood donation process, availability of trained staff Potential complications (fainting, bruising) Tests performed on donated blood for TTI (limitations/window period) Procedure in the event of a positive test result Donor confidentiality Importance of regular donations Donation intervals High risk behaviour and how to avoid infection risk Importance of maintaining a healthy lifestyle How to self-defer Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Pre - donation counselling  A confidential discussion conducted by a trained medical doctor or a nurse/lab staff  Occurs before every donation as a routine step in the selection of the donor  Donor must answer questionnaire with accurate and consistent information AIMS: • Give information to the donor • Provide advice and answer any questions or concerns • Refer donor for further treatment if required Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Pre-donation counselling DONOR DEFERRAL: When donors don’t meet the criteria for selection Temporary: Permanent: • Donor usually healthy but unsuitable on a particular occasion eg medication/travel/recovering from illness • Can donate once circumstances for deferral no longer exist • Important to provide information on further management if appropriate • Behaviour – high risk for TTI • Serious medical illness Can be self-deferral if donor has been exposed to a TTI Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Pre-donation counselling DONOR DEFERAL Donor may have negative feelings of rejection: • • • • Counsellor must be sensitive to these feeling Provide clear explanation Maintain confidentiality Refer for further treatment if required Important to counsel appropriately to encourage temporarily deferred donors to return • Give information on the reason for deferral and how to have a healthy lifestyle • Provide a date that they are eligible to return (if temporary) Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Counselling during donation  Provide information on the venepuncture procedure  Show appreciation to donor for the valuable contribution; gain donor trust to encourage return  Makes donor feel comfortable; reduce worry  Minimise possibility of a reaction  Give advice regarding post-donation care • Ensure donor understands importance of informing blood service (post-donation) if blood may not be safe for transfusion • Donor to advise if they have an infection or reaction post donation Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Post-donation counselling Which donors need counselling  Donors who request self-exclusion post-donation due to possible risk of TTI  Donors who are found to have positive or reactive tests for TTI or who have unusual blood cell serology results  Donors who have experienced adverse reactions during or after blood donation Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Post-donation counselling All donors who require post donation counselling require: Prompt counselling Assurance of CONFIDENTIALITY Face to face counselling is best, if not possible then phone counselling is the next best option A trained professional who can provide counselling with empathy Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Post-donation counselling All donors who require post donation counselling require: Sufficient time to permit donor questions Accurate and consistent information Referral for appropriate clinical management Post-donation availability of results and the notification of abnormal results should be explained to the donor Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Post-donation counselling The AIMS of post-donation counselling:  To obtain a fresh sample for additional confirmation if required  To explain: • test results • the need for confirmation of the results • the health implications for the donor • eligibility for blood donation in the future • The donor’s rights regarding disclosure  To encourage donors to disclose sensitive information, including the possible source of the infection Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Post-donation counselling The AIMS of post-donation counselling:  To clarify doubts and concerns raised by donors  To alleviate donors’ worry and provide psychological support  To advise donors on precautions for preventing the transmission of TTIs to others (safe behaviour)  To refer donors for further investigations, management, treatment and care, if necessary Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Post-donation counselling Identification of positive TTI in donor Invite the donor to attend a counselling session by letter or phone Inform them that they are being contacted because one of the mandatory screening tests is abnormal and they need to return to discuss the result and implications with the doctor Verify the identify of the donor and inform that the counselling is confidential Inform the donor of the type of abnormal results they have simply and clearly (eg HCV, HBV, HIV, Syphilis) Give the donor time to consider the information and ensure they understand the result Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Post-donation counselling Identification of positive TTI in donor Discuss each test performed and the consequence of a positive result. Provide in a manner that is sensitive and appropriate to gender, culture, behaviour, language and geographical location of the donor Discuss the natural history of the disease if appropriate and health consequences, identify the possible source of infection and risk factors Check if the donor has any symptoms of the disease Encourage donor to ask further questions Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Post-donation counselling Identification of positive TTI in donor Provide donor details of: • Confirmatory testing available (other centres) • Options for further investigation, treatments and medical management Discuss precautions to prevent transmission: • Sharing implements, safe sex, hepatitis B vaccination Inform the donor that they can no longer donate blood Check if the donor’s partner is a blood donor or has donated in the past. • Advise donor to let their partner know so they can be tested and made aware of precautions Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Post-donation counselling Identification of positive TTI in donor Assess the donor’s reaction: • If negative – offer comfort and support until the donor is calm • Discuss how to manage or understand strong emotions and reactions including ways to deal with loss and grief, depression, anger and anxiety Assess all support available to the person, and ensure (where possible) referral to a support agency which can be accessed at the donor’s discretion. Recognise the impact that the test result may have on the donor Ensure the donor is provide with relevant information on the test result and future care/treatment Discuss possible disclosure of the result, including when and how this may happen and to whom Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Post-donation counselling Identification of positive TTI in donor Give donor printed material to cover all aspects of the disease (precautions, treatment, referral and contact details of hospital health departments) Ensure the donor is aware they can come back at any time with queries or clarification Arrange a specific date and time for a follow-up visit or referral Add the donor to a permanent donor deferral registry which is kept confidential All notes are to be kept locked - Positive results should be coded to keep the result confidential Notify the Health department so burden of disease is known Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Donation Referral of donors with positive TTI Positive TTI identified (laboratory) How long for tests to be completed? Laboratory staff notify medical officers How long to notify medical officers/staff who will contact donor? Donor notified How long after donation is donor notified of positive TTI testing. Donor recalled Who recalls donor? Will donor come in to centre or counselling performed over the phone? Donor counselling Referral to specialist medical care (when required) Who performs the counselling? Who can provide specialist treatment? How is the donor referred? Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Post-donation counselling BENEFITS      The abnormal results are provided to the donor in a safe and confidential environment. The donor is referred for management of TTI The donor understands the routes of transmission of TTI and can minimise further transmission Future donations from donors with confirmed TTI can be reduced with less risk to BTS staff and less wastage Can maintain donor/public confidence in blood centre, a deferred donor could still be an ambassador Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Post-donation counselling BENEFITS The BTS can collect demographic and risk exposure information about TTI positive donors as part of its haemovigilance program. This information can help in making future decisions about donor selection criteria and the usefulness of questions in the donor questionnaire. It can also help in informing marketing decisions about specific recruitment activities. Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Challenges  Ensuring consistent messages to donors  Developing clear procedures to ensure consistency  Ensuring there are adequate physical facilities for confidential counselling  Ensuring there are specialist trained staff  Providing practical counselling training to staff  Difficulty contacting donors for counselling  Negotiating referral with healthcare providers Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Where to from here? SUGGESTIONS?  Develop a national policy on blood donor counselling  Develop national procedures for the management of donor counselling: • Testing procedures • Donor contact procedures • Timelines for contact • Staff training requirements • Referral practices Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Establishing a National system  Management and counselling of donors is an essential part of the     donation process National health authorities and BTS are responsible for ensuring that policies, guidelines and infrastructure are in place to ensure a reliable counselling system There should be SOPs and documentation for all stages of donor counselling Manual or electronic records should exist which ensure confidentiality and traceability (donor records, donor deferral registry) Provide specific training on communication and counselling for all staff involved in counselling at any stage Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Resources AABB - Blood Donor Health and Safety http://marketplace.aabb.org/EbusPPROD/Marketplace/AllProducts/ProductDetail.aspx?ProductId= 1330 WHO Blood Donor Counselling Implementation Guidelines www.who.int/bloodsafety/voluntary_donation/Blooddonorcounselling.pdf Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Group Activity - Handbook Blood donor counselling role play In small groups, act out the scenarios provided and then discuss together Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Questions Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Acknowledgements  Hong Kong Red Cross  Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies  AABB  WHO/IFRC – • Pre-donation Counselling and Donor Selection (Donor 5.2) • Post-donation Counselling (DP 5.6) • Post-donation Counselling (Donor 5.7) • Blood Donor Selection – Guidelines on Assessing Donor Suitability for Blood Donation • Blood Donor Counselling – Implementation Guidelines
Blood Donation Process (Presentation)
Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Blood Donation Process A presentation for the Nepal Red Cross Society National Blood Transfusion Service Ms Emily Tonks On behalf of GAP and Hong Kong Red Cross 26th August 2014 Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Purpose and Outcomes of Workshop  Clarify the steps in the blood donation process  Clarify the importance of standard operating procedures  Identify opportunities for improvements in your own centres Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Steps in donation process 1. 2. 3. 4. Reception/Registration (pre-donation information) Donor medical questionnaire completed Donor interview Health assessment (including Haemoglobin check and donor’s informed consent) 5. Donation 6. Post donation care and counselling (including treatment of adverse reactions) Reception/ Registration Donor questionnaire completed Donor interview Health assessment Donation Post donation care Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Reception/ Registration Donor questionnaire completed Donor interview Health assessment Donation Post donation care Donor Reception 1. Greet and welcome the donor 2. Check donor history Donor may have donated too recently or may have been told never to donate blood 3. Make sure that the donor has had food and fluids in the last 4 hours 4. Pre-donation information Explain the blood donation process 5. Give the donor a Blood Donor Form and Health Questionnaire to complete 6. Direct the donor to the waiting area to be seen by interviewing staff for the confidential interview. Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Reception/ Registration Donor questionnaire completed Donor interview Health assessment Donation Donor questionnaire  Easy for donor to complete  No confusing questions  Gathers all relevant information on donor health and background  Relevant to the local population (local language)  Answers are discussed in donor interview Post donation care Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Example of donor questionnaire (WHO) Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Example of donor questionnaire (WHO) Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Reception/ Registration Donor questionnaire completed Donor interview Health assessment Donation Donor Interview  Make sure donor is comfortable – privacy  Start by identifying the donor  Complete the Health Questionnaire with the donor if not already completed.  Check that the donor understands the question and explain they must answer honestly  Compare donor questionnaire/information with historical records Post donation care Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Reception/ Registration Donor questionnaire completed Donor interview Health assessment Donation Donor Interview  Donor to read the declaration statement (or staff read the declaration statement to donor) and sign and date  Fingerprint is acceptable if donor cannot sign If a donor cannot donate blood temporarily or permanently, explain the reason to the donor Post donation care Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Reception/ Registration Donor questionnaire completed Donor interview Health assessment Donation Post donation care Donor Interview DONOR SELECTION GUIDELINES  National criteria for blood donor selection should be based on: • • • • • National/local epidemiological data on infectious diseases Nutritional and health status of the general population Local customs Health and safety outcomes – donors and recipients International best practice Should be reviewed regularly REF: WHO/IFRC Pre-donation counselling and donor selection Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Reception/ Registration Donor questionnaire completed Donor interview Health assessment Donation Post donation care Group Activity 1 - Handbook  Use of the Blood Donor Selection Guidelines Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Reception/ Registration Donor questionnaire completed Donor interview Health assessment Donation Post donation care Why do we have Donor Selection Guidelines  To make sure that it is safe for the donor to donate blood  To reduce the risk of transfusion-transmissible infection (TTI) or other adverse effects to blood recipients  To protect blood service staff  To build trust in the safety of the blood service Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Reception/ Registration Donor questionnaire completed Donor interview Health assessment Donation Donor Health Screen Appearance • Donor must look well and not under the influence of drugs/alcohol Age • 18 – 60 years Weight • Min: 45kg (for 350ml collection) or >60kg (for 450ml collection) Blood Pressure (Nepal SOP) • Systolic: 110-160 mmHg • Diastolic: 70-96 mmHg Haemoglobin (Nepal SOP) • 12.0 g/dl (minimum) WHO Recommendations BP Systolic: 100-140 mmHg BP Diastolic: 60-90 mmHg Male Hb: 13.0 g/dl Female Hb: 12.0 g/dl Post donation care Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Reception/ Registration Donor questionnaire completed Donor interview Health assessment Donation Whole Blood Collection  Importance of PPE (personal protective equipment) and hygiene: • Always wear gloves • Iodine and alcohol swab to venepuncture site • Hand washing after procedure • Appropriate disposal of needles and equipment Post donation care Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Reception/ Registration Donor questionnaire completed Donor interview Health assessment Donation Whole Blood Collection Adverse reactions  Vasovagal episodes (fainting) and bruises/ haematomas at the venepuncture site are the most common  Staff should provide first aid and reassurance to donors  Serious reactions may require further medical treatment or referral Post donation care Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Reception/ Registration Donor questionnaire completed Donor interview Health assessment Donation Post donation care Post donation donor care Donor to remain in chair for at least 5 minutes Donor to remain in refreshment area for at least 10 minutes • • Encourage donor to drink fluids Instruct donor to drink adequate fluid during the day following donation, and avoid strenuous exercise or lifting anything heavy for 4 hours. Instruct the donor to report any adverse reaction that may occur after leaving the centre • • • Provide the donor with a phone number for reporting adverse reactions Attend to donor adverse reactions if required Report all donor adverse events Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Reception/ Registration Donor questionnaire completed Donor interview Health assessment Donation Post donation donor care Post-donation information  Tell donor if they feel dizzy, lightheaded, sweating, nausea, yawning or feel hot, they should lie down with their feet elevated and drink plenty of water  Any bruising to the needle site will resolve  Ask donor to call if they become unwell in the 7 days following donation  Remind donor they will be contacted if their screening tests are abnormal  Give a leaflet of post donation instructions to the donor  Thank the donor – encourage them to come back in 12 weeks time to donate again. Post donation care Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Resources WHO Blood Donor Selection Guidelines on Assessing Donor Suitability for Blood Donation www.who.int/bloodsafety/publications/bts_guideline_donor_suitability/en/ Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Where to from here  Update Standard Operating Procedures  Staff training Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Questions Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Acknowledgements  Hong Kong Red Cross  Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies  AABB  WHO/IFRC – • Pre-donation Counselling and Donor Selection (Donor 5.2) • Post-donation Counselling (DP 5.6) • Post-donation Counselling (Donor 5.7) • Blood Donor Selection – Guidelines on Assessing Donor Suitability for Blood Donation • Blood Donor Counselling – Implementation Guidelines

Pages